 AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 27,
2017     

Exhibit 2.1

  

  


    


 

  


 

  


 

  


   

  


 

  


 

  


 

  


 

  

AGREEMENT AND PLAN OF MERGER

  


 

  

By and Among

  


 

  

THE SPECTRANETICS CORPORATION,

  


 

  

PHILIPS HOLDING USA INC.

  


 

  

and

  


 

  

HEALTHTECH MERGER SUB, INC.

  


 

  

Dated as of June 27, 2017

  


 

  


 

  


 

  


 

  


   

  


 

  


 

  


 

    

  

 

  

  

TABLE OF CONTENTS

  


 

  

Page

  


 

      |  

ARTICLE I

  

  

The Transactions

  |   
---|---|--- 
     |  |   
    

SECTION 1.01.

  |  

The Offer

  |  

2

   
    

SECTION 1.02.

  |  

Company Actions

  |  

5

   
    

SECTION 1.03.

  |  

The Merger

  |  

6

   
    

SECTION 1.04.

  |  

Closing

  |  

6

   
    

SECTION 1.05.

  |  

Effective Time

  |  

6

   
    

SECTION 1.06.

  |  

Merger Without Meeting of Stockholders

  |  

6

   
    

SECTION 1.07.

  |  

Effects of the Merger

  |  

7

   
    

SECTION 1.08.

  |  

Certificate of Incorporation and By-laws of the Surviving Corporation

  |  

7

   
    

SECTION 1.09.

  |  

Directors and Officers of the Surviving Corporation

  |  

7

   
     |  |   
     |  

ARTICLE II

  

  

Effect of the Merger on the Capital Stock;

  

Exchange of Certificates

  |   
     |  |   
    

SECTION 2.01.

  |  

Effect on Capital Stock

  |  

7

   
    

SECTION 2.02.

  |  

Exchange of Shares

  |  

9

   
    

SECTION 2.03.

  |  

Company Equity Awards; Company ESPP

  |  

11

   
    

SECTION 2.04.

  |  

Adjustments

  |  

14

   
     |  |   
     |  

ARTICLE III

  

  

Representations and Warranties of the Company

  |   
     |  |   
    

SECTION 3.01.

  |  

Organization and Standing; Subsidiaries

  |  

14

   
    

SECTION 3.02.

  |  

Capital Stock

  |  

16

   
    

SECTION 3.03.

  |  

Authority; Noncontravention

  |  

17

   
    

SECTION 3.04.

  |  

Company SEC Documents; Undisclosed Liabilities

  |  

19

   
    

SECTION 3.05.

  |  

Absence of Certain Changes

  |  

21

   
    

SECTION 3.06.

  |  

Litigation

  |  

22

   
    

SECTION 3.07.

  |  

Compliance with Laws; Permits

  |  

22

   
    

SECTION 3.08.

  |  

Regulatory Matters

  |  

23

   
    

SECTION 3.09.

  |  

Tax Matters

  |  

26

   
    

SECTION 3.10.

  |  

Employee Benefits

  |  

28

   
    

SECTION 3.11.

  |  

Labor Matters

  |  

30

   
    

SECTION 3.12.

  |  

Environmental Matters

  |  

30

   
    

SECTION 3.13.

  |  

Intellectual Property

  |  

31

   
    

SECTION 3.14.

  |  

Rights Agreement; Anti-Takeover Provisions

  |  

34

   
   


 

  


 

    

  


 

  


 

     

SECTION 3.15.

  |  

Personal Property

  |  

34

   
---|---|--- 
    

SECTION 3.16.

  |  

Real Property

  |  

34

   
    

SECTION 3.17.

  |  

Material Contracts

  |  

35

   
    

SECTION 3.18.

  |  

Insurance

  |  

37

   
    

SECTION 3.19.

  |  

Affiliate Transactions

  |  

37

   
    

SECTION 3.20.

  |  

Merger Approval

  |  

38

   
    

SECTION 3.21.

  |  

Opinion of Financial Advisors

  |  

38

   
    

SECTION 3.22.

  |  

Brokers and Other Advisors

  |  

38

   
    

SECTION 3.23.

  |  

Information Supplied; Offer Documents

  |  

38

   
     |  |   
     |  

ARTICLE IV

  

  

Representations and Warranties of Parent and Merger Sub

  |   
     |  |   
    

SECTION 4.01.

  |  

Organization and Standing

  |  

39

   
    

SECTION 4.02.

  |  

Authority; Noncontravention

  |  

39

   
    

SECTION 4.03.

  |  

Litigation

  |  

40

   
    

SECTION 4.04.

  |  

Ownership and Operations of Merger Sub

  |  

41

   
    

SECTION 4.05.

  |  

Information Supplied; Offer Documents

  |  

41

   
    

SECTION 4.06.

  |  

No Ownership of Company Common Stock

  |  

41

   
    

SECTION 4.07.

  |  

Financing

  |  

42

   
    

SECTION 4.08.

  |  

Certain Arrangements

  |  

42

   
    

SECTION 4.09.

  |  

Brokers and Other Advisors

  |  

42

   
    

SECTION 4.10.

  |  

Guarantee

  |  

42

   
     |  |   
     |  

ARTICLE V

  

  

Covenants and Agreements

  |   
     |  |   
    

SECTION 5.01.

  |  

Conduct of Business

  |  

42

   
    

SECTION 5.02.

  |  

No Solicitation; Change in Recommendation

  |  

47

   
    

SECTION 5.03.

  |  

Reasonable Best Efforts; Approvals

  |  

51

   
    

SECTION 5.04.

  |  

Public Announcements

  |  

53

   
    

SECTION 5.05.

  |  

Access to Information; Confidentiality

  |  

53

   
    

SECTION 5.06.

  |  

Indemnification and Insurance

  |  

54

   
    

SECTION 5.07.

  |  

Rule 16b-3

  |  

56

   
    

SECTION 5.08.

  |  

Employee Matters

  |  

56

   
    

SECTION 5.09.

  |  

Notification of Certain Matters; Stockholder Litigation

  |  

59

   
    

SECTION 5.10.

  |  

Parent Vote

  |  

60

   
    

SECTION 5.11.

  |  

Tax Matters

  |  

60

   
    

SECTION 5.12.

  |  

Rule 14d-10 Matters

  |  

61

   
    

SECTION 5.13.

  |  

Key Product Matters

  |  

61

   
    

SECTION 5.14.

  |  

Stock Exchange Delisting

  |  

62

   
    

SECTION 5.15.

  |  

Convertible Notes

  |  

62

   
   


 

  


 

  

 

ii  

  


 

  


 

      |  

ARTICLE VI

  

  

Conditions Precedent

  |   
---|---|--- 
     |  |   
    

SECTION 6.01.

  |  

Conditions to Each Party's Obligation to Effect the Merger

  |  

63

   
     |  |   
     |  

ARTICLE VII

  

  

Termination

  |   
     |  |   
    

SECTION 7.01.

  |  

Termination

  |  

63

   
    

SECTION 7.02.

  |  

Effect of Termination

  |  

65

   
    

SECTION 7.03.

  |  

Termination Fees

  |  

66

   
     |  |   
     |  

ARTICLE VIII

  

  

Miscellaneous

  |   
     |  |   
    

SECTION 8.01.

  |  

No Survival of Representations and Warranties

  |  

67

   
    

SECTION 8.02.

  |  

Amendment or Supplement

  |  

67

   
    

SECTION 8.03.

  |  

Extension of Time, Waiver, Etc

  |  

67

   
    

SECTION 8.04.

  |  

Assignment

  |  

67

   
    

SECTION 8.05.

  |  

Counterparts

  |  

68

   
    

SECTION 8.06.

  |  

Entire Agreement; Third-Party Beneficiaries; No Other Representations or
Warranties

  |  

68

   
    

SECTION 8.07.

  |  

Governing Law; Jurisdiction

  |  

69

   
    

SECTION 8.08.

  |  

Specific Enforcement

  |  

70

   
    

SECTION 8.09.

  |  

WAIVER OF JURY TRIAL

  |  

70

   
    

SECTION 8.10.

  |  

Notices

  |  

70

   
    

SECTION 8.11.

  |  

Severability

  |  

71

   
    

SECTION 8.12.

  |  

Fees and Expenses

  |  

72

   
    

SECTION 8.13.

  |  

Definitions

  |  

72

   
    

SECTION 8.14.

  |  

Interpretation

  |  

78

   
   


 

  

  

    

Annex I

  |  

Conditions to the Offer

   
---|--- 
    

Exhibit A

  |  

Form of Guarantee

   
    

Exhibit B

  |  

Certificate of Incorporation of Surviving Corporation

   
    

Exhibit C

  |  

By-laws of Surviving Corporation

   
  

   
 

  


 

  

 

iii  

  

  

 

  

AGREEMENT AND PLAN OF MERGER

  


 

  

AGREEMENT AND PLAN OF MERGER (this " _Agreement_ ") dated as of June 27, 2017,
among THE SPECTRANETICS CORPORATION, a Delaware corporation (the " _Company_
"), PHILIPS HOLDING USA INC., a Delaware corporation (" _Parent_ "), and
HEALTHTECH MERGER SUB, INC., a Delaware corporation and a wholly owned
subsidiary of Parent (" _Merger Sub_ ").

  


 

  

WHEREAS, upon the terms and subject to the conditions set forth in this
Agreement, Merger Sub has agreed to commence a cash tender offer to acquire
any and all of the outstanding shares of the common stock, par value $0.001
per share, of the Company (" _Company Common Stock_ ") for $38.50 per share
(such amount, or any other amount per share paid in such offer in accordance
with this Agreement, the " _Offer Price_ "), net to the seller in cash,
without interest (such offer, as may be extended and amended from time to time
as permitted under, or required by, this Agreement, the " _Offer_ ");

  


 

  

WHEREAS, following the consummation of the Offer, upon the terms and subject
to the conditions set forth in this Agreement and in accordance with Section
251(h) of the General Corporation Law of the State of Delaware (the " _DGCL_
"), Merger Sub will be merged with and into the Company (the " _Merger_ "),
with the Company surviving the Merger, and pursuant to the Merger each share
of Company Common Stock that is not validly tendered and irrevocably accepted
for payment pursuant to the Offer (except as otherwise provided herein) will
be converted into the right to receive the Offer Price, net to the seller in
cash, without interest;

  


 

  

WHEREAS, Parent, Merger Sub and the Company acknowledge and agree that the
Merger shall be effected under Section 251(h) of the DGCL and, subject to the
terms of this Agreement, effected as soon as practicable following the
consummation of the Offer;

  


 

  

WHEREAS, the Board of Directors of the Company has (i) duly authorized and
approved the execution, delivery and performance by the Company of this
Agreement and the consummation by the Company of the Transactions, and (ii)
declared this Agreement advisable and (iii) recommended that the Company's
stockholders tender their shares of Company Common Stock in the Offer;

  


 

  

WHEREAS, the Board of Directors of each of Parent and Merger Sub has duly
authorized and approved the execution, delivery and performance by each of
Parent and Merger Sub of this Agreement and the consummation by Parent and
Merger Sub of the Transactions, and the Board of Directors of Merger Sub has
declared this Agreement advisable;

  


 

  

WHEREAS, Parent, in its capacity as sole stockholder of Merger Sub, will adopt
this Agreement by written consent immediately following its execution;

 

  

  

  

 

1  

  

  

 

  

WHEREAS, Koninklijke Philips N.V., a corporation organized under the laws of
The Netherlands and the parent company of Parent (the " _Guarantor_ ") is
executing and delivering a guarantee in the form attached hereto as _Exhibit
A_ (the " _Guarantee_ ") simultaneously with the execution and delivery of
this Agreement; and

  


 

  

WHEREAS, the Company, Parent and Merger Sub desire to make certain
representations, warranties, covenants and agreements in connection with this
Agreement.

  


 

  

NOW, THEREFORE, in consideration of the foregoing and the representations,
warranties, covenants and agreements contained in this Agreement, and
intending to be legally bound hereby, the parties hereto agree as follows:

  


 

  

ARTICLE I

  


 

  

 _The Transactions_

  


 

  

SECTION 1.01. _The Offer._

  


 

  

(a) As promptly as practicable after the date of this Agreement but in no
event more than ten Business Days after the date of this Agreement, Merger Sub
shall (and Parent shall cause Merger Sub to) commence (within the meaning of
Rule 14d-2 under the Exchange Act) the Offer.

  


 

  

(b) In accordance with the terms and conditions of this Agreement, and subject
only to the satisfaction or waiver (to the extent such waiver is permitted by
applicable Law) of the conditions set forth in Annex I (collectively, the "
_Offer Conditions_ "), Merger Sub shall (and Parent shall cause Merger Sub
to), at or as promptly as practicable following the Expiration Time,
irrevocably accept for payment (the time of acceptance for payment, the "
_Offer Acceptance Time_ ") and, at or as promptly as practicable following the
Offer Acceptance Time (but in any event within three Business Days (calculated
as set forth in Rule 14d-1(g)(3) under the Exchange Act) thereafter) pay for
all shares of Company Common Stock validly tendered and not properly withdrawn
pursuant to the Offer. Parent shall provide or cause to be provided to Merger
Sub, at the Offer Acceptance Time and on a timely basis at all times
thereafter, the funds necessary to purchase any shares of Company Common Stock
that Merger Sub becomes obligated to purchase pursuant to the Offer.

  


 

  

(c) The Offer shall be made by means of an offer to purchase (the " _Offer to
Purchase_ ") in accordance with the terms set forth in this Agreement and
subject only to the Minimum Condition and the other Offer Conditions. Merger
Sub expressly reserves the right to (i) increase the Offer Price, (ii) waive
any Offer Condition other than the Minimum Condition and (iii) make any other
changes to the terms and conditions of the Offer not inconsistent with the
terms of this Agreement; _provided_ , _however_ , that unless otherwise
expressly provided by this Agreement, without the prior written consent of the
Company, Merger Sub shall not, and Parent shall cause Merger Sub not to, (A)
decrease the Offer Price, (B) change the form of consideration payable in the
Offer,

  


 

  


 

  


 

  

 

2  

 

  

  

  

 

(C) decrease the maximum number of shares of Company Common Stock sought to be
purchased in the Offer, (D) impose any conditions to the Offer other than the
Offer Conditions, (E) amend, modify or supplement any of the Offer Conditions
in a manner that makes such Offer Condition more difficult to satisfy, (F)
amend, modify or waive the Minimum Condition, (G) except as otherwise required
or expressly permitted by Section 1.01(e), extend or otherwise change the
Expiration Time, (H) provide for any "subsequent offering period" within the
meaning of Rule 14d-11 under the Exchange Act or (I) otherwise amend, modify
or supplement any of the other material terms of the Offer in a manner that
makes the Offer Conditions more difficult to satisfy, except for actions
described in any of clauses (A) through (I) that are (1) expressly required by
this Agreement, (2) required by Law or (3) taken in response to written
comments or questions received from the SEC. The Offer may not be terminated
prior to its scheduled Expiration Time, unless this Agreement is terminated in
accordance with Article VII.

  


 

  

(d) The Offer shall expire at midnight (New York City time) (i.e., one minute
after 11:59 p.m., New York City time) on the date that is 20 Business Days
(calculated in accordance with Rule 14d-1(g)(3) under the Exchange Act)
following the commencement (within the meaning of Rule 14d-2 under the
Exchange Act) of the Offer (such initial expiration date and time of the
Offer, the " _Initial Expiration Time_ ") or, if the Offer has been extended
pursuant to and in accordance with Section 1.01(e), the date and time to which
the Offer has been so extended (the Initial Expiration Time, or such later
expiration date and time to which the Offer has been so extended, the "
_Expiration Time_ ").

  


 

  

(e) Merger Sub shall, and Parent shall cause Merger Sub to, extend the Offer
from time to time as follows:

  


 

  

(i) If, at the then-scheduled Expiration Time, any of the Offer Conditions has
not been satisfied or waived by Parent and Merger Sub (to the extent such
waiver is permitted under this Agreement and applicable Law), then Merger Sub
shall, and Parent shall cause Merger Sub to, extend the Offer on one or more
occasions in consecutive increments of up to 10 Business Days each (each such
increment to end at 5:00 p.m., New York City time, on the last Business Day of
such increment) in order to permit the satisfaction of such Offer
Condition(s); and

  


 

  

(ii) Merger Sub shall extend the Offer for the minimum period required by
applicable Law, interpretation or position of the SEC or its staff or The
NASDAQ Stock Market LLC (" _NASDAQ_ ") or its staff;

  


 

  

 _provided_ , _however_ , that, in each case, in no event shall Merger Sub be
required to extend the Offer beyond the earliest to occur of (x) the
termination of this Agreement pursuant to Article VII and (y) the End Date.

  


 

  

(f) The Offer Price shall be adjusted appropriately and proportionately to
reflect the effect of any stock split, reverse stock split, stock dividend
(including any dividend or other distribution of securities convertible into
Company Common Stock),

 

  

  

  

 

3  

  

  

 

  

reorganization, recapitalization, reclassification, combination, exchange of
shares or other like change with respect to Company Common Stock occurring on
or after the date hereof and at or prior to the Offer Acceptance Time, and
such adjustment to the Offer Price shall provide to the holders of shares of
Company Common Stock the same economic effect as contemplated by this
Agreement prior to such action; _provided_ that nothing in this Section
1.01(f) shall be construed to permit the Company to take any action with
respect to its securities that is prohibited by this Agreement.

  


 

  

(g) In the event that this Agreement is terminated in accordance with Article
VII, Merger Sub shall (and Parent shall cause Merger Sub to) as promptly as
practicable (and in any event within 24 hours of such termination) irrevocably
and unconditionally terminate the Offer, shall not acquire any shares of
Company Common Stock pursuant to the Offer and shall cause any depository
acting on behalf of Parent or Merger Sub to return, in accordance with
applicable Law, all tendered shares of Company Common Stock to the registered
holders thereof.

  


 

  

(h) As promptly as practicable on the date of commencement of the Offer
(within the meaning of Rule 14d-2 under the Exchange Act), Parent and Merger
Sub shall (i) file with the SEC a Tender Offer Statement on Schedule TO with
respect to the Offer (together with all exhibits, amendments and supplements
thereto, the " _Schedule TO_") that will contain or incorporate by reference
the Offer to Purchase and form of the related letter of transmittal (the
Schedule TO, together with all documents included therein pursuant to which
the Offer will be made, the " _Offer Documents_ ") and (ii) cause the Offer
Documents to be disseminated to holders of shares of Company Common Stock.
Each of Parent, Merger Sub and the Company shall promptly correct any
information provided by it for use in the Offer Documents if and to the extent
that such information shall have become false or misleading in any material
respect, and Parent shall use all reasonable efforts to promptly cause the
Offer Documents as so corrected to be filed with the SEC and to promptly be
disseminated to holders of shares of Company Common Stock, in each case as and
to the extent required by applicable Law. The Company shall promptly furnish
or otherwise make available to Parent, Merger Sub or Parent's legal counsel
any information concerning the Company and the Company's Subsidiaries that is
required by the Exchange Act to be set forth in the Offer Documents. The
Company and its counsel shall be given reasonable opportunity to review and
comment on the Offer Documents prior to the filing thereof with the SEC.
Parent and Merger Sub agree to provide the Company and its counsel with any
comments (including a summary of any oral comments) that Parent, Merger Sub or
their counsel may receive from the SEC or its staff with respect to the Offer
Documents promptly after receipt of such comments. Each of Parent and Merger
Sub shall give the Company and its counsel a reasonable opportunity to
participate in the response to any comments of the SEC or its staff with
respect to the Offer Documents and shall respond promptly to any such
comments.

  


 

  

(i) Parent, Merger Sub and the Paying Agent with respect to the Offer shall be
entitled to deduct and withhold from the Offer Price payable pursuant to the
Offer such amounts as are required to be deducted and withheld with respect to
the making of such payment under the Internal Revenue Code of 1986, as amended
(the

 

  

  

  

 

4  

  

  

 

  

" _Code_ "), the U.S. Treasury Regulations promulgated thereunder, or any
provision of state, local or non-U.S. Tax Law. To the extent amounts are so
withheld and paid over to the appropriate Taxing Authority, the withheld
amounts shall be treated for all purposes of this Agreement as having been
paid to the person in respect of which such deduction and withholding was
made.

  


 

  

SECTION 1.02. _Company Actions._

  


 

  

(a) As promptly as practicable on the day that the Offer is commenced, the
Company shall, concurrently with or following the filing of the Schedule TO,
file with the SEC and disseminate to holders of shares of Company Common Stock
a Tender Offer Solicitation/Recommendation Statement on Schedule 14D-9
(together with any exhibits, amendments or supplements thereto, the "
_Schedule 14D-9_ ") that, subject to Section 5.02, shall contain the Company
Board Recommendation. Each of Parent, Merger Sub and the Company shall
promptly correct any information provided by it for use in the Schedule 14D-9
if and to the extent that such information shall have become false or
misleading in any material respect, and the Company shall use all reasonable
efforts to cause the Schedule 14D-9 as so corrected to promptly be filed with
the SEC and to promptly be disseminated to holders of shares of Company Common
Stock, in each case as and to the extent required by applicable Law. Parent
and Merger Sub shall promptly furnish or otherwise make available to the
Company or its legal counsel any information concerning Parent, Merger Sub or
any Parent Related Parties that is required by the Exchange Act to be set
forth in the Schedule 14D-9. Unless the Board of Directors of the Company has
made an Adverse Recommendation Change, Parent and its counsel shall be given
reasonable opportunity to review and comment on the Schedule 14D-9 and any
amendment thereto prior to the filing thereof with the SEC. Unless the Board
of Directors of the Company has made an Adverse Recommendation Change, the
Company shall provide Parent and its counsel with any comments (including a
summary of any oral comments) the Company or its counsel may receive from the
SEC or its staff with respect to the Schedule 14D-9 promptly after receipt of
such comments. The Company shall give Parent and its counsel a reasonable
opportunity to participate in the response to any comments of the SEC or its
staff with respect to the Schedule 14D-9, except if the Board of Directors of
the Company has made an Adverse Recommendation Change or in connection
therewith, and the Company shall respond promptly to any such comments.

  


 

  

(b) In connection with the Offer, the Company shall (or shall cause its
transfer agent to) promptly furnish Parent with a list of its stockholders,
mailing labels and any available listing or computer file containing the names
and addresses of all record holders of shares of Company Common Stock and
lists of securities positions of shares of Company Common Stock held in stock
depositories as of the most recent practicable date, to the extent known by
the Company after making timely inquiries to the Company's transfer agent for
such lists (including lists of non-objecting beneficial owners), and shall
provide to Parent such additional information (including updated lists of
stockholders, mailing labels and lists of securities positions) as Parent may
reasonably request in connection with the Offer. Parent and Merger Sub and
their Representatives shall hold in confidence pursuant to the Confidentiality
Agreement the information

 

  

  

  

 

5  

  

  

  

 

contained in any such labels, listings and files, shall use such information
only in connection with the Transactions and, if this Agreement shall be
terminated, shall, upon request, deliver, and shall use their reasonable
efforts to cause their Representatives to deliver, to the Company or destroy
(at the Company's election) all copies and any extracts or summaries from such
information then in their possession or control.

  


 

  

(c) Subject to Section 5.02, the Company consents to the inclusion in the
Offer Documents of a description of the Company Board Recommendation.

  


 

  

SECTION 1.03. _The Merger._ Upon the terms and subject to the conditions set
forth in this Agreement, and in accordance with the provisions of the DGCL
(including Section 251(h) of the DGCL), at the Effective Time, Merger Sub
shall be merged with and into the Company, the separate corporate existence of
Merger Sub shall thereupon cease, and the Company shall be the surviving
corporation in the Merger. The Company, as the surviving corporation after the
Merger, is hereinafter referred to as the " _Surviving Corporation_ ".

  


 

  

SECTION 1.04. _Closing._ The closing of the Merger (the " _Closing_ ") shall
take place at 10:00 a.m. (New York City time) on a date to be specified by
Parent and the Company (the " _Closing Date_ "), which date shall be as soon
as practicable following the Offer Acceptance Time, subject to the
satisfaction or waiver (to the extent such waiver is permitted by applicable
Law) of the conditions set forth in Article VI (other than those conditions
that by their terms are to be satisfied at the Closing, but subject to the
satisfaction or waiver of those conditions at such time) (but in no event
later than the second Business Day following such satisfaction or waiver of
such conditions), at the offices of Cravath, Swaine and Moore LLP, 825 Eighth
Avenue, New York, New York 10019, unless another date, time or place is agreed
to in writing by Parent and the Company.

  


 

  

SECTION 1.05. _Effective Time._ Subject to the provisions of this Agreement,
as soon as practicable on the Closing Date, the parties hereto shall cause the
Merger to be consummated by filing a certificate of merger executed in
accordance with, and in such form as is required by, the relevant provisions
of the DGCL (the " _Certificate of Merger_ "), and shall make all other
filings, recordings or publications required under the DGCL in connection with
the Merger. The Merger shall become effective at the time that the Certificate
of Merger is filed with the Secretary of State of the State of Delaware (the "
_Secretary of State_ ") or, to the extent permitted by applicable Law, at such
later time as is agreed to by the parties hereto prior to the filing of such
Certificate of Merger and specified in the Certificate of Merger (the time at
which the Merger becomes effective is herein referred to as the " _Effective
Time_ ").

  


 

  

SECTION 1.06. _Merger Without Meeting of Stockholders._ The Merger shall be
effected under Section 251(h) of the DGCL, without a vote of the stockholders
of the Company. The parties agree to take all necessary and appropriate action
to cause the Merger to become effective as soon as practicable following the
consummation (within the meaning of Section 251(h) of the DGCL) of the Offer,
without

  

  

  

  

 

6  

  

  

  

a vote of the stockholders of the Company in accordance with Section 251(h) of
the DGCL.

  

  

 

SECTION 1.07. _Effects of the Merger._ The Merger shall have the effects
provided in this Agreement and as set forth in the applicable provisions,
including Section 259, of the DGCL. Without limiting the generality of the
foregoing and subject thereto, at the Effective Time, all the properties,
rights, privileges, powers and franchises of the Company and Merger Sub shall
vest in the Surviving Corporation and all debts, liabilities and duties of the
Company and Merger Sub shall become the debts, liabilities and duties of the
Surviving Corporation.

  


 

  

SECTION 1.08. _Certificate of Incorporation and By-laws of the Surviving
Corporation._ At the Effective Time, the certificate of incorporation of the
Surviving Corporation shall be amended and restated in its entirety to be in
the form attached hereto as _Exhibit B_ until thereafter amended as provided
therein or by applicable Law (subject to Section 5.06). The parties hereto
shall take all requisite action so that, at the Effective Time, the by-laws of
the Surviving Corporation shall be amended and restated in their entirety to
be in the form attached hereto as _Exhibit C_ until thereafter amended as
provided therein or by applicable Law (subject to Section 5.06).

  


 

  

SECTION 1.09. _Directors and Officers of the Surviving Corporation._

  


 

  

(a) The directors of Merger Sub immediately prior to the Effective Time shall
be the directors of the Surviving Corporation immediately following the
Effective Time, until their respective successors are duly elected or
appointed and qualified or their earlier death, resignation or removal in
accordance with the charter and by-laws of the Surviving Corporation.

  


 

  

(b) The officers of Merger Sub immediately prior to the Effective Time shall
be the officers of the Surviving Corporation until their respective successors
are duly appointed and qualified or their earlier death, resignation or
removal in accordance with the charter and by-laws of the Surviving
Corporation.

  


 

  

ARTICLE II

  


 

  

 _Effect of the Merger on the Capital Stock;_

  

 _Exchange of Certificates_

  


 

  

SECTION 2.01. _Effect on Capital Stock._ At the Effective Time, by virtue of
the Merger and without any action on the part of the Company, Parent, Merger
Sub or the holder of any shares of Company Common Stock or any shares of
capital stock of Parent or Merger Sub:

  


 

  

(a) _Capital Stock of Merger Sub._ Each issued and outstanding share of
capital stock of Merger Sub shall be converted into and become one validly
issued, fully paid and nonassessable share of common stock, par value $0.001,
of the Surviving Corporation. 
 

 

  

  

 

7  

 

  

  

  

 

(b) _Cancelation of Treasury Stock and Parent-Owned Stock; Treatment of Stock
Owned by Company Subsidiaries._ Each share of Company Common Stock that is
owned by the Company as treasury stock immediately prior to the Effective Time
shall be canceled and shall cease to exist and no consideration shall be
delivered in exchange therefor. Each share of Company Common Stock then held
by Parent or Merger Sub that was accepted for payment by Merger Sub in the
Offer shall be canceled and shall cease to exist and no consideration shall be
delivered in exchange therefor.

  


 

  

(c) _Conversion of Company Common Stock._ Each share of Company Common Stock
issued and outstanding immediately prior to the Effective Time (other than (i)
Company Restricted Shares to be treated in accordance with Section 2.03, (ii)
Appraisal Shares to be treated in accordance with Section 2.01(d) and (iii)
shares of Company Common Stock to be canceled in accordance with Section
2.01(b)) shall be converted automatically into and shall thereafter represent
only the right to receive the Offer Price, net to the seller in cash, without
interest (the " _Merger Consideration_ "). As of the Effective Time, all such
shares of Company Common Stock shall no longer be outstanding and shall
automatically be canceled and shall cease to exist, and each holder of a
certificate which immediately prior to the Effective Time represented any such
shares of Company Common Stock (each, a " _Certificate_ ") or non-certificated
shares of Company Common Stock held in book entry form (each, a " _Book Entry
Share_ ") shall cease to have any rights with respect thereto, except the
right to receive the Merger Consideration, without interest, to be paid in
consideration therefor upon surrender of such Certificate or Book Entry Share
in accordance with Section 2.02(b).

  


 

  

(d) _Appraisal Rights._ Notwithstanding any provision of this Agreement to the
contrary, shares of Company Common Stock that are issued and outstanding
immediately prior to the Effective Time and that are held by holders who are
(i) entitled to demand and have properly demanded their rights to be paid the
fair value of such shares of Company Common Stock in accordance with Section
262 of the DGCL (the " _Appraisal Shares_ ") and (ii) have neither effectively
withdrawn nor lost (through failure to perfect or otherwise) their rights to
such appraisal and payment under the DGCL, shall not be canceled and converted
into the right to receive the Merger Consideration as provided in Section
2.01(c), and the holders of Appraisal Shares shall be entitled to only such
rights as are granted by Section 262 of the DGCL; _provided_ , _however_ ,
that if any holder of Appraisal Shares (A) under the circumstances permitted
by and in accordance with the DGCL, affirmatively withdraws or loses (through
failure to perfect or otherwise) its right to appraisal of such Appraisal
Shares, (B) fails to establish its entitlement to appraisal rights as provided
in the DGCL or (C) takes or fails to take any action, the consequence of which
is that such holder is not entitled to payment for its shares under the DGCL,
then in each such case, such holder or holders (as the case may be) shall
forfeit the right to appraisal of such shares of Company Common Stock and such
shares of Company Common Stock shall thereupon cease to constitute Appraisal
Shares, and each such share of Company Common Stock shall, to the fullest
extent permitted by applicable Law, thereafter be deemed to have been
converted into and to have become, as of the Effective Time, the right to
receive, without interest thereon, the Merger Consideration. The Company shall
promptly notify Parent of any written demands received by the Company for
appraisal of any shares of Company Common

 

  

  

  

 

8  

  

  

 

  

Stock and attempted withdrawals of such demands, and Parent shall have the
right to participate in and direct negotiations and proceedings with respect
to such demands for appraisal. Prior to the Effective Time, the Company shall
not, without the prior written consent of Parent or as otherwise required by
an Order, make any payment with respect to, or settle or offer to settle, any
such demands or waive any failure to timely deliver a written demand for
appraisal in accordance with the DGCL.

  


 

  

SECTION 2.02. _Exchange of Shares._

  


 

  

(a) _Paying Agent._ Prior to the Closing Date, Parent shall designate a bank
or trust company reasonably acceptable to the Company to act as agent (the "
_Paying Agent_ ") for the payment of the Merger Consideration in accordance
with this Article II and, in connection therewith, shall prior to the Closing
Date enter into an agreement with the Paying Agent in a form reasonably
acceptable to the Company. At or prior to the Effective Time, Parent shall
deposit or cause to be deposited with the Paying Agent an amount in cash
sufficient to pay the aggregate Merger Consideration (such cash being
hereinafter referred to as the " _Exchange Fund_ "). Pending its disbursement
to the holders of Company Common Stock, the Exchange Fund shall be invested by
the Paying Agent as directed by Parent in (i) short-term direct obligations of
the United States of America, (ii) short-term obligations for which the full
faith and credit of the United States of America is pledged to provide for the
payment of principal and interest, (iii) short-term commercial paper rated the
highest quality by each of Moody's Investors Service, Inc. and Standard and
Poor's Ratings Services or (iv) certificates of deposit, bank repurchase
agreements or banker's acceptances of commercial banks with capital exceeding
$10 billion. Parent shall promptly replace or cause to be replaced any funds
deposited with the Paying Agent lost through any investment made pursuant to
this Section 2.02(a). The Paying Agent shall be required to hold the Exchange
Fund for the benefit of holders of Company Common Stock, and to promptly make
the payments provided for in this Article II. The Exchange Fund shall not be
used for any purpose not expressly provided for in this Agreement. Nothing
contained in this Section 2.02(a) and no investment losses resulting from
investment of the funds deposited with the Paying Agent shall diminish the
rights of any holder of Company Common Stock to receive the Merger
Consideration as provided herein.

  


 

  

(b) _Payment Procedures._ As soon as reasonably practicable after the
Effective Time (but in no event more than three business days thereafter),
Parent and the Surviving Corporation shall cause the Paying Agent to mail to
each person who was, at the Effective Time, a holder of record of Company
Common Stock (other than the Company Common Stock to be canceled or converted
in accordance with Section 2.01(b)) (i) a letter of transmittal (which shall
specify that delivery shall be effected, and risk of loss and title to the
Certificates or Book Entry Shares, as applicable, shall pass, only upon
delivery of the Certificates to the Paying Agent, and which shall be in such
form and shall have such other customary provisions (including customary
provisions regarding delivery of an "agent's message" with respect to Book
Entry Shares) as Parent and the Company may reasonably agree prior to the
Closing Date) and (ii) instructions for use in effecting the surrender of the
Certificates or Book Entry Shares in exchange for payment of the Merger
Consideration as provided in Section 2.01(c).

 

  

  

  

 

9  

  

  

 

  

Upon surrender of a Certificate or a Book Entry Share for cancelation to the
Paying Agent, together with such letter of transmittal, duly completed and
validly executed in accordance with such letter's instructions (and such other
customary documents as may reasonably be required by the Paying Agent), the
holder of such Certificate or Book Entry Share shall be entitled to receive in
exchange therefor the Merger Consideration for each share of Company Common
Stock formerly represented by such Certificate or Book Entry Share, and the
Certificate or Book Entry Share so surrendered shall forthwith be canceled. If
payment of the Merger Consideration is to be made to a person other than the
person in whose name the surrendered Certificate or Book Entry Share is
registered, it shall be a condition of payment that (x) the Certificate or
Book Entry Share so surrendered shall be properly endorsed or shall otherwise
be in proper form for transfer and (y) the person requesting such payment
shall have paid any transfer and other Taxes required by reason of the payment
of the Merger Consideration to a person other than the registered holder of
such Certificate or Book Entry Share surrendered and shall have established to
the reasonable satisfaction of the Surviving Corporation that such Tax either
has been paid or is not applicable. Until surrendered as contemplated by this
Section 2.02, each Certificate and Book Entry Share shall be deemed at any
time after the Effective Time to represent only the right to receive the
Merger Consideration as contemplated by this Article II, without interest.

  


 

  

(c) _No Further Ownership Rights in Company Common Stock._ The Merger
Consideration paid in respect of shares of Company Common Stock upon the
surrender for exchange of Certificates or Book Entry Shares in accordance with
the terms of this Article II shall be deemed to have been paid in full
satisfaction of all rights pertaining to the shares of Company Common Stock
previously represented by such Certificates or Book Entry Shares, and at the
Effective Time, the stock transfer books of the Company shall be closed and
thereafter there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation of the shares of Company Common
Stock that were outstanding immediately prior to the Effective Time. From and
after the Effective Time, the holders of Certificates that represented
ownership of shares of Company Common Stock and Book Entry Shares outstanding
immediately prior to the Effective Time shall cease to have any rights with
respect to such shares, except as otherwise provided for herein or by
applicable Law. Subject to the last sentence of Section 2.02(d), if, at any
time after the Effective Time, Certificates and Book Entry Shares are
presented to the Surviving Corporation for any reason, they shall be canceled
and exchanged as provided in this Article II.

  


 

  

(d) _Termination of the Exchange Fund._ Any portion of the Exchange Fund that
remains undistributed to the holders of Company Common Stock for 180 days
after the Effective Time shall be delivered to Parent, upon demand, and any
holder of Certificates who has not theretofore complied with this Article II
shall thereafter look only to the Surviving Corporation for, and the Surviving
Corporation shall remain liable for, payment of its claim for Merger
Consideration (subject to abandoned property, escheat and other similar Laws).
Any amounts remaining unclaimed by such holders immediately prior to such time
at which such amounts would otherwise escheat to or become the property of any
Governmental Authority shall become, to the extent

 

  

  

  

 

10  

  

  

 

  

permitted by applicable Law, the property of the Surviving Corporation, free
and clear of all claims or interest of any person previously entitled thereto.

  


 

  

(e) _No Liability._ None of Parent, Merger Sub, the Company, the Surviving
Corporation or the Paying Agent shall be liable to any person in respect of
any portion of the Merger Consideration delivered to a public official
pursuant to any applicable abandoned property, escheat or similar Law.

  


 

  

(f) _Lost Certificates._ If any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the person claiming
such Certificate to be lost, stolen or destroyed and, if required by the
Surviving Corporation, the posting by such person of a bond in such reasonable
amount as the Surviving Corporation may direct, as indemnity against any claim
that may be made against it with respect to such Certificate, the Paying Agent
shall pay and deliver in exchange for such lost, stolen or destroyed
Certificate the Merger Consideration to be paid in respect of the shares of
Company Common Stock formerly represented by such Certificate.

  


 

  

(g) _Withholding._ Parent, the Surviving Corporation and the Paying Agent
shall be entitled to deduct and withhold from the Merger Consideration or
Equity Award Consideration such amounts as are required to be deducted and
withheld with respect to the making of such payment under the Code, the U.S.
Treasury Regulations promulgated thereunder, or any provision of state, local
or non-U.S. Tax Law. To the extent amounts are so withheld and paid over to
the appropriate Taxing Authority, the withheld amounts shall be treated for
all purposes of this Agreement as having been paid to the person in respect of
which such deduction and withholding was made.

  


 

  

SECTION 2.03. _Company Equity Awards; Company ESPP._

  


 

  

(a) _Corporate Actions._ Prior to the Effective Time, the Company shall take
such actions as are necessary (including obtaining any resolutions of the
Board of Directors of the Company or, if appropriate, any committee thereof
administering the Company Stock Plans) to provide that:

  


 

  

(i) subject to Section 2.02(g), each Company Stock Option, whether vested or
unvested, that is outstanding immediately prior to the Effective Time shall,
as of the Effective Time, be canceled and the holder thereof shall then become
entitled to receive solely, in full satisfaction of the rights of such holder
with respect thereto, a lump-sum cash payment, without interest, equal to the
product of (A) the number of shares of Company Common Stock for which such
Company Stock Option has not then been exercised and (B) the excess, if any,
of the Offer Price over the exercise price per share of Company Common Stock
subject to such Company Stock Option, _provided_ that all Company Stock
Options with an exercise price per share greater than the Offer Price shall be
cancelled and the holder thereof shall not have any right to receive any
consideration in respect thereof;

  

  

  

 

11  

 

  

  

  

 

(ii) subject to Section 2.02(g), each Company Restricted Share outstanding
immediately prior to the Effective Time shall, as of the Effective Time, be
canceled and converted into the right of the holder thereof to receive solely,
in full satisfaction of the rights of such holder with respect thereto, a
lump-sum cash payment, without interest, equal to the Offer Price;

  


 

  

(iii) subject to Section 2.02(g), each Company RSU outstanding immediately
prior to the Effective Time shall, as of the Effective Time, be canceled and
the holder thereof shall then become entitled to receive solely, in full
satisfaction of the rights of such holder with respect thereto, a lump-sum
cash payment, without interest, equal to the product of (A) the number of
shares of Company Common Stock subject to such Company RSU immediately prior
to the Effective Time and (B) the Offer Price; and

  


 

  

(iv) subject to Section 2.02(g), each Company PSU outstanding immediately
prior to the Effective Time shall, as of the Effective Time, be canceled and
the holder thereof shall then become entitled to receive solely, in full
satisfaction of the rights of such holder with respect thereto, a lump-sum
cash payment, without interest, equal to the product of (A) (i) for Company
PSUs granted in 2016, the number of shares of Company Common Stock subject to
such Company PSU (provided that, any applicable performance conditions shall
be deemed to be achieved at 150% of the target performance level) and (ii) for
Company PSUs granted in 2017, the number of shares of Company Common Stock
subject to such Company PSU (provided that, any applicable performance
conditions shall be deemed to be achieved at the target performance level) and
(B) the Offer Price; _provided_ , that the treatment set forth in this Section
2.03(a)(iv) shall not apply to Company PSUs granted in 2016 to the extent
otherwise agreed among the Company, Parent and the holder of such Company
PSUs.

  


 

  

(b) _Payments with respect to Company Equity Awards._ Promptly after the
Effective Time (but in any event no later than five days after the Effective
Time), the Surviving Corporation shall pay through its payroll systems the
amounts due pursuant to (i) Section 2.03(a)(i) to the holders of Company Stock
Options (the aggregate amount of such cash payable to the holders of Company
Stock Options, the " _Option Consideration_ "), (ii) Section 2.03(a)(ii) to
holders of Company Restricted Shares (the aggregate amount of such cash
payable to the holders of Company Restricted Shares, the " _Restricted Share
Consideration_ "), (iii) Section 2.03(a)(iii) to holders of Company RSUs (the
aggregate amount of such cash payable to holders of Company RSUs, the " _RSU
Consideration_ ") and (iv) Section 2.03(a)(iv) to holders of Company PSUs (the
aggregate amount of such cash payable to holders of Company PSUs, the " _PSU
Consideration_ " and, together with the Option Consideration, Restricted Share
Consideration and RSU Consideration, the " _Equity Award Consideration_ ");
_provided_ , _however_ , that in the case of any such amounts that constitute
non-qualified deferred compensation under Section 409A of the Code, the
Surviving Corporation shall pay such amounts at the earliest time permitted
under the terms of the applicable agreement, plan or arrangement that will not
trigger a tax or penalty under Section 409A of the Code.

  

 

  

  

 

12  

  

  

  

 

(c) _Company ESPP._ Prior to the Effective Time, the Company shall take all
actions necessary to terminate the Company ESPP. The Company shall determine
the rights of participants in the Company ESPP with respect to any offering
period then underway under the Company ESPP by treating a Business Day to be
determined by the Company that is prior to the Effective Time as the last day
of such offering period (the " _Final Investment Date_ ") and by treating such
shortened offering period as a fully effective and completed offering period
for all purposes under the Company ESPP. The Company shall treat any shares of
Company Common Stock acquired prior to or on the Final Investment Date as
outstanding shares of Company Common Stock for purposes of Section 2.01.
Following the date hereof, (i) the Company shall take no action pursuant to
the terms of the Company ESPP to commence any new purchase or offering periods
and (ii) the applicable purchase price for shares of Company Common Stock
shall not be decreased below the levels set forth in the Company ESPP as of
the date hereof.

  


 

  

(d) At or prior to the Effective Time, the Company, the Board of Directors of
the Company and the Compensation Committee of the Board of Directors of the
Company (the " _Compensation Committee_ "), as applicable, shall adopt any
resolutions and take any actions that are necessary to (i) effectuate the
treatment of the Company Equity Awards pursuant to Section 2.03(a) and Section
2.03(b) and (ii) cause the Company Stock Plans to terminate at or prior to the
Effective Time. The Company shall take all actions necessary to ensure that
from and after the Effective Time neither Parent nor the Surviving Corporation
will be required to deliver shares of Company Common Stock or other capital
stock of the Company to any person pursuant to or in settlement of Company
Equity Awards.

  


 

  

(e) For purposes of this Agreement:

  


 

  

(i) " _Company Equity Award_ " means a Company PSU, Company Restricted Share,
Company RSU or Company Stock Option.

  


 

  

(ii) " _Company ESPP_ " means the Company's 2010 Employee Stock Purchase Plan,
as amended.

  


 

  

(iii) " _Company PSU_ " means any restricted stock unit award subject to
performance-based vesting conditions, payable in shares of Company Common
Stock or the value of which is determined with reference to the value of
shares of Company Common Stock, whether granted under a Company Stock Plan or
otherwise.

  


 

  

(iv) " _Company Restricted Share_ " means any share of Company Common Stock
subject to vesting or forfeiture conditions granted under a Company Stock Plan
or otherwise.

  


 

  

(v) " _Company RSU_ " means any (A) restricted stock unit award subject solely
to employment or service based vesting conditions or (B) Company PSU that is,
immediately prior to the consummation of the Offer, subject solely to

  

  

 

  

  

 

13  

  

  

  

 

employment or service based vesting conditions, in each case payable in shares
of Company Common Stock or the value of which is determined with reference to
the value of shares of Company Common Stock, whether granted under a Company
Stock Plan or otherwise.

  


 

  

(vi) " _Company Stock Option_ " means any option to purchase Company Common
Stock granted under a Company Stock Plan or otherwise (other than an ESPP
Purchase Right).

  


 

  

(vii) " _Company Stock Plans_ " means the Company's 2016 Incentive Award Plan
and 2006 Incentive Award Plan, in each case, as amended.

  


 

  

(viii) " _ESPP Purchase Right_ " means an option to purchase Company common
stock under the Company ESPP.

  


 

  

SECTION 2.04. _Adjustments._ Notwithstanding any provision of this Article II
to the contrary, if between the date hereof and the Effective Time the
outstanding shares of Company Common Stock shall have been changed into a
different number of shares or a different class by reason of the occurrence or
record date of any stock dividend, subdivision, reclassification,
recapitalization, split, combination, exchange of shares or similar
transaction, the Merger Consideration and the Equity Award Consideration, as
applicable, shall be appropriately adjusted to reflect such stock dividend,
subdivision, reclassification, recapitalization, split, combination, exchange
of shares or similar transaction; _provided_ that nothing in this Section 2.04
shall be construed to permit the Company to take any action with respect to
its securities that is prohibited by this Agreement.

  


 

  

ARTICLE III

  


 

  

 _Representations and Warranties of the Company_

  


 

  

The Company represents and warrants to Parent and Merger Sub that, except as
(i) set forth in the disclosure letter delivered by the Company to Parent and
Merger Sub on the date hereof (the " _Company Disclosure Letter_ ") (it being
understood that any information set forth in one section or subsection of the
Company Disclosure Letter shall be deemed to apply to and qualify the section
or subsection of this Agreement to which it corresponds and each other section
or subsection of this Agreement to the extent that it is reasonably apparent
that such information is relevant to such other section or subsection) or (ii)
disclosed in the Company SEC Documents or any other report, schedule, form,
statement or other document (including exhibits and other information
incorporated therein) filed with, or furnished to, the SEC and publicly
available prior to the date of this Agreement, other than any risk factor
disclosures contained in the "Risk Factors" section thereof:

  


 

  

SECTION 3.01. _Organization and Standing; Subsidiaries._

  


 

  

(a) The Company is a corporation duly organized, validly existing and in good
standing under the Laws of the State of Delaware. The Company has all

  

  

  

 

14  

 

  

  

 

  

requisite corporate power and authority to (i) own, lease or otherwise hold
its properties and assets in the manner in which they are currently owned,
used and held, (ii) conduct its business as it is now being conducted and
(iii) perform its obligations under all Contracts by which it is bound. The
Company is duly licensed or qualified to do business and is in good standing
(where such concept is recognized under applicable Law) in each jurisdiction
in which the nature of its business or the ownership, leasing or operation of
its properties and assets makes such qualification, licensing or good standing
necessary, except where the failure to be so qualified, licensed or in good
standing would not reasonably be expected to have a Material Adverse Effect.
The Company has made available to Parent, prior to the date of this Agreement,
accurate and complete copies of the Amended and Restated Certificate of
Incorporation of the Company (the " _Company Certificate_ ") and the Amended
and Restated Bylaws of the Company (the " _Company Bylaws_ ").

  


 

  

(b) Section 3.01(b) of the Company Disclosure Letter sets forth an accurate
and complete list of each Subsidiary of the Company that, as of the date
hereof, is a significant subsidiary (as such term is defined in Rule 12b-2
under the Exchange Act) of the Company (each, a " _Significant Subsidiary_ "),
together with the jurisdiction of incorporation or formation of each such
Significant Subsidiary, and neither the Company nor any of its Subsidiaries
own any capital stock, equity interest or other direct or indirect ownership
interest in any other person other than securities in a publicly traded
company held for investment by the Company or any of its Subsidiaries and
consisting of less than 1% of the outstanding capital stock of such company.
As of the date hereof, all of the outstanding capital stock of, or other
equity or voting interests in, each Significant Subsidiary is directly or
indirectly owned by the Company. As of the date hereof, all the shares of
capital stock of, or other equity or voting interests in, each such
Significant Subsidiary owned by the Company have been duly authorized and
validly issued and are fully paid and, in the case of shares of capital stock,
nonassessable and are owned directly or indirectly by the Company free and
clear of all Liens, other than Permitted Liens, and free of any restriction on
the right to vote, sell or otherwise dispose of such capital stock or other
equity or voting interests.

  


 

  

(c) Each Significant Subsidiary is duly organized, validly existing and in
good standing (where such concept is recognized under applicable Law) under
the Laws of the jurisdiction of its organization, except where the failure to
be so organized, existing and in good standing would not reasonably be
expected to have a Material Adverse Effect. Each Significant Subsidiary has
all requisite corporate power and authority to (i) own, lease or otherwise
hold its properties and assets in the manner in which they are currently
owned, used and held, (ii) conduct its business as it is now being conducted
and (iii) perform its obligations under all Contracts by which it is bound.
Each Significant Subsidiary of the Company is duly licensed or qualified to do
business and is in good standing (where such concept is recognized under
applicable Law) in each jurisdiction in which the nature of its business or
the ownership, leasing or operation of its properties and assets makes such
qualification, licensing or good standing necessary, except where the failure
to be so qualified, licensed or in good standing would not reasonably be
expected to have a Material Adverse Effect.

  

  

  

 

15  

  

  

  

 

SECTION 3.02. _Capital Stock._

  


 

  

(a) The authorized capital stock of the Company consists of 120,000,000 shares
of Company Common Stock and 5,000,000 shares of preferred stock, par value
$0.001 per share (" _Company Preferred Stock_ "). At the close of business on
June 26, 2017 (the " _Capitalization Date_ ") (i) 43,848,089 shares of Company
Common Stock were issued and outstanding (including 82,103 Company Restricted
Shares), (ii) 6,406,474 shares of Company Common Stock were reserved and
available for issuance pursuant to the Company Stock Plans, of which (A)
2,885,555 shares were issuable upon exercise of outstanding Company Stock
Options, (B) 617,527 shares were issuable upon vesting and settlement of
outstanding Company RSUs and (C) 526,275 shares were issuable upon vesting and
settlement of outstanding Company PSUs (assuming settlement of outstanding
Company PSUs based on achievement of applicable performance goals at 150% of
the target performance level for Company PSUs granted in 2016 and the target
performance level for Company PSUs granted in 2017), (iii) 788,241 shares of
Company Common Stock were reserved and available for purchase under the
Company ESPP and (iv) no shares of Company Preferred Stock were issued or
outstanding.

  


 

  

(b) Except as set forth in Section 3.02(a), as of the Capitalization Date,
there are (i) no outstanding shares of capital stock of, or other equity or
voting interests in, the Company, (ii) no outstanding securities, instruments,
bonds, debentures, notes or other obligations of the Company convertible into
or exchangeable for shares of capital stock of, or other equity or voting
interests in, the Company other than the Convertible Notes, (iii) no
preemptive rights or outstanding options, warrants, rights or other
commitments or agreements to acquire from the Company, or that obligate the
Company to issue, any capital stock of, or other equity or voting interests
in, or any securities convertible into or exchangeable for shares of capital
stock of, or other equity or voting interests in, the Company, (iv) no
obligations of the Company to grant, extend or enter into any subscription,
warrant, right, convertible or exchangeable security or other similar
agreement or commitment relating to any capital stock of, or other equity or
voting interests in, the Company (the items in clauses (i), (ii), (iii) and
(iv) being referred to collectively as " _Company Securities_ ") and (v) no
other obligations by the Company or any of its Subsidiaries to make any
payments based on the price or value of any Company Securities or dividends
paid thereon. There are no outstanding agreements of any kind that obligate
the Company or any of its Subsidiaries to repurchase, redeem or otherwise
acquire any Company Securities (except pursuant to the forfeiture of Company
Equity Awards, ESPP Purchase Rights or other equity awards or the acquisition
by the Company of shares of Company Common Stock in settlement of the exercise
price of Company Stock Options, or for purposes of satisfying Tax withholding
obligations with respect to holders of Company Equity Awards, ESPP Purchase
Rights or other equity awards), or obligate the Company to grant, extend or
enter into any such agreements relating to any Company Securities, including
any agreements granting any preemptive rights, subscription rights, anti-
dilutive rights, rights of first refusal or similar rights with respect to any
Company Securities. No Subsidiary of the Company owns any Company Common
Stock. Neither the Company nor any of its Subsidiaries is a party to any
stockholders' agreement, voting trust agreement, registration rights agreement
or other 
 

  


  
 

  

 

16  

  


 

  


 

  

similar agreement or understanding relating to any Company Securities or any
other agreement relating to the disposition, voting or dividends with respect
to any Company Securities. All outstanding shares of Company Common Stock have
been duly authorized and validly issued and are fully paid, nonassessable and
free of preemptive rights. Since the Capitalization Date through the date
hereof, neither the Company nor any of its Subsidiaries has (A) issued any
Company Securities or incurred any obligation to make any payments based on
the price or value of Company Securities or dividends paid thereon, other than
pursuant to Company Equity Awards or ESPP Purchase Rights that were
outstanding as of the Capitalization Date or (B) established a record date
for, declared, set aside for payment or paid any dividend on, or made any
other distribution in respect of, any shares of the Company's capital stock.

  


 

  

(c) As of the Capitalization Date, there was outstanding $230,000,000
aggregate principal amount of Convertible Notes.

  


 

  

(d) Section 3.02(d) of the Company Disclosure Letter contains an accurate and
complete list, as of the Capitalization Date, of Company Equity Awards and
other equity-based awards denominated in Company Common Stock outstanding
under the Company Stock Plans, including the number of shares of Company
Common Stock subject to each Company Equity Awards and the grant date, term
and exercise price with respect to each Company Equity Award, as applicable.

  


 

  

SECTION 3.03. _Authority; Noncontravention._

  


 

  

(a) The Company has all requisite corporate power and authority to execute and
deliver this Agreement and to perform its obligations hereunder and has taken
all corporate action necessary in order to execute, deliver and perform its
obligations under this Agreement and, assuming the representations and
warranties set forth in Section 4.06 are true and correct and that the
Transactions are consummated in accordance with Section 251(h) of the DGCL, to
consummate the Transactions. The execution, delivery and performance by the
Company of this Agreement, and, assuming the representations and warranties
set forth in Section 4.06 are true and correct and that the Transactions are
consummated in accordance with Section 251(h) of the DGCL, the consummation by
it of the Transactions, have been duly authorized by the Board of Directors of
the Company and, except for filing the Certificate of Merger with the
Secretary of State pursuant to the DGCL, no other corporate action on the part
of the Company is necessary to authorize the execution, delivery and
performance by the Company of this Agreement and the consummation by it of the
Transactions. This Agreement has been duly executed and delivered by the
Company and, assuming the due authorization, execution and delivery hereof by
each of the other parties hereto, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in accordance with
its terms, except as such enforceability (i) may be limited by bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar
Laws of general application affecting or relating to the enforcement of
creditors' rights generally and (ii) is subject to general principles of
equity, whether considered in a proceeding at law or in equity (the "
_Bankruptcy and Equity Exception_ ").

  

  


 

  


 

  

 

17  

  


 

  


 

  

(b) The Board of Directors of the Company, at a meeting duly called and held,
adopted resolutions (i) approving and declaring advisable this Agreement, the
Merger and the execution, delivery and performance by the Company of this
Agreement and the consummation of the Transactions, (ii) resolving that the
Merger shall be effected under Section 251(h) of the DGCL and (iii)
recommending that the Company's stockholders accept the Offer and tender their
shares of Company Common Stock in the Offer (such recommendation, the "
_Company Board Recommendation_ "), which resolutions have not, except after
the date hereof as permitted by Section 5.02, been subsequently rescinded,
modified or withdrawn.

  


 

  

(c) The execution, delivery and performance of this Agreement by the Company
do not, and the consummation by the Company of the Merger and the Transactions
and compliance by the Company with the provisions of this Agreement do not and
will not, conflict with, or result in any violation or breach of, or default
(with or without notice or lapse of time, or both) under, or give rise to a
right of termination, modification, cancelation or acceleration of any
obligation or to the loss of any benefit under, or result in the creation of
any Lien (except for a Permitted Lien) upon any of the properties or assets of
the Company or any of its Subsidiaries under, (i) the Company Certificate or
the Company Bylaws or the comparable organizational documents of any of the
Significant Subsidiaries, (ii) any Material Contract or (iii) subject to
receipt of the governmental filings and other matters referred to in Section
3.03(d), any (A) statute, law (including common law), ordinance, rule or
regulation (domestic or foreign) issued, promulgated or entered into by or
with any Governmental Authority (each, a " _Law_ ") applicable to the Company
or any of its Subsidiaries or any of their respective properties or assets or
(B) order, writ, injunction, decree, judgment, award, settlement or
stipulation issued, promulgated or entered into by or with any Governmental
Authority or competent arbitral tribunal (each, an " _Order_ ") applicable to
the Company or any of its Subsidiaries or any of their respective properties
or assets, other than, in the case of clauses (ii) and (iii), any such
conflicts, violations, breaches, defaults, rights of termination,
modification, cancelation or acceleration, losses or Liens that would not
reasonably be expected to have a Material Adverse Effect.

  


 

  

(d) No consent, approval, order or authorization of, or registration,
declaration or filing with, any Governmental Authority is required by or with
respect to the Company or any of its Subsidiaries in connection with the
execution and delivery of this Agreement by the Company or the consummation by
the Company of the Transactions, except for (i) filings required under, and
compliance with other applicable requirements of, the HSR Act and any other
applicable Antitrust Law, (ii) compliance with applicable requirements of the
Exchange Act, including the filing with the SEC of the Schedule 14D-9, (iii)
compliance with the rules and regulations of the NASDAQ, (iv) the filing of
the Certificate of Merger with the Secretary of State pursuant to the DGCL and
of appropriate documents with the relevant authorities of other jurisdictions
in which the Company or any of its Subsidiaries is qualified to do business,
(v) compliance with any applicable international, federal or state securities
or "blue sky" Laws and (vi) such other consents, approvals, orders,
authorizations, registrations, declarations and filings the failure of which
to be obtained, made or given would not reasonably be expected to have a
Material Adverse Effect.

  


 

  

 

18  

  


 

  

SECTION 3.04. _Company SEC Documents; Undisclosed Liabilities._

  


 

  

(a) The Company has on a timely basis filed with or furnished to the SEC all
material reports, schedules, forms, statements and other documents (including
exhibits and all other information incorporated therein) required to be filed
by the Company under the Securities Act or the Exchange Act since January 1,
2016 (the " _Company SEC Documents_ "). As of their respective effective dates
(in the case of Company SEC Documents that are registration statements filed
pursuant to the requirements of the Securities Act) and as of their respective
SEC filing dates (in the case of all other Company SEC Documents), the Company
SEC Documents complied as to form in all material respects with the
requirements of the Securities Act, the Exchange Act or the Sarbanes-Oxley
Act, as the case may be, applicable to such Company SEC Documents, and none of
the Company SEC Documents as of such respective dates (or, if amended prior to
the date hereof, the date of the filing of such amendment, with respect to the
disclosures that are amended) contained any untrue statement of a material
fact or omitted to state a material fact necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading.

  


 

  

(b) The consolidated financial statements of the Company (including the
related notes and schedules) included or incorporated by reference in the
Company SEC Documents complied as to form, as of their respective dates of
filing with the SEC, in all material respects with the published rules and
regulations of the SEC with respect thereto, had been prepared in all material
respects in accordance with GAAP (except, in the case of unaudited statements,
as permitted by rules and regulations of the SEC) applied on a consistent
basis during the periods involved (except (i) as may be indicated in the notes
thereto or (ii) as permitted by Regulation S-X) and fairly presented in all
material respects the consolidated financial position of the Company and its
consolidated Subsidiaries as of the dates thereof and the consolidated results
of their operations and cash flows for the periods shown (subject, in the case
of unaudited statements, to normal yearend adjustments that are not,
individually or in the aggregate, material). No financial statements of any
person other than the Company are required by GAAP to be included in the
consolidated financial statements of the Company.

  


 

  

(c) The Company maintains, and at all times since January 1, 2016 has
maintained, a system of internal controls over financial reporting (as defined
in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) which is designed to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in
accordance with GAAP, and includes those policies and procedures that: (i)
pertain to the maintenance of records that in reasonable detail accurately and
fairly reflect the transactions and dispositions of the assets of the Company;
(ii) provide reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and that
receipts and expenditures are being made only in accordance with
authorizations of management and directors of the Company; and (iii) provide
reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the assets of the Company that could have a
material effect on the financial statements. To the Knowledge of the Company,
except as set forth in the Company SEC Documents filed

  

  


 

  


 

  

 

19  

  


 

  


 

  

prior to the date of this Agreement, since January 1, 2016, neither the
Company nor the Company's independent registered accountant has identified or
been made aware of: (A) any significant deficiency or material weakness in the
design or operation of internal control over financial reporting utilized by
the Company; (B) any fraud, whether or not material, that involves the
management or other employees of the Company; or (C) any claim or allegation
regarding any of the foregoing.

  


 

  

(d) The Company maintains disclosure controls and procedures required by Rule
13a-15 or 15d-15 under the Exchange Act that are designed to ensure that all
information required to be disclosed in the Company's reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the rules and forms of the SEC and that
all such information is accumulated and communicated to the Company's
management as appropriate to allow timely decisions regarding required
disclosure and to enable each of the principal executive officer of the
Company and the principal financial officer of the Company to make the
certifications required under the Exchange Act with respect to such reports.
The Company is in compliance in all material respects with all current listing
and corporate governance requirements of NASDAQ.

  


 

  

(e) Neither the Company nor any of its Subsidiaries is a party to or has any
obligation or other commitment to become a party to any material
securitization transaction, off-balance sheet partnership or any similar
Contract (including any Contract relating to any transaction or relationship
between or among the Company or any of its Subsidiaries, on the one hand, and
any unconsolidated Affiliate, including any structured finance, special
purpose or limited purpose entity, on the other hand, or any material "off-
balance sheet arrangements" (as defined in Item 303(a) of Regulation S-K under
the Exchange Act)) where the result, purpose or intended effect of such
Contract is to avoid disclosure of any material transaction involving, or
material liabilities of, the Company or any of its Subsidiaries in any
published financial statements or other Company SEC Documents of the Company
or any of its Subsidiaries.

  


 

  

(f) To the Knowledge of the Company, there have been no material written or
oral inquiries, interrogatories or comments with respect to any of the Company
SEC Documents from the SEC, NASDAQ or any other Governmental Authority
received since January 1, 2015. As of the date of this Agreement, there are no
outstanding or unresolved comments in comment letters received from the SEC
with respect to the Company SEC Documents. To the Knowledge of the Company,
none of the Company SEC Documents is the subject of ongoing SEC review and
there are no inquiries or investigations by the SEC or any material internal
investigations pending or threatened, in each case regarding any accounting
practices of the Company and its Subsidiaries.

  


 

  

(g) Except as permitted by the Exchange Act, including Sections 13(k)(2) and
(3), since the enactment of the Sarbanes-Oxley Act, neither the Company nor
any of its Affiliates acting on behalf of the Company or any of its
Subsidiaries has made, arranged, modified (in any material respect) or
forgiven personal loans to any executive officer or director of the Company or
any of its Subsidiaries.

  

  


 

  


 

  

 

20  

  


 

  


 

  

(h) To the Knowledge of the Company, since January 1, 2015, (i) neither the
Company nor any of its Subsidiaries or any auditor, accountant or
representative of the Company or any of its Subsidiaries has reported its
knowledge of any material complaint, allegation, assertion or claim, whether
written or oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Company or any of its Subsidiaries or their
respective internal accounting controls relating to periods after January 1,
2015 (except for any of the foregoing which have no reasonable basis) and (ii)
no attorney representing the Company or any of its Subsidiaries, whether or
not employed by the Company or any of its Subsidiaries, has reported evidence
of a material violation of securities Laws or evidence of breach of fiduciary
duty or similar Law, by the Company or the Board of Directors of the Company
or any committee thereof or any director or executive officer of the Company.

  


 

  

(i) Neither the Company nor any of its Subsidiaries has any liabilities of any
nature (whether accrued, absolute, contingent or otherwise) that would be
required under GAAP, as in effect on the date hereof, to be reflected on a
consolidated balance sheet of the Company, except liabilities (i) reflected or
reserved against in the balance sheet (including the notes thereto) of the
Company and its Subsidiaries included in the Company's Quarterly Report on
Form 10-Q for the quarterly period ending March 31, 2017, (ii) incurred after
March 31, 2017, in the ordinary course of business, (iii) incurred after the
date hereof not in violation of this Agreement, (iv) incurred in connection
with this Agreement or otherwise incurred in connection with the Transactions
or (v) as would not reasonably be expected to have a Material Adverse Effect.

  


 

  

SECTION 3.05. _Absence of Certain Changes._ From December 31, 2016, through
the date hereof:

  


 

  

(a) There has not occurred any event, change, action, failure to act or
transaction that would reasonably be expected to have a Material Adverse
Effect.

  


 

  

(b) (i) Except for the execution and performance of this Agreement and the
discussions, negotiations and transactions related thereto, the Company and
its Subsidiaries have conducted their respective businesses only in the
ordinary course of such businesses; (ii) there has not been any material
damage, destruction or other casualty loss with respect to any material asset
or property owned, leased or otherwise used by the Company or any of its
Subsidiaries, whether or not covered by insurance; (iii) there has not been
any declaration, accrual, setting aside or payment of any dividend or other
distribution with respect to any shares of capital stock of the Company or any
of its Subsidiaries (except for dividends or other distributions by any direct
or indirect wholly-owned Subsidiary to the Company or to any wholly-owned
Subsidiary of the Company), or any repurchase, redemption or other acquisition
by the Company or any of its Subsidiaries of any outstanding securities of the
Company or any of its Subsidiaries; (iv) there has not been any material
change in any method of accounting or accounting practice or internal controls
(including internal controls over financial reporting) by the Company or any
of its Subsidiaries, except those changes required by a change in GAAP or SEC
rules and regulations; and (v) there has not been any agreement to do any of
the foregoing.

  


 

  


 

  


 

  

 

21  

  

  

  

SECTION 3.06. _Litigation._ There are no actions, suits, claims or proceedings
(collectively, " _Actions_ ") pending or, to the Knowledge of the Company,
threatened against the Company or any of its Subsidiaries or, to the Knowledge
of the Company, against any present or former officer, director or employee of
the Company or any of its Subsidiaries in such individual's capacity as such,
or any Order to which the Company or any of its Subsidiaries is subject,
except, in each case, for those that would not reasonably be expected to have
a Material Adverse Effect.

  


 

  

SECTION 3.07. _Compliance with Laws; Permits._

  


 

  

(a) Except as would not reasonably be expected to have a Material Adverse
Effect, the Company and each of its Subsidiaries is, and has at all times
since January 1, 2015 through the date of this Agreement been, in compliance
with applicable Laws. To the Knowledge of the Company, the Company and each of
its Subsidiaries have not received any notice from any Governmental Authority
alleging that the Company or any of its Subsidiaries is in material violation
of any applicable Law that has not been cured as of the date hereof. To the
Knowledge of the Company, as of the date of this Agreement, no material
investigation or review by any Governmental Authority with respect to the
Company or any of its Subsidiaries is pending or threatened.

  


 

  

(b) The Company and each of its Subsidiaries hold all licenses, franchises,
permits, certificates, clearances, 510(k)s and PMAs, approvals (including
product approvals and investigational device exemptions) and authorizations
from Governmental Authorities (collectively, " _Permits_ ") necessary for the
lawful conduct of their respective businesses, except where the failure to
hold a Permit would not reasonably be expected to have a Material Adverse
Effect. To the Knowledge of the Company, no material violation, suspension,
withdrawal, revocation, or cancellation of any Permits necessary for the
lawful conduct of the Company and its Subsidiaries is pending or threatened,
and the Company is, and has been, in compliance in all material respects with
the terms of all such Permits. All such Permits are in full force and effect,
except where the failure to be in full force and effect would not reasonably
be expected to be have a Material Adverse Effect, and, to the Knowledge of the
Company, no material Permits will be terminated or impaired or become
terminable, in whole or in part, as a result of the Transactions. This Section
3.07 does not relate to the Company SEC Documents or financial statements,
which are the subject of Section 3.04, Tax matters, which are the subject of
Section 3.09, employee benefit matters, which are the subject of Section 3.10,
labor matters, which are the subject of Section 3.11, environmental matters,
which are the subject of Section 3.12, or Intellectual Property matters, which
are the subject of Section 3.13.

  


 

  

(c) The Company, its Subsidiaries and, to the Knowledge of the Company, their
respective owners, officers, directors, employees and agents are in compliance
with and since January 1, 2015 have complied with (i) the Foreign Corrupt
Practices Act of 1977, as amended (the " _FCPA_ ") and (ii) all other anti-
bribery, anti-corruption and anti-money laundering applicable Laws of each
jurisdiction in which the Company and its Subsidiaries operate or have
operated and in which any agent thereof is conducting or has conducted
business involving the Company or any of its Subsidiaries,

  

  


 

  


 

  

 

22  

  


 

  


 

  

except, in each case of clauses (i) and (ii), as would not, individually or in
the aggregate, reasonably be expected to result in a material liability to the
Company and its Subsidiaries, taken as a whole. Except as would not,
individually or in the aggregate, reasonably be expected to result in a
material liability to the Company and its Subsidiaries, taken as a whole,
since January 1, 2015, none of the Company, any of its Subsidiaries and/or, to
the Knowledge of the Company, any of their respective owners, officers,
directors, employees and agents have paid, offered or promised to pay, or
authorized or ratified the payment, directly or indirectly, of any monies or
anything of value to any person, including national, provincial, municipal,
foreign or other Government Official or any political party or official
thereof or any candidate for political office for the purpose of influencing
any act or decision of such official or of any Governmental Authority to
obtain or retain business, or direct business to any person or to secure any
other improper benefit or advantage, in each case in violation of the FCPA and
any Laws described in clause (ii). The Company and its Subsidiaries have (A)
instituted policies and procedures that are reasonably designed to ensure
compliance with the FCPA and other applicable anti-bribery, anti-corruption
and anti-money laundering Laws in each jurisdiction in which the Company or
any of its Subsidiaries operate and (B) maintained such policies and
procedures in force.

  


 

  

(d) To the Knowledge of the Company, since January 1, 2015, the Company and
each of its Subsidiaries have been and currently are in compliance in all
material respects with relevant sanctions and export control Laws and
regulations in jurisdictions in which the Company or any of its Subsidiaries
do business or are otherwise subject to jurisdiction, including the United
States International Traffic in Arms Regulations, the Export Administration
Regulations and United States sanctions Laws and regulations administered by
the United States Department of the Treasury's Office of Foreign Assets
Control.

  


 

  

SECTION 3.08. _Regulatory Matters._

  


 

  

(a) To the Knowledge of the Company, since July 1, 2014, the Company and each
of its Subsidiaries have complied and are complying in all material respects
with all applicable Laws with respect to their businesses and the products
designed, manufactured, distributed, marketed, exclusively licensed, or
branded by or for the Company or any of its Subsidiaries (the " _Company
Products_ ") including: (i) any applicable U.S. Food and Drug Administration
(" _FDA_ ") investigational device exemption, institutional review board or
ethics committee approval (collectively, an " _IRB approval_ "), premarket
approval, 510(k) clearance, de novo clearance, device classification order, CE
mark, or the foreign equivalent of any of the preceding; (ii) the Controlled
Substances Act and the regulations promulgated by the Drug Enforcement
Administration; (iii) the applicable state laws and regulations; and (iv) the
Anti-Kickback Statute (42 U.S.C.  1320a-7b), the Civil Monetary Penalty
Statute (42 U.S.C.  1320a-7a), the False Claims Act (31 U.S.C.  3729 et
seq.), the Federal Sunshine Act (42 U.S.C.  1320a-7h), and all of the
regulations promulgated under all such statutes.

  


 

  

(b) To the Knowledge of the Company, since July 1, 2014, neither the Company
nor any of its Subsidiaries has received notice of, or been subject to, any

  


 

  

 

23  

  


 

  


 

  

material adverse inspectional finding, data integrity review, investigation,
penalty, fine, reprimand, sanction, assessment, request for corrective or
remedial action, warning letter, regulatory letter, untitled letter, FDA Form
483 or other compliance or enforcement notice, communication or correspondence
from FDA or any other Governmental Authority (including any notified body)
related to its business or any Company Product.

  


 

  

(c) To the Knowledge of the Company, the Company and its Subsidiaries have
complete and up-to-date copies of all material regulatory submissions and
Permits related to the Company Products, including all investigational device
exemptions, IRB approvals, premarket approval applications, 510(k) premarket
notifications, de novo requests and CE marks and any supplements or amendments
to any of the preceding.

  


 

  

(d) None of the Company Products is currently or, since July 1, 2014, has been
subject to a material recall, removal, market withdrawal or any other
corrective action that would require a report to FDA under 21 C.F.R. Part 806
(collectively, a " _Recall_ "), nor is any Recall of any Company Product
currently under consideration by the Company or any of its Subsidiaries. To
the Knowledge of the Company, no manufacturer or supplier of a Company Product
is considering a Recall with respect to a Company Product. To the Knowledge of
the Company, since July 1, 2014, (i) the Company and its Subsidiaries have not
been materially restrained in their ability to manufacture, process,
distribute, supply, import, market or sell any of the Company Products and
(ii) the Company and its Subsidiaries have been developing, manufacturing,
testing, packaging, labeling, storing, distributing, marketing,
commercializing and selling each of the Company Products in material
compliance with applicable Laws.

  


 

  

(e) Except as would not reasonably be expected to result in a material
liability to the Company and its Subsidiaries, taken as a whole, or materially
affect the development, manufacture, testing, packaging, labeling, storage,
distribution, marketing, commercialization and sale of the Company Products,
and to the Knowledge of the Company, since July 1, 2014, neither the Company
nor any of its Subsidiaries or employees have (i) made an untrue statement of
material fact or fraudulent statement to FDA or any other Governmental
Authority, or in any records or documentation prepared or maintained to comply
with the applicable Laws, with respect to its business or any Company Product;
(ii) failed to disclose a material fact required to be disclosed to any
Governmental Authority; or (iii) been investigated by the FDA, National
Institutes of Health, Office of the Inspector General for the Department of
Health and Human Services, Department of Justice or other comparable
Governmental Authority for data or healthcare program fraud. To the Knowledge
of the Company, neither the Company nor any of its Subsidiaries nor any of
their officers, directors and employees (in each case, in their capacity as
such) have, in any material respect, made or offered any payment, gratuity or
other thing of value that is prohibited by any Law to personnel of the FDA or
any other Governmental Authority since July 1, 2014.

  


 

  

(f) To the Knowledge of the Company, since July 1, 2014, neither the Company
nor any of its Subsidiaries nor any of their employees (i) has violated or
caused a violation of any federal or state health care fraud and abuse or
false claims statute or

  


 

  


 

  


 

  

 

24  

  


 

  

  

regulation, including the Anti-Kickback Statute and related regulations, that
is applicable to the Company or any of its Subsidiaries, (ii) has been
debarred, excluded, suspended or threatened with debarment or exclusion under
any Law, including under 21 U.S.C.  335a, 42 U.S.C.  1320a-7, and relevant
regulations in 42 C.F.R. Part 1001 or (iii) has been assessed or threatened
with assessment of civil money penalties pursuant to 21 U.S.C.  335b, 21
C.F.R. Part 17 or 42 U.S.C. Part 1003 except, in the case of clauses (i) and
(iii), as would not, individually or in the aggregate, reasonably be expected
to result in a material liability to the Company or its Subsidiaries.

  


 

  

(g) To the Knowledge of the Company, since July 1, 2014, neither the Company
nor any of its Subsidiaries nor any of their employees or agents have violated
or caused a violation of (i) the Health Insurance Portability and
Accountability Act, the Health Information Technology for Economic and
Clinical Health Act and related regulations (collectively, " _HIPAA_ "), (ii)
any other federal or state privacy or security statute or regulation, (iii)
any laws or regulations of any jurisdiction other than the United States
(including, but not limited to, the European Union Data Directive) with
respect to the use, collection, storage, disclosure or transfer of any data or
Personally Identifiable Information, (iv) any state privacy and security
statutes and regulations or (v) privacy policies of the Company or of any of
its respective customers, subcontractors or partners (to the extent that the
Company is or has been bound by such privacy policies) (collectively, " _Data
Protection Requirements_ "), except, in each case of clauses (ii) through (v),
as would not, individually or in the aggregate, reasonably be expected to
result in a material liability to the Company and its Subsidiaries, taken as a
whole. To the Knowledge of the Company, the Company and each of its
Subsidiaries has at all times since July 1, 2014 taken all steps reasonably
necessary (including implementing and monitoring compliance with adequate
measures with respect to technical and physical security) to ensure that all
Personally Identifiable Information is protected against loss and against
unauthorized access, use, modification or disclosure. To the Knowledge of the
Company, the Company is not currently involved in, or the subject of, and
since July 1, 2014 has not been involved in or the subject of, any written
Actions related to any Data Protection Requirements. To the Knowledge of the
Company, since July 1, 2014, no material breach or security incident in
relation to any Personally Identifiable Information held by the Company has
occurred or is threatened, and there has been no material unauthorized or
illegal processing of any Personally Identifiable Information held by the
Company. To the Knowledge of the Company, since July 1, 2014, no circumstance
has arisen in which Data Protection Requirements would require the Company to
notify a Governmental Authority or any other person of a data security breach,
security incident or violation of any data security policy.

  


 

  

(h) There are not presently pending, nor, to the Knowledge of the Company,
threatened, any material civil, criminal or administrative actions or suits
alleging any hazard or defect in design, manufacture, materials or workmanship
with respect to any Company Product, including, without limitation, failure to
warn or breach of any express or implied warranty or representation.

  


 

  

 

25  

  


 

  

SECTION 3.09. _Tax Matters._

  


 

  

(a) The Company and each of its Subsidiaries has prepared (or caused to be
prepared) and timely filed (taking into account valid extensions of time
within which to file) all material Tax Returns required to be filed by any of
them, and all such filed Tax Returns (taking into account all amendments
thereto) are true, complete and accurate in all material respects;

  


 

  

(b) all material Taxes owed by the Company and each of its Subsidiaries that
are due (whether or not shown as due on a Tax Return) have been timely paid
or, if not yet due and payable, adequately reserved against in accordance with
GAAP;

  


 

  

(c) no deficiency for any material amount of Taxes has been proposed or
asserted in writing or assessed by any Taxing Authority against the Company or
any of its Subsidiaries that remains unpaid or unresolved;

  


 

  

(d) the Company and each of its Subsidiaries has not received written notice
of any pending audits, examinations, investigations, proposed adjustments,
claims or other proceedings in respect of any material amount of Taxes of the
Company or any of its Subsidiaries;

  


 

  

(e) the Company and its Subsidiaries have delivered or made available to
Parent copies of all U.S. federal and state income Tax Returns filed by the
Company or any of its Subsidiaries for the 2014 and 2015 taxable years and a
schedule describing the types, jurisdictions and, if material, amounts of non-
income Taxes paid by the Company or any of its Subsidiaries for the 2014 and
2015 taxable years;

  


 

  

(f) all material Taxes required to be withheld or collected by the Company or
any of its Subsidiaries have been withheld and collected and, to the extent
required by applicable Law, timely paid to the appropriate Governmental
Authority;

  


 

  

(g) there are no Liens for any material amount of Taxes on any of the assets
of the Company or any of its Subsidiaries, other than Permitted Liens;

  


 

  

(h) neither the Company nor any of its Subsidiaries has been a "controlled
corporation" or a "distributing corporation" in any distribution occurring
during the two-year period ending on the date of this Agreement that was
purported or intended to be governed by Section 355 of the Code (or any
similar provision of state, local or non-U.S. Law);

  


 

  

(i) to the Knowledge of the Company, no claim has been received or is expected
to be received with respect to the Company or any of its Subsidiaries from a
Taxing Authority in a jurisdiction where such entity does not file Tax Returns
that it is or may be subject to taxation by, or required to file any Tax
Return in, that jurisdiction;

  


 

  

(j) neither the Company nor any of its Subsidiaries (i) has obtained any
private letter ruling of the IRS or comparable rulings of other taxing
authorities in the

  


 

  


 

  

 

26  

  


 

  

  

last two years or, to the Knowledge of the Company, in the last three to six
years, (ii) to the Knowledge of the Company, has, or has ever had, a permanent
establishment in any country other than the country of its organization or
(iii) has granted to any person any power of attorney that is currently in
force with respect to any Tax matter;

  


 

  

(k) neither the Company nor any of its Subsidiaries will be required to
include any material item of income in, or exclude any material item of
deduction from, taxable income for any taxable period (or portion thereof)
ending after the Closing Date as a result of any (i) change in method of
accounting for a taxable period ending on or prior to the Closing Date, (ii)
"closing agreement" as described in Code Section 7121 (or any corresponding or
similar provision of state, local, or nonU.S. income Tax law) executed on or
prior to the Closing Date, (iii) installment sale or open transaction
disposition made on or prior to the Closing Date other than in the ordinary
course of business, (iv) prepaid amount received on or prior to the Closing
Date or (v) any election pursuant to Code Section 108(i);

  


 

  

(l) neither the Company nor any of its Subsidiaries has been a member of an
affiliated group of corporations filing a consolidated federal income Tax
return (other than a group the common parent of which is the Company) or has
any liability for the Taxes of any person (other than the Company or any of
its Subsidiaries) under U.S. Treasury Regulation Section 1.1502-6 (or any
similar provision of any state, local or non-U.S. Law), as a transferee or
successor;

  


 

  

(m) neither the Company nor any of its Subsidiaries is a party to, or bound
by, or has any obligation under, any Tax sharing Contract, Tax allocation
agreement, Tax indemnity obligation or similar written agreement, arrangement
or understanding other than (i) Contracts solely among the Company and its
Subsidiaries and (ii) customary Tax indemnification provisions in Contracts
the primary purpose of which does not relate to Taxes;

  


 

  

(n) neither the Company nor any of its Subsidiaries has currently in effect
any waiver of any statute of limitations in respect of any material amount of
Taxes or any agreement to any extension of time with respect to the filing of
a material Tax Return or an assessment or deficiency for any material amount
of Taxes (other than pursuant to extensions of time to file Tax Returns
obtained in the ordinary course of business);

  


 

  

(o) neither the Company nor any of its Subsidiaries has participated in any
"reportable transaction" within the meaning of U.S. Treasury Regulation
Section 1.60114(b);

  


 

  

(p) the Company has made available to Parent an accurate and complete copy of
the letter agreement of Tax Authorities Utrecht-Gooi, dated October 25, 2011,
concerning certain Tax matters relating to Spectranetics International B.V.;
and

  


 

  


 

  

 

27  

  


 

  

(q) at no time during the past five years has the Company or any of its
Subsidiaries been a United States real property holding corporation within the
meaning of Code Section 897(c)(2).

  


 

  

SECTION 3.10. _Employee Benefits._

  


 

  

(a) Section 3.10(a) of the Company Disclosure Letter contains an accurate and
complete list, as of the date hereof, of each material U.S. Company Plan. With
respect to each material U.S. Company Plan, the Company has made available to
Parent accurate and complete copies (to the extent applicable) of (i) the plan
document or a written description thereof (or, if appropriate, a form
thereof), including any amendments thereto, and all related trust agreements,
other than any document that the Company or any of its Subsidiaries is
prohibited from making available to Parent as the result of applicable Law
relating to the safeguarding of data privacy, (ii) the most recent annual
report on Form 5500 filed with the IRS and the most recent actuarial valuation
or similar report, (iii) the most recent IRS determination or opinion letter
received by the Company, (iv) the most recent summary plan description, (v)
each insurance or group annuity contract or other funding vehicle and (vi) all
material correspondence to or from any Governmental Authority in the last
three years with respect to audits or investigations of any operational
failure of a Company Plan.

  


 

  

(b) Each U.S. Company Plan has been administered in compliance with its terms
and applicable Laws, including ERISA, and the Code, as applicable, other than
instances of noncompliance that would not, individually or in the aggregate,
reasonably be expected to result in any material liability to the Company and
its Subsidiaries, taken as a whole. Each U.S. Company Plan intended to be
"qualified" within the meaning of Section 401(a) of the Code has received a
favorable determination letter from the IRS or is entitled to rely upon a
favorable opinion issued by the IRS and, to the Knowledge of the Company,
there are no existing circumstances or any events that have occurred that
could reasonably be expected to cause the loss of any such qualification
status of any such U.S. Company Plan. There are no pending or, to the
Knowledge of the Company, threatened or anticipated claims (other than routine
claims for benefits) by, on behalf of or against any U.S. Company Plan or any
trust related thereto that could, individually or in the aggregate, reasonably
be expected to result in any material liability to the Company and its
Subsidiaries, taken as a whole, and no audit or other proceeding by a
Governmental Authority is pending or, to the Knowledge of the Company,
threatened or anticipated with respect to such U.S. Company Plan. Except as
would not, individually or in the aggregate, reasonably be expected to result
in any material liability to the Company and its Subsidiaries, taken as a
whole, (i) the Company has not engaged in a transaction in connection with
which the Company reasonably could be subject to either a civil penalty
assessed pursuant to Section 409 or 502(i) of ERISA or a Tax imposed pursuant
to Section 4975 or 4976 of the Code and (ii) the Company has not, nor, to the
Knowledge of the Company, has any of its respective directors, officers (in
each case, in their capacity as such) or any other "fiduciary," as such term
is defined in Section 3 of ERISA, committed any breach of fiduciary
responsibility imposed by ERISA or any other applicable Law with respect to
the U.S. Company Plans which would

  


 

  


 

  

 

28  

  


 

  


 

  

subject the Company or its directors, officers or employees (in each case, in
their capacity as such) to any liability under ERISA or any applicable Law.

  


 

  

(c) Except as would not, individually or in the aggregate, reasonably be
expected to result in any material liability to the Company and its
Subsidiaries, taken as a whole, the Company and each of its Subsidiaries (i)
has performed all obligations required to be performed under each U.S. Company
Plan and (ii) is not in default with respect to or in violation of any U.S.
Company Plan.

  


 

  

(d) All Company Equity Awards (i) were granted in compliance in all material
respects with all applicable Law and all of the terms and conditions of the
applicable Company Stock Plan pursuant to which they were issued and (ii)
qualify in all material respects for the tax and accounting treatment afforded
to such Company Equity Award in the Company's Tax Returns and the financial
statements of the Company, respectively.

  


 

  

(e) With respect to each U.S. Company Plan that is subject to Title IV or
Section 302 of ERISA or Section 412 or 4971 of the Code, (i) no material
liability under Title IV of ERISA has been incurred by the Company or any
Commonly Controlled Entity that has not been satisfied in full and, to the
Knowledge of the Company, no condition exists that presents a risk to the
Company of incurring any material liability under such Title and (ii) all
contributions required to be made with respect thereto (whether pursuant to
the terms of such U.S. Company Plan or by applicable Laws) have been made in
all material respects. Neither the Company nor any of its Subsidiaries has at
any time during the six years prior to the date hereof participated in or
contributed to a "multiemployer plan" (as defined in Section 3(37) of ERISA).

  


 

  

(f) Section 3.10(f) of the Company Disclosure Letter sets forth, as of the
date hereof, each material U.S. Company Plan that provides health, medical or
life insurance or other welfare benefits (whether or not insured) with respect
to employees or former employees (or any of their beneficiaries) of the
Company or any of its Subsidiaries after retirement or other termination of
employment, other than coverage or benefits (i) required to be provided under
Part 6 of Title I of ERISA or Section 4980(B)(f) of the Code, or any other
applicable Laws or (ii) the full cost of which is borne by the employee or
former employee (or any of their beneficiaries).

  


 

  

(g) Except as otherwise contemplated by this Agreement, the consummation of
the Transactions will not, either alone or in combination with another event,
(i) entitle any current or former employee of the Company to severance pay or
a material increase in severance pay upon any termination of employment after
the date of this Agreement, (ii) accelerate the time of payment or vesting, or
increase the amount of compensation payable by the Company or any of its
Subsidiaries to any of their respective directors, officers or employees,
(iii) cause the Company to transfer or set aside any assets to fund any
benefits under any Company Plan, (iv) limit or restrict the right to amend,
terminate or transfer the assets of any Company Plan on or following the Offer
Acceptance Time or (v) result in the payment of any amount that could,

  


 

  


 

  

 

29  

  


 

  


 

  

individually or in combination with any other such payment, constitute an
"excess parachute payment" as defined in Section 280G(b)(1) of the Code.

  


 

  

(h) Neither the Company nor any Subsidiary has any obligation to provide, and
no Company Plan provides any individual with the right to, a gross up,
indemnification, reimbursement or other payment for any excise or additional
taxes, interest or penalties incurred pursuant to Section 409A or Section 4999
of the Code.

  


 

  

(i) Except as would not reasonably be expected to have a Material Adverse
Effect, all Foreign Company Plans (i) have been maintained in accordance with
all applicable requirements, (ii) if they are intended to qualify for special
Tax treatment, meet all the requirements for such treatment, (iii) if they are
intended to be funded and/or book-reserved, are funded and/or book-reserved,
as appropriate, based upon reasonable actuarial assumptions and (iv) have no
unfunded liabilities that, as of the Effective Time, will not be offset by
insurance or are fully accrued on the Company's financial statements.

  


 

  

(j) Sections 3.05, 3.10, 3.11 and 3.17 contain the sole and exclusive
representations and warranties of the Company with respect to employee
benefits matters.

  


 

  

SECTION 3.11. _Labor Matters._

  


 

  

(a) Neither the Company nor any of its Subsidiaries is a party to any
collective bargaining agreement or other material Contract with any labor
union, works council or similar organization. Since January 1, 2015 to the
date hereof, to the Knowledge of the Company, there have been no material
activities or proceedings of any labor organization to organize any employees
of the Company or any of its Subsidiaries and no material demand for
recognition as the exclusive bargaining representative of any employees has
been made by or on behalf of any labor or similar organization and, as of the
date hereof, there is no material pending or, to the Knowledge of the Company,
threatened strike, lockout, slowdown or work stoppage by or with respect to
the employees of the Company or any of its Subsidiaries.

  


 

  

(b) As of the date hereof, the Company is in material compliance with all
applicable Laws in respect of labor, employment, fair employment practices
(including equal employment opportunity laws), terms and conditions of
employment, classification of employees, workers' compensation, occupational
safety and health, affirmative action, employee privacy, plant closings and
wage and hour.

  


 

  

(c) Sections 3.05, 3.10, 3.11 and 3.17 contain the sole and exclusive
representations and warranties of the Company with respect to labor matters.

  


 

  

SECTION 3.12. _Environmental Matters._

  


 

  

(a) Except as would not reasonably be expected to have a Material Adverse
Effect, (i) the Company and each of its Subsidiaries have since January 1,
2015 been in compliance with all Laws and Orders relating to pollution or the
protection of health and safety or the environment or natural resources
(collectively, "Environmental

  


 

  


 

  

 

30  

  


 

  


 

  

Laws") applicable to the Company or its Subsidiaries and the Company and its
Subsidiaries hold, and are in compliance with, all Permits that are required
under applicable Environmental Laws for the lawful conduct of their respective
businesses as currently conducted; (ii) to the Knowledge of the Company, (A)
no person has been exposed to any substance regulated as "toxic" or
"hazardous" under any Environmental Law ("Hazardous Substance") at a property
or facility currently or formerly owned or operated by the Company or any of
its Subsidiaries in a manner that could reasonably be expected to result in
material liability to the Company or any of its Subsidiaries under any
Environmental Law and (B) there are and have been no material Hazardous
Substances present or released on, at, under or from any property or facility,
including the Owned Real Property and Leased Real Property, in a manner that
could reasonably be expected to result in any material claim against or
material liability to the Company or any of its Subsidiaries under any
Environmental Law; (iii) as of the date hereof, neither the Company nor any of
its Subsidiaries has received written notice of any claim, demand, order,
notice of violation or information request nor, to the Knowledge of the
Company, is any threatened, and the Company is not subject to any Action or
Order (A) asserting or imposing an obligation on the part of the Company or
any of its Subsidiaries to conduct remedial investigations or clean-up
activities under applicable Environmental Laws, (B) alleging or addressing
non-compliance by the Company or any of its Subsidiaries with any applicable
Environmental Law or (C) alleging or imposing liability of the Company or any
of its Subsidiaries under any applicable Environmental Law; and (iv) neither
the Company nor any of its Subsidiaries has, by agreement or operation of Law,
assumed, undertaken or otherwise become subject to any liability of another
person relating to any Environmental Law other than any indemnities in
Contracts entered into in the ordinary course of business or leases for real
property.

  


 

  

(b) Sections 3.04, 3.05 and this Section 3.12 contain the sole and exclusive
representations and warranties of the Company with respect to Environmental
Laws.

  


 

  

SECTION 3.13. _Intellectual Property._

  


 

  

(a) Section 3.13(a) of the Company Disclosure Letter sets forth an accurate
and complete list of all Registered Intellectual Property owned by (whether
solely or jointly) or exclusively licensed to the Company or any of its
Subsidiaries as of the date of this Agreement (the " _Registered IP_ "),
setting forth for each item (i) the owner, (ii) the registration or
application number (as applicable), (iii) the registration or application date
(as applicable) and (iv) the applicable filing jurisdiction.

  


 

  

(b) Except as would not reasonably be expected to have a Material Adverse
Effect:

  


 

  

(i) The Registered IP is subsisting and, to the Knowledge of the Company,
valid and enforceable.

  


 

  

(ii) The Company and its Subsidiaries own, free and clear of all Liens, other
than Permitted Liens, or license or have the right to use all Intellectual

  


 

  


 

  

 

31  

  


 

  

Property used in and material to the operation of their businesses as
currently conducted.

  


 

  

(iii) None of the Intellectual Property owned or purported to be owned by the
Company or any of its Subsidiaries is subject to any pending or outstanding
Order that adversely restricts the use, transfer, registration or licensing of
any such Intellectual Property by the Company or any of its Subsidiaries or
otherwise adversely affects the validity, scope, use, registrability or
enforceability of any such Intellectual Property.

  


 

  

(iv) To the Knowledge of the Company, the conduct of the businesses of the
Company and its Subsidiaries as currently conducted does not infringe upon,
misappropriate or otherwise violate, and has not infringed, misappropriated or
otherwised violated since January 1, 2015, the Intellectual Property of any
person.

  


 

  

(v) To the Knowledge of the Company, neither the Company nor any of its
Subsidiaries has received any written notice since January 1, 2015 from any
person, of any Actions pending or threatened (including "cease and desist"
letters and written invitations to take a patent license) against the Company
or any of its Subsidiaries, (A) asserting the infringement, misappropriation
or other violation of any Intellectual Property by the Company or any of its
Subsidiaries or (B) challenging the validity, scope, enforceability, priority
or registrability of, or any right, title or interest of the Company or any of
its Subsidiaries with respect to, any Intellectual Property owned by the
Company or any of its Subsidiaries.

  


 

  

(vi) To the Knowledge of the Company, no third party is currently infringing,
misappropriating or otherwise violating any Intellectual Property owned by the
Company or any of its Subsidiaries.

  


 

  

(vii) To the Knowledge of the Company, neither the Company nor any of its
Subsidiaries has sent any written notice since January 1, 2015, to any person,
and there are no pending Actions by the Company or any of its Subsidiaries,
(A) asserting the infringement, misappropriation or other violation of any
Intellectual Property owned by the Company or any of its Subsidiaries or (B)
challenging the validity, enforceability, scope, priority or registrability
of, or any right, title or interest of any person with respect to, any
Intellectual Property.

  


 

  

(viii) Unless otherwise evidenced by the documents recorded at the U.S. Patent
Office Assignment Database, all Registered Intellectual Property listed on
Section 3.13(a) of the Company Disclosure Letter as owned by the Company or
any of its Subsidiaries, the Company and its Subsidiaries have obtained from
each employee or contractor who has created or developed any Registered
Intellectual Property for or on behalf of the Company or its Subsidiaries, a
written, valid, and enforceable assignment of such Registered Intellectual
Property to the Company or one of its Subsidiaries, as applicable. To the
Knowledge of the Company, such assignments have complied with all applicable
Laws, including applicable Laws

  


 

  

  

 

32  

  


 

  

regarding remuneration or compensation, to effectuate a valid assignment, and
no such employee or contractor owns or has any claim, right (whether or not
currently exercisable) or interest to or in any Registered Intellectual
Property owned or purported to be owned by the Company or any of its
Subsidiaries.

  


 

  

(ix) To the Knowledge of the Company, since January 1, 2015 to the date of
this Agreement, no funding, facilities or personnel of any Governmental
Authority or any university, college, research institute or other educational
institution is being used, directly or indirectly, to create, in whole or in
part, Intellectual Property owned or purported to be owned by the Company or
any of its Subsidiaries, except for any such funding or use of facilities or
personnel that does not result in such Governmental Authority or institution
obtaining ownership rights to such Intellectual Property.

  


 

  

(x) To the Knowledge of the Company, since January 1, 2015, the Company and
its Subsidiaries have taken all commercially reasonable efforts to protect the
confidentiality and value of all Trade Secrets which are material to the
conduct of the Company's and its Subsidiaries' businesses and, to the
Knowledge of the Company, such Trade Secrets have not been used, disclosed to
or discovered by any person except pursuant to written, valid and enforceable
non-disclosure and/or license agreements. To the Knowledge of the Company, no
current or former employee, consultant, contractor, partner or investor of any
Company or any of its Subsidiaries is currently in unauthorized possession of
any of such Trade Secrets.

  


 

  

(xi) To the Knowledge of the Company, since January 1, 2015, no industry
standards body or any similar organization of which the Company or any of its
Subsidiaries is now or has been a member, promoter or contributor has
requested in writing that the Company or any of its Subsidiaries grant or
offer to any other person any license or right to any Intellectual Property
owned by the Company or any of its Subsidiaries.

  


 

  

(xii) To the Knowledge of the Company, as of the date of this Agreement, there
are no defects in any software included in any product or service of the
Company or any of its Subsidiaries that would prevent the same from performing
materially in accordance with its user specifications and, to the Knowledge of
the Company, there are no viruses, worms, Trojan horses or similar disabling
codes or programs in any of software included in any product or service of the
Company.

  


 

  

(xiii) To the Knowledge of the Company, the IT Assets (A) meet the needs of
the Company's business as currently conducted, (B) since January 1, 2015 have
not malfunctioned or failed in a manner that has had a material impact on the
businesses of the Company and its Subsidiaries and (C) are free from material
bugs or other defects as of the date of this Agreement. Each of the Company
and its Subsidiaries has implemented reasonable backup and disaster recovery
technology processes consistent with industry commercial standards. To

  


 

  


 

  

 

33  

  


 

  

the Knowledge of the Company, no person has gained unauthorized access to the
IT Assets.

  


 

  

(xiv) Neither the Company nor any of its Subsidiaries is party to any Contract
pursuant to which (A) a license, covenant not to sue or other right is granted
by a third party under any material Intellectual Property to the Company or
any of its Subsidiaries, other than non-exclusive licenses and agreements for
commercially available off-the-shelf software or (B) a license, covenant not
to sue or other right is granted by the Company or any of its Subsidiaries
under any material Intellectual Property to any third party, in each case,
other than non-exclusive end-user licenses (without any right to sublicense)
entered into in the ordinary course of business (" _IP License Agreements_ ").

  


 

  

(c) Other than Sections 3.05, 3.06, 3.07 and 3.17, this Section 3.13 contains
the sole and exclusive representations and warranties of the Company with
respect to Intellectual Property matters.

  


 

  

SECTION 3.14. _Rights Agreement; Anti-Takeover Provisions_ _._

  


 

  

(a) The Company is not party to any stockholder rights agreement, "poison
pill" or similar anti-takeover agreement or plan.

  


 

  

(b) Assuming the accuracy of the representations and warranties set forth in
Section 4.06, the Board of Directors of the Company has taken all necessary
action so that the restrictions applicable to business combinations contained
in Section 203 of the DGCL and any takeover, anti-takeover, moratorium, "fair
price", "control share" or other similar Law (collectively, " _Takeover Laws_
") applicable to the Company does not, and will not, apply to this Agreement
or the Transactions.

  


 

  

SECTION 3.15. _Personal Property._ Except as would not reasonably be expected
to have a Material Adverse Effect, the Company and its Subsidiaries have good
and valid title to all the personal properties and assets reflected on the
most recent audited balance sheet of the Company and its Subsidiaries included
in the Company SEC Documents as being owned by the Company or one of its
Subsidiaries or acquired after the date thereof that are material to the
Company and its Subsidiaries, taken as a whole (except for properties and
assets that have been disposed of since the date thereof).

  


 

  

SECTION 3.16. _Real Property_.

  


 

  

(a) Section 3.16(a) of the Company Disclosure Letter sets forth as of the
date of this Agreement an accurate and complete list of the parcels of real
property owned (partially or fully) by the Company and any of its Subsidiaries
(the " _Owned Real Property_ "). As of the date hereof, (i) the Company and
each of its Subsidiaries, as applicable, has good and insurable title to the
Owned Real Property, free and clear of all Liens other than Permitted Liens,
in all material respects, (ii) there are no material outstanding options or
rights of first refusal to purchase the Owned Real Property, or any portion of
the Owned Real Property or interest therein, and no third party has any
material right to occupy or use any portion of the Owned Real Property and
(iii) there are

  


 

  


 

  

 

34  

  

  

  

no material pending, or to the Knowledge of the Company, threatened,
condemnation proceedings with respect to any of the Owned Real Property.

  


 

  

(b) Section 3.16(b) of the Company Disclosure Letter sets forth as of the date
of this Agreement an accurate and complete list of each lease or sublease
pursuant to which the Company and any of its Subsidiaries leases or subleases
real property to or from any other person involving total lease obligations
over the remaining duration of such leases in excess of $500,000 (the "
_Leased Real Property_ "). The Company has made available to Parent each such
lease or sublease with respect to the Leased Real Property (including all
amendments related thereto, the " _Leases_ "), and such Leases are in full
force and effect in all material respects. The Company or the applicable
Subsidiary holds a valid and existing leasehold interest in each Leased Real
Property in all material respects. Neither the Company nor any of its
Subsidiaries is in material breach or material default of its obligations
under the Leases. To the Knowledge of the Company, each other party to each
Lease has performed in all material respects all obligations required to be
performed by it under such Lease. No third party has any right to occupy any
portion of the Leased Real Property except as would not, individually or in
the aggregate, reasonably be expected to result in a material liability to the
Company and its Subsidiaries, taken as a whole.

  


 

  

(c) Together with the Owned Real Property, the Leased Real Property constitute
all of the real estate properties necessary to operate the business of the
Company and its Subsidiaries in all material respects as it is currently
conducted.

  


 

  

SECTION 3.17. _Material Contracts._

  


 

  

(a) Section 3.17(a) of the Company Disclosure Letter sets forth a list of all
Material Contracts as of the date of this Agreement. For purposes of this
Agreement, " _Material Contract_ " means any Contract to which the Company or
any of its Subsidiaries is a party or by which the Company or any of its
Subsidiaries or any of their respective properties or assets is bound (other
than this Agreement and the Company Plans) that:

  


 

  

(i) is or would be required to be filed by the Company as a "material
contract" pursuant to Item 601(b)(10) of Regulation S-K or that would be
required to be disclosed under Item 404 of Regulation S-K;

  


 

  

(ii) is with respect to a joint venture, partnership, strategic alliance,
limited liability corporation or other similar arrangement;

  


 

  

(iii) provides for Indebtedness of the Company or any of its Subsidiaries
having an outstanding or committed amount in excess of $5 million, other than
Indebtedness between or among any of the Company and any of its Subsidiaries;

  


 

  

(iv) relates to the acquisition or disposition of any business or assets
(whether by merger, sale of stock, sale of assets or otherwise) for aggregate
consideration under such Contract in excess of $5 million (A) that was entered

  

  

  

 

35  

  


 

  

into on or after January 1, 2016 or (B) pursuant to which any material earn-
out or deferred or contingent payment obligations remain outstanding (in each
case excluding, for the avoidance of doubt, acquisitions or dispositions of
supplies, inventory, merchandise or products in the ordinary course of
business or of supplies, inventory, merchandise or products that are obsolete,
worn out, surplus or no longer used or useful in the conduct of business of
the Company or its Subsidiaries);

  


 

  

(v) prohibits the payment of dividends or distributions in respect of the
capital stock of the Company or any of its wholly owned Subsidiaries,
prohibits the pledging of the capital stock or other equity interests of the
Company or any of its wholly owned Subsidiaries or prohibits the issuance of
any guarantee by the Company or any of its wholly owned Subsidiaries;

  


 

  

(vi) is an IP License Agreement;

  


 

  

(vii) is material to the business of the Company and its Subsidiaries, taken
as a whole, and contains provisions that prohibit the Company or any of its
Subsidiaries or any person that controls, or is under common control with, the
Company from competing in any line of business or grants a right of
exclusivity to any person that prevents the Company or any of its Subsidiaries
from entering any territory, market or field or freely engaging in business
anywhere in the world, other than (A) Contracts with suppliers, distributors
or vendors containing geographic restrictions on where the Company or any of
its Subsidiaries are permitted to sell supplies, inventory, merchandise,
products or other assets purchased by the Company or any of its Subsidiaries
under such Contracts and (B) Contracts that can be terminated (including such
restrictive provisions) by the Company or any of its Subsidiaries on less than
90 days' notice without payment by the Company or any of its Subsidiaries of
any material penalty;

  


 

  

(viii) is a settlement, conciliation or similar agreement with or before any
Governmental Authority and pursuant to which the Company will be required
after the date of this Agreement to pay consideration in excess of $500,000;

  


 

  

(ix) is outside the ordinary course of business and requires by its terms, or
is reasonably likely to require, the payment or delivery of cash or other
consideration by or to the Company or any of its Subsidiaries in an amount
having an expected value in excess of $1 million in the fiscal year ending
December 31, 2017 or in any fiscal year thereafter;

  


 

  

(x) contains a put, call or similar right pursuant to which the Company or any
of its Subsidiaries would be required to purchase or sell, as applicable, any
equity interests of any person;

  


 

  

(xi) is a Government Contract; or

  


 

  

(xii) is a Contract with (A) any of the Company's ten largest vendors based on
the total amount of payments received by each such vendor from the

  


 

  


 

  

 

36  

  


 

  

Company in the fiscal year ending December 31, 2016 or (B) any of the
Company's ten largest customers or distributors based on the total amount of
revenue received by the Company from each such customer or distributor in the
fiscal year ending December 31, 2016.

  


 

  

(b) The Company has made available to Parent an unredacted, accurate and
complete copy of each Material Contract or has publicly made available such
Material Contract in the Electronic Data Gathering, Analysis and Retrieval
(EDGAR) database of the SEC; _provided_ that certain Material Contracts have
been made available to Parent with names and certain personal information
redacted. Except as would not reasonably be expected to have a Material
Adverse Effect, as of the date hereof, (i) each Material Contract is valid and
binding on the Company or its applicable Subsidiary, and to the Knowledge of
the Company, each other party thereto, subject to the Bankruptcy and Equity
Exception, and is in full force and effect in accordance with its terms,
except to the extent such Material Contract has expired in accordance with its
terms, (ii) neither the Company nor any of its Subsidiaries is in breach or
violation of, or in default under, any Material Contract and (iii) to the
Knowledge of the Company, no event or condition exists which (with or without
notice or lapse of time, or both) would constitute a default on the part of
the Company or any of its Subsidiaries under any Material Contract. Since
January 1, 2016 through the date hereof, the Company has not received any
written notice regarding any violation or breach or default under any Material
Contract that has not since been cured, except for violations or breaches that
would not reasonably be expected to have a Material Adverse Effect. Neither
the Company nor any of its Subsidiaries has waived in writing any rights under
any Material Contract, other than waivers that would not reasonably be
expected to have a Material Adverse Effect. To the Knowledge of the Company,
as of the date hereof, no party to any Material Contract has given the Company
or any of its Subsidiaries written notice of its intention to cancel or
terminate such Material Contract.

  


 

  

SECTION 3.18. _Insurance._ Prior to the date of this Agreement, the Company
has delivered or made available to Parent or a representative of Parent
accurate and complete copies of each material insurance policy under which the
Company and any of its Subsidiaries is an insured or otherwise the principal
beneficiary of coverage and all material self-insurance programs and
arrangements relating to the business, assets and operations of the Company
and its Subsidiaries. Except as would not reasonably be expected to have a
Material Adverse Effect, all such policies, programs and arrangements are in
full force and effect, no notice of cancellation or modification has been
received and there is no existing default or event which, with the giving of
notice or lapse of time or both, would constitute a default by any insured
thereunder.

  


 

  

SECTION 3.19. _Affiliate Transactions._ No director or officer of the Company
or members of their "immediate family" (as such terms are defined in Rule
16a-1 of the Exchange Act), other than in his or her capacity as a director,
officer or employee of the Company or any of its Subsidiaries, (a) is
currently involved, directly or indirectly, in any material business
arrangement or other material relationship with the Company or any of its
Subsidiaries where the amount involved exceeds $120,000 or (b) directly or
indirectly owns, or otherwise has any right, title, interest in, to or under,

  


 

  


 

  

 

37  

  


 

  

  

any material property or right, tangible or intangible, that is currently used
by the Company or any of its Subsidiaries, is material to the conduct of the
business of the Company and its Subsidiaries as currently conducted, taken as
a whole, and where the amount involved exceeds $120,000.

  


 

  

SECTION 3.20. _Merger Approval._ Following the Offer Acceptance Time, assuming
satisfaction of the Minimum Condition, no vote of the holders of any class or
series of the Company's capital stock will be required in order to adopt this
Agreement, and the Merger may be effected under Section 251(h) of the DGCL
without any such vote.

  


 

  

SECTION 3.21. _Opinion of Financial Advisors._ The Board of Directors of the
Company has received the opinion of J.P. Morgan Securities LLC, to the effect
that, as of the date hereof and subject to the limitations, qualifications and
assumptions set forth therein, the Offer Price and the Merger Consideration to
be paid to the holders (other than Parent and its Affiliates) of shares of
Company Common Stock is fair from a financial point of view to such holders.
It is agreed and understood that such opinions are for the benefit of the
Board of Directors of the Company and may not be relied on by Parent or Merger
Sub.

  


 

  

SECTION 3.22. _Brokers and Other Advisors._ Except for J.P. Morgan Securities
LLC, the fees and expenses of which will be paid by the Company, no broker,
investment banker, financial advisor or other person is entitled to any
broker's, finder's, financial advisor's or other similar fee or commission in
connection with the Transactions based upon arrangements made by or on behalf
of the Company or any of its Subsidiaries.

  


 

  

SECTION 3.23. _Information Supplied; Offer Documents_. None of the information
supplied or to be supplied by or on behalf of the Company or its Subsidiaries
for inclusion or incorporation by reference in the Offer Documents (including
any amendments or supplements thereto) will, at the time the Offer Documents
(or any amendment or supplement thereto) is filed with the SEC or at the time
the Offer Documents (or any amendment or supplement thereto) are first
published, sent or given to the stockholders of the Company, contain any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they are made, not misleading. The
Schedule 14D-9 (including any amendment or supplement thereto) will comply as
to form in all material respects with the requirements of the Exchange Act and
will not, at the time filed with the SEC and at the time first published, sent
or given to the stockholders of the Company, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading. Notwithstanding the
foregoing, the Company and its Subsidiaries make no representation or warranty
with respect to statements made or incorporated by reference therein based on
information supplied by or on behalf of Parent or Merger Sub thereof for
inclusion or incorporation by reference in the Schedule 14D-9.

  


 

  


 

  

 

38  

  


 

  

  

ARTICLE IV

  


 

  

 _Representations and Warranties of Parent and Merger Sub_

  


 

  

Parent and Merger Sub jointly and severally represent and warrant to the
Company that:

  


 

  

SECTION 4.01. _Organization and Standing._ Each of Parent and Merger Sub is a
corporation duly organized, validly existing and in good standing under the
Laws of the State of Delaware. Each of Parent and Merger Sub has all requisite
corporate power and authority to own, lease or otherwise hold its properties
and assets in the manner in which they are currently owned, used and held, and
to conduct its business as it is now being conducted, except where the failure
to have such power and authority would not reasonably be expected to have a
Parent Material Adverse Effect. Each of Parent and Merger Sub is duly licensed
or qualified to do business and is in good standing (where such concept is
recognized under applicable Law) in each jurisdiction in which the nature of
its business or the ownership, leasing or operation of its properties and
assets makes such qualification, licensing or good standing necessary, except
where the failure to be so qualified, licensed or in good standing would not
reasonably be expected to have a Parent Material Adverse Effect. Parent has
made available to the Company, prior to the date of this Agreement, accurate
and complete copies of Parent's and Merger Sub's certificates of incorporation
and by-laws or comparable governing documents, each as amended to the date
hereof.

  


 

  

SECTION 4.02. _Authority; Noncontravention._

  


 

  

(a) Each of Parent and Merger Sub has all requisite corporate power and
authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the Transactions. No vote of holders of capital
stock of Parent is necessary to approve this Agreement or the consummation by
Parent and Merger Sub of the Merger and the other Transactions. The execution
and delivery of this Agreement by Parent and Merger Sub and the consummation
by Parent and Merger Sub of the Transactions have been duly authorized and
approved by the respective Boards of Directors of Parent and Merger Sub, and
except for the adoption of this Agreement by Parent in its capacity as the
sole stockholder of Merger Sub (which adoption shall be effected by the
written consent of Parent immediately following the execution of this
Agreement), no other corporate proceedings on the part of Parent or Merger Sub
are necessary to authorize this Agreement or the consummation of the
Transactions. This Agreement has been duly executed and delivered by Parent
and Merger Sub and, assuming the due authorization, execution and delivery
hereof by the Company, constitutes a legal, valid and binding obligation of
each of Parent and Merger Sub, enforceable against each of them in accordance
with its terms, subject to the Bankruptcy and Equity Exception.

  


 

  

(b) The Board of Directors of Parent has adopted resolutions approving the
execution, delivery and performance by Parent of this Agreement and the
consummation of the Transactions, which resolutions have not been subsequently

  


 

  


 

  

 

39  

  

  

  

rescinded, modified or withdrawn. The Board of Directors of Merger Sub has
adopted resolutions (i) unanimously approving the Merger and the execution,
delivery and performance by Merger Sub of this Agreement and the consummation
of the Transactions, (ii) declaring that this Agreement is advisable and (iii)
directing that this Agreement be submitted for adoption by Merger Sub's
stockholder, which resolutions have not been subsequently rescinded, modified
or withdrawn.

  


 

  

(c) The execution, delivery and performance of this Agreement by Parent and
Merger Sub do not, and the consummation by Parent and Merger Sub of the
Transactions and compliance with Parent and Merger Sub with the provisions of
this Agreement do not and will not require any consent by any person under,
conflict with, or result in any violation or breach of, or default (with or
without notice or lapse of time, or both) under, or give rise to a right of
termination, modification, cancelation or acceleration of any obligation or to
the loss of any benefit under, or result in the creation of any Lien upon, any
of the properties or assets of Parent or any of its Subsidiaries under, (i)
the certificate of incorporation, by-laws or other comparable charter or
organizational documents of Parent or Merger Sub, (ii) any Contract to which
Parent or any of its Subsidiaries is a party or any of their respective
properties, rights or other assets is subject or (iii) subject to receipt of
the governmental filings and other matters referred to in Section 4.02(d), any
Law or Order applicable to Parent or any of its Subsidiaries or any of their
respective properties or assets, other than, in the case of clauses (ii) and
(iii), any such conflicts, violations, breaches, defaults, rights of
termination, modification, cancelation or acceleration, losses or Liens that
would not reasonably be expected to have a Parent Material Adverse Effect.

  


 

  

(d) No notice, report, consent, approval, permit, order or authorization of,
registration, declaration or other action by or in respect of, or filing with,
any Governmental Authority is required by or with respect to Parent or any of
its Subsidiaries in connection with the execution and delivery of this
Agreement by Parent and Merger Sub or the consummation by Parent and Merger
Sub of the Transactions, except for (i) compliance with the applicable
requirements of the Exchange Act, including the filing with the SEC of the
Offer Documents, (ii) filings required under, and compliance with other
applicable requirements of, the HSR Act and any other applicable Antitrust
Law, (iii) the filing of the Certificate of Merger with the Secretary of State
and (iv) such other notices, reports, consents, approvals, permits, orders,
authorizations, registrations, declarations, filings and actions the failure
of which to be obtained, made or given would not reasonably be expected to
have a Parent Material Adverse Effect.

  


 

  

SECTION 4.03. _Litigation._ There are no Actions pending or, to the Knowledge
of Parent and Merger Sub, threatened against Parent or Merger Sub or any of
their respective Affiliates, or any Order to which Parent or Merger Sub or any
of their respective Affiliates is subject, except, in each case, for those
that would not reasonably be expected to have a Parent Material Adverse
Effect.

  

  

  


 

  

 

40  

  

  

  

SECTION 4.04. _Ownership and Operations of Merger Sub._

  


 

  

(a) As of the date of this Agreement, the authorized capital stock of Merger
Sub consists of 1,000 shares of common stock, par value $0.001 per share. All
of the issued and outstanding capital stock of Merger Sub is owned
beneficially and of record either by Parent or a wholly owned subsidiary of
Parent, free and clear of all Liens.

  


 

  

(b) Merger Sub was formed solely for the purpose of engaging in the
Transactions, has no assets, liabilities or obligations of any nature other
than those incident to its formation and pursuant to Transactions and, prior
to the Effective Time, will not have engaged in any other business activities
other than those relating to the Transactions.

  


 

  

SECTION 4.05. _Information Supplied; Offer Documents._ None of the information
supplied or to be supplied by or on behalf of Parent or Merger Sub for
inclusion or incorporation by reference in the Schedule 14D-9 (including any
amendments or supplements thereto) will, at the time the Schedule 14D-9 (or
any amendment or supplement thereto) is filed with the SEC or at the time the
Schedule 14D9 (or any amendment or supplement thereto) is first published,
sent or given to the stockholders of the Company, contain any untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances under which they are made, not misleading. The Offer Documents
(including any amendment or supplement thereto) will comply as to form in all
material respects with the requirements of the Exchange Act and will not, at
the time filed with the SEC and at the time first published, sent or given to
the stockholders of the Company, contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading. Notwithstanding the
foregoing, Parent and Merger Sub make no representation or warranty with
respect to statements made or incorporated by reference therein based on
information supplied by or on behalf of the Company or any Affiliates thereof
for inclusion or incorporation by reference in the Offer Documents.

  


 

  

SECTION 4.06. _No Ownership of Company Common Stock._ None of Parent, Merger
Sub or any of their Affiliates is or has been during the past three years an
"interested stockholder" of the Company as defined in Section 203 of the DGCL.
None of Parent, Merger Sub or any of their controlled Affiliates beneficially
owns, directly or indirectly, or is the record holder of (or during the past
three years has beneficially owned, directly or indirectly, or been the record
holder of), or is (or during the past three years has been) a party to any
Contract (other than this Agreement), arrangement or understanding for the
purpose of acquiring, holding, voting or disposing of, in each case, any
shares of Company Common Stock or any option, warrant or other right to
acquire any shares of Company Common Stock.

  


 

  


 

  

 

41  

  


 

  

SECTION 4.07. _Financing._

  


 

  

(a) Parent has, or will have prior to the Closing, sufficient cash to enable
Merger Sub and the Surviving Corporation to pay all amounts payable to the
stockholders of the Company upon consummation of the Transactions and to
otherwise satisfy all of its obligations under this Agreement.

  


 

  

(b) In no event shall the receipt or availability of any funds or financing by
or to Parent or any of its Affiliates or any other financing transaction be a
condition to any of the obligations of Parent or Merger Sub hereunder.

  


 

  

SECTION 4.08. _Certain Arrangements._ As of the date hereof, there are no
Contracts or other arrangements or understandings (whether oral or written) or
commitments to enter into Contracts or other arrangements or understandings
(whether oral or written) (a) between Parent, Merger Sub or any of their
Affiliates, on the one hand, and any member of the Company's management or
Board of Directors, on the other hand, that relate in any way to the Company
or any of its Subsidiaries, the Company Common Stock or the Transactions or
(b) pursuant to which any stockholder of the Company would be entitled to
receive consideration of a different amount or nature than the Merger
Consideration.

  


 

  

SECTION 4.09. _Brokers and Other Advisors._ Except for Merrill Lynch, Pierce,
Fenner and Smith Incorporated, the fees and expenses of which will be paid by
Parent or Merger Sub, no broker, investment banker, financial advisor or other
person is entitled to receive from the Company any broker's, finder's,
financial advisor's or other similar fee or commission in connection with the
Transactions based upon arrangements made by or on behalf of Parent, Merger
Sub or any of their respective Affiliates.

  


 

  

SECTION 4.10. _Guarantee._ Concurrently with the execution of this Agreement,
Parent has delivered to the Company an accurate and complete copy of the
executed Guarantee. The Guarantee is in full force and effect and is a legal,
valid and binding obligation of the Guarantor, enforceable against the
Guarantor in accordance with its terms, and no event has occurred which
constitutes a default on the part of the Guarantor under the Guarantee.

  


 

  

ARTICLE V

  


 

  

 _Covenants and Agreements_

  


 

  

SECTION 5.01. _Conduct of Business._ (a) During the period from the date
hereof until the Effective Time, except as required by applicable Law, as
contemplated, required or permitted by this Agreement or as described in
Section 5.01(a) of the Company Disclosure Letter, unless Parent otherwise
consents in writing (such consent not to be unreasonably withheld, delayed or
conditioned), the Company shall, and shall cause each of its Subsidiaries to,
carry on its business in all material respects in the ordinary course of
business. To the extent consistent with the foregoing, the

  


 

  


 

  

 

42  

  


 

  


 

  

Company shall, and shall cause its Subsidiaries to, use its and their
commercially reasonable efforts to preserve its and each of its Subsidiaries'
business organizations substantially intact and preserve existing relations
with key customers, suppliers, distributors, partners, employees, Governmental
Authorities and other persons with whom the Company or its Subsidiaries have
significant business relationships, in each case, consistent with past
practice. Without limiting the generality of the foregoing, and except as
required by applicable Law, as contemplated, required or permitted by this
Agreement or as described in Section 5.01(a) of the Company Disclosure Letter,
during such period, unless Parent otherwise consents in writing (such consent
not to be unreasonably withheld, delayed or conditioned), the Company shall
not, and shall not permit any of its Subsidiaries to:

  


 

  

(i) amend the Company Certificate or the Company Bylaws or amend in any
material respect the comparable organizational documents of any Subsidiary of
the Company;

  


 

  

(ii) (A) issue, sell, grant, deliver, pledge, transfer, encumber or authorize
the issuance, sale, grant, delivery, pledge, transfer or encumbrance by the
Company of any shares of its capital stock or other equity or voting
interests, or any securities or rights convertible into, exchangeable or
exercisable for, or evidencing the right to subscribe for any shares of its
capital stock or other equity or voting interests, or any rights, calls,
warrants, restricted securities, right to acquire or options to purchase any
shares of its capital stock or other equity or voting interests, except for
any issuance, sale or grant (1) between or among the Company and its
Subsidiaries or (2) required pursuant to the exercise or settlement of Company
Equity Awards, ESPP Purchase Rights or other equity awards or obligations
under the Company Plans outstanding on the date hereof in accordance with the
terms of the applicable Company Plan in effect on the date hereof or granted
after the date hereof not in violation of this Agreement, (B) redeem, purchase
or otherwise acquire any of its outstanding shares of capital stock or other
equity or voting interests, or any rights, warrants or options to acquire any
shares of its capital stock or other equity or voting interests, except (x)
pursuant to written commitments in effect as of the date hereof with former
directors or employees in connection with the termination of their services to
the Company or any of its Subsidiaries or (y) in connection with the
satisfaction of Tax withholding obligations with respect to Company Equity
Awards, ESPP Purchase Rights or other equity awards, acquisitions by the
Company in connection with the forfeiture of such equity awards, or
acquisitions by the Company in connection with the net exercise of Company
Stock Options, (C) in the case of the Company, establish a record date for,
declare, accrue, set aside for payment or pay any dividend on, or make any
other distribution in respect of, any shares of its capital stock or other
equity or voting interests or (D) split, combine, subdivide or reclassify any
shares of its capital stock or other equity or voting interests;

  


 

  

(iii) (A) incur or guarantee any Indebtedness or enter into any "keep well" or
other Contract to maintain any financial statement condition of another

  


 

  


 

  

 

43  

  


 

  


 

  

person, except for (1) Indebtedness, guarantees, "keep well" or other
Contracts between or among any of the Company and any of its Subsidiaries, (2)
letters of credit issued in the ordinary course of business) and (3)
Indebtedness incurred under the Credit Agreements (including in respect of
letters of credit), or (B) make any loans, capital contributions or advances
to any person, other than to the Company or any Subsidiary of the Company;

  


 

  

(iv) adopt or implement any stockholder rights plan or similar arrangement;

  


 

  

(v) other than with respect to Intellectual Property, sell, lease, license or
otherwise transfer to any person, in a single transaction or series of related
transactions, material properties or assets, except (A) dispositions of
obsolete, worn out or surplus assets or assets that are no longer used or
useful in the conduct of the business of the Company or any of its
Subsidiaries, (B) transfers between or among the Company and its Subsidiaries,
(C) pursuant to existing Contracts in effect on the date hereof or (D) in the
ordinary course of business (which for the avoidance of doubt shall include
(i) leases, subleases or licenses of immaterial portions of Owned Real
Property or Leased Real Property in the ordinary course of business and (ii)
sales or other dispositions of supplies, inventory, merchandise or products in
the ordinary course of business);

  


 

  

(vi) sell, transfer, license, encumber, abandon, cancel, permit to lapse or
otherwise dispose of any Intellectual Property owned by the Company or any of
its Subsidiaries except grant non-exclusive licenses (without any right to
sublicense) of such Intellectual Property in the ordinary course of business;

  


 

  

(vii) make or authorize capital expenditures, except (A) in an aggregate
amount not to exceed the aggregate amount budgeted in the Company's capital
expense budget approved by its Board of Directors that was made available to
Parent prior to the date of this Agreement (the " _Capital Expense Budget_ ")
and (B) capital expenditures in excess of the aggregate amount budgeted in the
Capital Expense Budget not exceeding $1 million in the aggregate during any
fiscal quarter;

  


 

  

(viii) make any acquisition of any business (whether by merger, sale of stock,
sale of assets or otherwise), except in the ordinary course of business (which
for the avoidance of doubt shall include acquisitions of supplies, inventory,
merchandise or products in the ordinary course of business);

  


 

  

(ix) (A) grant to any director, officer or employee any increase in
compensation (except that the Company: (1) may provide increases in
compensation or benefits to employees at the director level and below in the
ordinary course of business and (2) may make annual or quarterly bonus
payments and sales commission payments in the ordinary course of business
pursuant to the terms of a Company Plan in effect on the date hereof, (B)
grant to any director, officer or employee any increase in severance, change-
in-control,

  


 

  


 

  

 

44  

  


 

  


 

  

retention or termination pay (other than in connection with promotions in the
ordinary course of business), (C) enter into any employment or consulting
agreement with any director, officer or employee, (D) except as permitted
under clause (B), establish, adopt, enter into, terminate or amend any
collective bargaining agreement or Company Plan (or any plan, program,
arrangement, practice or agreement that would be a Company Plan if it were in
existence on the date hereof) other than amendments that do not materially
increase the cost of maintaining such Company Plan, (E) take any action to
accelerate any compensation, rights or benefits under any Company Plan, fund
or in any other way secure the payment of any compensation, rights or benefits
under any Company Plan, or amend or waive any vesting criteria under any
Company Plan, (F) materially change any actuarial or other assumptions used to
calculate funding obligations with respect to any Company Plan that is
required by applicable Law to be funded or change the manner in which
contributions to such plans are made or the basis on which such contributions
are determined, except as may be required by GAAP or applicable Law, (G)
forgive any loans to any director, officer or employee, or (H) hire any
employee above the director level or engage any independent contractor or
consultant (who is a natural person) with annual fees in excess of $250,000,
except, in the case of each of clauses (A) through (H), as required pursuant
to the terms of any Company Plan in effect on the date hereof; _provided_ ,
_however_ , that the foregoing shall not restrict the Company or any of its
Subsidiaries from (i) entering into or making available to newly hired
employees or to employees in the context of promotions based on job
performance or workplace requirements, in each case, in the ordinary course of
business, plans, agreements, benefits and compensation arrangements that have
a value that is consistent with the past practice of making compensation and
benefits available to newly hired or promoted employees in similar positions
and (ii) providing newly hired employees with cash-based awards of up to
$25,000 per employee for employees below the director level and up to $50,000
per employee for employees at the director level, in amounts and with vesting
schedules and other material terms that are consistent with those of the
equity awards historically granted to similarly situated newly hired employees
of the Company or its Subsidiaries in the ordinary course of business;
_provided_ that the consummation of the Transactions shall not, either alone
or in combination with another event, accelerate the time of payment or
vesting of such cash-based awards);

  


 

  

(x) make any material change in (A) its financial accounting methods,
principles or policies materially affecting the consolidated assets,
liabilities or results of operations of the Company and its Subsidiaries,
except as may be required by a change in GAAP or (B) its policies regarding
inventory, sales or receivables, except in the case of this clause (B) in the
ordinary course of business consistent with past practice;

  


 

  

(xi) adopt a plan or agreement of complete or partial liquidation or
dissolution, merger, consolidation, restructuring, recapitalization or other
reorganization of the Company or any of its Subsidiaries;

  


 

  


 

  

 

45  

  


 

  


 

  

(xii) grant any Lien, other than Permitted Liens, on any of its material
assets other than to secure Indebtedness permitted under Section 5.01(a)(iii);

  


 

  

(xiii) settle, release, waive or compromise any pending or threatened Action,
other than Actions (A) relating to a breach of this Agreement or (B) pursuant
to a settlement that does not relate to any of the Transactions and that
results solely in a monetary obligation involving only the payment of monies
by the Company or any of its Subsidiaries in settlement or compromise of
amounts that do not, individually or in the aggregate, exceed $500,000
(inclusive of insurance proceeds);

  


 

  

(xiv) other than as required by applicable Law, (A) make any change (or file a
request to make any such change) in any method of Tax accounting, any annual
Tax accounting period or any material Tax election, (B) file any material
amendment to any Tax Return, (C) settle or compromise any claim or assessment
in respect of material Taxes, (D) surrender any claim for a refund of material
Taxes, (E) enter into any closing agreement relating to material Taxes, (F)
file any material Tax Return that is inconsistent with past practice, (G)
consent to any extension or waiver of the limitations period applicable to any
Tax claim or assessment in respect of material Taxes (in each case of clauses
(A) through (G), other than in the ordinary course of business) or (H) take
any action (other than in the ordinary course of business) which would
reasonably be expected to result in a material increase in the Tax liability
of the Company or any of its Subsidiaries, or, in respect of any taxable
period (or portion thereof) ending after the Closing Date, the Tax liability
of Parent or the Company;

  


 

  

(xv) form any Subsidiary or enter into any joint venture, partnership, limited
liability corporation or similar arrangement;

  


 

  

(xvi) amend or modify in any material respect any Material Contract, other
than in the ordinary course of business consistent with past practice; or

  


 

  

(xvii) authorize any of, or commit or agree, in writing or otherwise, to take
any of, the foregoing actions.

  


 

  

(b) Neither Parent nor Merger Sub shall knowingly take or permit any of their
respective Affiliates to take any action that could reasonably be expected to
prevent or to impede, interfere with, hinder or delay in any material respect
the consummation of the Transactions.

  


 

  

(c) Nothing contained in this Agreement is intended to give Parent, directly
or indirectly, the right to control or direct the Company's or its
Subsidiaries' operations prior to the Effective Time, and nothing contained in
this Agreement is intended to give the Company, directly or indirectly, the
right to control or direct Parent's or its Subsidiaries' operations. Prior to
the Effective Time, each of Parent and the Company shall exercise, consistent
with the terms and conditions of this Agreement, complete control and
supervision over its and its Subsidiaries' respective operations.

  


 

  


 

  

 

46  

  


 

  


 

  

SECTION 5.02. _No Solicitation; Change in Recommendation._

  


 

  

(a) The Company shall, and shall cause each of its Subsidiaries to, and shall
cause its Representatives to, (i) immediately cease any solicitation,
encouragement, discussions or negotiations with any persons with respect to a
Takeover Proposal that existed prior to the date of this Agreement and (ii)
from the date hereof until the Effective Time, not, directly or indirectly,
(A) initiate, solicit or knowingly facilitate or encourage (including by way
of furnishing non-public information) the making of any Takeover Proposal, (B)
engage in, continue or otherwise participate in any discussions or
negotiations regarding, or furnish to any other person any non-public
information in connection with, in response to or for the purpose of
facilitating or encouraging, a Takeover Proposal, (C) enter into any letter of
intent, memorandum of understanding, agreement in principle, merger agreement,
acquisition agreement or other similar agreement with respect to either a
Takeover Proposal or any proposal or offer that could reasonably be expected
to lead to a Takeover Proposal or (D) release any person from, waive any
provision of or fail to enforce any standstill agreement to which the Company
or any of its Subsidiaries is a party, unless taking such action is reasonably
likely to lead to the receipt by the Company of a Superior Proposal. The
Company shall promptly deliver a written notice to each person that entered
into a confidentiality agreement in anticipation of potentially making a
Takeover Proposal to the effect that the Company is ending all discussions and
negotiations with such person with respect to any Takeover Proposal, effective
on the date hereof, and the notice shall also demand such person to promptly
return or destroy all confidential information concerning the Company and its
Subsidiaries.

  


 

  

(b) Notwithstanding anything contained in Section 5.02(a) or any other
provision of this Agreement to the contrary, if at any time after the date
hereof and prior to the Offer Acceptance Time, the Company or any of its
Representatives receives an unsolicitied bona fide written Takeover Proposal,
which Takeover Proposal did not result from any breach of this Section 5.02,
then (i) the Company and its Representatives may contact such person or group
of persons making the Takeover Proposal to request that such person or group
clarify the terms and conditions thereof in writing and (ii) if (A) the Board
of Directors of the Company determines in good faith, after consultation with
its financial advisors and outside legal counsel, that such Takeover Proposal
constitutes or is reasonably likely to lead to a Superior Proposal and the
failure to take such action would be inconsistent with the directors'
fiduciary duties under applicable Law and (B) prior to or concurrently with
furnishing any information to, or entering into discussions or negotiations
with, the person or group of persons making such Takeover Proposal, the
Company provides written notice to Parent of the identity of such person or
group and of the Company's intention to furnish information to, or enter into
discussions with, such person or group, then the Company and its
Representatives may (x) enter into an Acceptable Confidentiality Agreement
with such person or group and furnish pursuant (but only pursuant) thereto
information (including non-public information) with respect to the Company and
its Subsidiaries to such person or group and (y) engage in or otherwise
participate in discussions or negotiations with such person or group. In the
event that, pursuant to clause (x) of the foregoing sentence, the Company
furnishes to a person or group of persons making a Takeover Proposal any
material non-public

  


 

  


 

  

 

47  

  


 

  


 

  

information concerning the Company or its Subsidiaries that has not previously
been furnished or made available to Parent or its Representatives, the Company
shall substantially contemporaneously make such information available to
Parent. As used in this Agreement, the term " _Acceptable Confidentiality
Agreement_ " means any confidentiality agreement entered into by the Company
from and after the date hereof that contains provisions that are no less
favorable in the aggregate to the Company than those contained in the
Confidentiality Agreement, except that such confidentiality agreement need not
include a standstill provision.

  


 

  

(c) The Company shall within 36 hours notify Parent in the event that the
Company or any of its Subsidiaries or its or their Representatives receives a
Takeover Proposal and shall, as promptly as practicable, (i) disclose to
Parent the material terms and conditions of any such Takeover Proposal and the
identity of the person or group of persons making such Takeover Proposal and
(ii) provide Parent a copy of all material written materials provided by any
person in connection with such Takeover Proposal. The Company shall keep
Parent reasonably and promptly informed of any material developments,
discussions or negotiations with respect to any such Takeover Proposal
(including any material changes thereto). The Company agrees that it and its
Subsidiaries will not, after the date of this Agreement, enter into any
confidentiality agreement with any person that prohibits the Company from
providing any information to Parent in accordance with this Section 5.02(c).

  


 

  

(d) Except as set forth in Section 5.02(e) and this Section 5.02(d), neither
the Board of Directors of the Company nor any committee thereof shall (i) (A)
withhold, withdraw or qualify (or modify in a manner adverse to Parent), or
publicly propose or announce any intention to withhold, withdraw or qualify
(or modify in a manner adverse to Parent), the Company Board Recommendation,
or fail to include the Company Board Recommendation in (or remove it from) the
Schedule 14D-9 or (B) approve or adopt, recommend the approval or adoption of
or declare advisable, or publicly propose or announce any intention to
recommend, approve, adopt or declare advisable, any Takeover Proposal (any
action described in this clause (i) being referred to as an " _Adverse
Recommendation Change_ "); _provided_ that the Board of Directors of the
Company may, and may cause the Company to, make a customary "stop, look and
listen" communication pursuant to Rule 14d-9(f) under the Exchange Act without
such action being considered an Adverse Recommendation Change or (ii)
authorize, cause or permit the Company or any of its Subsidiaries to execute
or enter into any letter of intent, memorandum of understanding, agreement in
principle, merger agreement, acquisition agreement or other similar agreement
related to any Takeover Proposal, other than an Acceptable Confidentiality
Agreement (each, a " _Company Acquisition Agreement_ "). Notwithstanding the
foregoing, prior to the Offer Acceptance Time, the Board of Directors of the
Company may (1) under circumstances not involving any Takeover Proposal, make
an Adverse Recommendation Change if a Change in Circumstance has occurred and
the Board of Directors of the Company has determined in good faith, after
consultation with its financial advisors and outside legal counsel, that the
failure to make such Adverse Recommendation Change would be inconsistent with
the directors' fiduciary duties under applicable Law or (2) in response to an
unsolicited bona fide written Takeover Proposal, which Takeover Proposal was
made or renewed on or after

  


 

  


 

  

 

48  

  


 

  


 

  

the date of this Agreement and did not result from any breach of this Section
5.02, (x) make an Adverse Recommendation Change and/or (y) cause the Company
to enter into a Company Acquisition Agreement providing for such Takeover
Proposal and concurrently terminate this Agreement pursuant to Section
7.01(d)(ii), in each case described in subclause (x) or subclause (y) of this
clause (2) if and only if the Board of Directors of the Company has determined
in good faith, after consultation with its financial advisors and outside
legal counsel, that such Takeover Proposal constitutes a Superior Proposal and
the failure to take such action would be inconsistent with the directors'
fiduciary duties under applicable Law. The Board of Directors of the Company
shall not, and shall cause the Company not to, take any action set forth in
clause (1) of the second sentence of this Section 5.02(d) unless (A) the
Company has given Parent at least four Business Days' prior written notice of
its intention to take such action (which notice shall specify in reasonable
detail the Change in Circumstance and the reasons for the Adverse
Recommendation Change), (B) the Company has negotiated, and has caused its
Representatives to negotiate, in good faith with Parent during such notice
period, to the extent Parent wishes to negotiate, so that such Change in
Circumstance would no longer necessitate an Adverse Recommendation Change and
(C) following the end of such notice period, the Board of Directors of the
Company has determined in good faith, after consultation with its financial
advisors and outside legal counsel, that the failure to make such Adverse
Recommendation Change in response to such Change in Circumstance would be
inconsistent with the directors' fiduciary duties under applicable Law. After
complying with the foregoing sentence with respect to an Adverse
Recommendation Change in response to a Change in Circumstance, the Company
shall have no further obligations under such sentence with respect to an
Adverse Recommendation Change in response to such Change in Circumstance, and
the Board of Directors of the Company shall not be required to comply with
such obligations with respect to any other Adverse Recommendation Change in
response to such Change in Circumstance. The Board of Directors of the Company
shall not, and shall cause the Company not to, take any action set forth in
clause (2) of the second sentence of this Section 5.02(d) unless (A) the
Company has given Parent at least five Business Days' prior written notice of
its intention to take such action (which notice shall specify the material
terms of any such Superior Proposal and the identity of the person or group of
persons making such Superior Proposal and copies of all material documents
relating to such Takeover Proposal), (B) the Company has negotiated, and has
caused its Representatives to negotiate, in good faith with Parent during such
notice period, to the extent Parent wishes to negotiate, to enable Parent to
propose in writing a binding offer to effect revisions to the terms of this
Agreement such that it would cause such Superior Proposal to no longer
constitute a Superior Proposal and (C) following the end of such notice
period, the Board of Directors of the Company has considered in good faith
such binding offer, and has determined that the Superior Proposal would
continue to constitute a Superior Proposal if the revisions proposed in such
binding offer were to be given effect and the failure to make such Adverse
Recommendation Change and/or enter into such Company Acquisition Agreement and
concurrently terminate this Agreement pursuant to Section 7.01(d)(ii) would be
inconsistent with the directors' fiduciary duties under applicable Law. The
provisions of the previous sentence shall also apply to any material amendment
to any Takeover Proposal or any successive Takeover Proposal and the

  


 

  


 

  

 

49  

  


 

  


 

  

Company shall be required to deliver a new written notice to Parent and comply
with the requirements of this Section 5.02(d) with respect to such new written
notice, except that references to the five Business Day period shall be deemed
to be references to a three Business Day period.

  


 

  

(e) Nothing in this Section 5.02 or elsewhere in this Agreement shall prohibit
the Company or the Board of Directors of the Company from (i) taking and
disclosing to the stockholders of the Company a position contemplated by Rule
14e-2(a) or Rule 14d-9 promulgated under the Exchange Act or Item 1012(a) of
Regulation M-A promulgated under the Exchange Act or (ii) making any
disclosure to the stockholders of the Company that is required by applicable
Law; _provided_ , _however_ that, in each case, if such disclosure has the
substantive effect of withholding, withdrawing, qualifying or modifying (in a
manner adverse to Parent) the Company Board Recommendation, such disclosure
shall be deemed to be an Adverse Recommendation Change.

  


 

  

(f) As used in this Agreement, the term " _Takeover Proposal_ " means any
inquiry, proposal or offer from any person or group of persons (other than
Parent and its Subsidiaries) relating to (i) any direct or indirect
acquisition, license, lease, exchange or other disposition of assets, in a
single transaction or series of related transactions, of 20% or more of the
consolidated assets of the Company and its Subsidiaries (which assets may
include equity securities of the Company's Subsidiaries) or to which 20% or
more of the Company's revenues or earnings on a consolidated basis are
attributable, (ii) any issuance or direct or indirect acquisition, in a single
transaction or series of related transactions, of 20% or more of the voting
power of or of any class of equity securities of the Company, (iii) any tender
offer or exchange offer that if consummated would result in any person or
group of persons beneficially owning 20% or more of the voting power of or of
any class of equity securities of the Company or (iv) any merger,
consolidation, share exchange, business combination, recapitalization,
liquidation, dissolution or similar transaction involving the Company pursuant
to which such person or group of persons (or the stockholders of any person)
would acquire, directly or indirectly, 20% or more of the consolidated assets
of the Company and its Subsidiaries or 20% or more of the aggregate voting
power of any class of equity securities of the Company or of the surviving
entity in a merger involving the Company or the resulting direct or indirect
parent of the Company or such surviving entity, in each case, other than the
Transactions.

  


 

  

(g) As used in this Agreement, the term " _Superior Proposal_ " means any
unsolicited bona fide written Takeover Proposal not resulting from a breach of
this Section 5.02 that the Board of Directors of the Company has determined in
its good faith judgment, after consultation with its financial advisors and
outside legal counsel, would be more favorable from a financial point of view
to the Company's stockholders than the Transactions, taking into account all
aspects of such Takeover Proposal, including legal, regulatory and financing
aspects and the timing and likelihood of closing; _provided_ that for purposes
of the definition of "Superior Proposal", the references to "20%" in the
definition of Takeover Proposal shall be deemed to be references to "50%".

  


 

  

(h) As used in this Agreement, the term " _Change in Circumstance_ " means a
material event, fact, circumstance, development or occurrence (other than any

  


 

  


 

  

 

50  

  


 

  


 

  

matter that relates to a Takeover Proposal) that is unknown to or by the Board
of Directors of the Company as of the date of this Agreement, which event,
fact, circumstance, development or occurrence becomes known to or by the Board
of Directors of the Company prior to the Offer Acceptance Time.

  


 

  

SECTION 5.03. _Reasonable Best Efforts; Approvals._

  


 

  

(a) Subject to the terms and conditions of this Agreement, each of the parties
hereto shall cooperate with the other parties and use (and shall cause their
respective Subsidiaries to use) their respective reasonable best efforts to
promptly (i) take, or cause to be taken, all actions, and do, or cause to be
done, and assist and cooperate with the other parties hereto in doing, all
things necessary, proper or advisable to cause the conditions to Closing to be
satisfied as promptly as reasonably practicable and to consummate and make
effective, in the most expeditious manner reasonably practicable, the
Transactions, including preparing and filing promptly and fully all
documentation to effect all necessary filings, notices, petitions, statements,
registrations, submissions of information, applications and other documents,
(ii) obtain all approvals, consents, registrations, waivers, permits,
authorizations, orders and other confirmations from any Governmental Authority
or third party necessary, proper or advisable to consummate the Transactions,
(iii) execute and deliver any additional instruments necessary to consummate
the Transactions and (iv) defend or contest in good faith any Action brought
by a third party that could otherwise prevent or impede, interfere with,
hinder or delay in any material respect the consummation of the Transactions,
in the case of each of clauses (i) through (iv), other than with respect to
filings, notices, petitions, statements, registrations, submissions of
information, applications and other documents, approvals, consents,
registrations, permits, authorizations and other confirmations relating to
Antitrust Laws, which are the subject of Sections 5.03(b), 5.03(c) and
5.03(d). In furtherance and not in limitation of the foregoing, the Company
and Parent shall each use its reasonable best efforts to (A) take all action
necessary to ensure that no Takeover Law is or becomes applicable to any of
the Transactions and refrain from taking any actions that would cause the
applicability of such Laws and (B) if the restrictions of any Takeover Law
become applicable to any of the Transactions, take all action necessary to
ensure that the Transactions may be consummated as promptly as practicable on
the terms contemplated by this Agreement and otherwise lawfully minimize the
effect of such Takeover Law on the Transactions.

  


 

  

(b) Each of the parties hereto agrees to (i) make an appropriate filing of a
Notification and Report Form pursuant to the HSR Act and any other applicable
Antitrust Law with respect to the Transactions as promptly as reasonably
practicable following the date hereof (and in any event within 10 days
following the date hereof), (ii) supply as promptly as reasonably practicable
any additional information and documentary material that may be requested
pursuant to the HSR Act or any other applicable Antitrust Law and (iii) take
or cause to be taken all other actions necessary to cause the expiration or
termination of the applicable waiting periods under the HSR Act and any other
applicable Antitrust Laws and to obtain all consents under any Antitrust Laws
that may be required by any Governmental Authority with competent
jurisdiction, so as to enable the parties hereto to consummate the
Transactions.

  


 

  


 

  

 

51  

  


 

  


 

  

(c) Nothing in this Agreement, including any provision of this Section 5.03,
shall require, or be construed to require, Parent or any of its Affiliates to
proffer to, or agree (i) to, sell, divest, lease, license, transfer, dispose
of or otherwise encumber, (ii) to hold separate and agree to sell, divest,
lease, license, transfer, dispose of or otherwise encumber before or after the
Offer Acceptance Time or the Effective Time, any assets, licenses, operations,
rights, product lines, businesses or interest therein of Parent, the Company
or any of their respective Affiliates (or to consent to any sale, divestiture,
lease, license, transfer, disposition or other encumbrance by the Company of
any of its assets, licenses, operations, rights, product lines, businesses or
interest therein or to any agreement by the Company to take any of the
foregoing actions) or (iii) to agree to any material changes (including
through a licensing arrangement) or restriction on, or other impairment of
Parent's ability to own or operate, any such assets, licenses, operations,
rights, product lines, businesses or interests therein or Parent's ability to
vote, transfer, receive dividends or otherwise exercise full ownership rights
with respect to the capital stock of the Company or the Surviving Corporation,
except for proffers and agreements to amend or modify Contracts between the
Company and/or its Subsidiaries and third parties or sell, divest, lease,
license, transfer, dispose or otherwise encumber, or to agree to changes,
restrictions or other impairments with respect to, any of Parent's or the
Company's (or their respective Affiliates') assets, licenses, operations,
rights, product lines, businesses or interest therein, where such amended,
sold, divested, leased, licensed, transferred, disposed or encumbered
Contracts, assets, licenses, operations, rights, product lines, businesses and
interests in the aggregate shall have accounted for $25 million or less of the
parties' and their respective Affiliates' gross revenues for the 12 months
ending December 31, 2016.

  


 

  

(d) Each of the parties hereto shall use its reasonable best efforts to (i)
cooperate in all respects with each other in connection with any filing or
submission with a Governmental Authority in connection with the Transactions
and in connection with any investigation or other inquiry by or before a
Governmental Authority relating to the Transactions, including any proceeding
initiated by a private party, (ii) keep the other parties hereto informed in
all material respects and on a reasonably timely basis of any material
communication received by such party from, or given by such party to, the
Federal Trade Commission (the " _FTC_ "), the Antitrust Division of the
Department of Justice (the " _DOJ_ ") or any other Governmental Authority and
of any material communication received or given in connection with any
proceeding by a private party, in each case regarding any of the Transactions,
(iii) subject to applicable Laws relating to the exchange of information, and
to the extent reasonably practicable, consult with the other parties hereto
with respect to information relating to the other parties hereto and their
respective Subsidiaries, as the case may be, that appears in any filing made
with, or written materials submitted to, any third person or any Governmental
Authority in connection with the Transactions, other than documents submitted
under Item 4(c) or 4(d) of the Notification and Report Form pursuant to the
HSR Act, and (iv) to the extent permitted by the FTC, the DOJ or such other
applicable Governmental Authority or other person, give the other parties
hereto the opportunity to attend and participate in such meetings and
conferences.

  


 

  


 

  

 

52  

  


 

  


 

  

SECTION 5.04. _Public Announcements._ Unless and until an Adverse
Recommendation Change has occurred, Parent and the Company shall consult with
each other before issuing, and give each other the opportunity to review and
comment upon, any press release or other public statements with respect to the
Transactions, and shall not issue any such press release or make any such
public statement prior to such consultation, except as may be required by
applicable Law, court process or the rules and regulations of any national
securities exchange or national securities quotation system and except for any
matters referred to in Section 5.02. The parties hereto agree that the initial
press release to be issued with respect to the Transactions following
execution of this Agreement shall be in the form heretofore agreed to by
Parent and the Company.

  


 

  

SECTION 5.05. _Access to Information; Confidentiality._ Except as set forth in
Section 5.05 of the Company Disclosure Letter, subject to applicable Law,
between the date of this Agreement and the earlier of the Effective Time and
the termination of this Agreement pursuant to Section 7.01, upon reasonable
notice, the Company shall afford to Parent and Parent's Representatives
reasonable access during normal business hours to the Company's officers,
employees, agents, properties, books, Contracts and records (other than any of
the foregoing that relate to the negotiation and execution of this Agreement,
or, subject to Section 5.02, to any Takeover Proposal or any other
transactions potentially competing with or alternative to the Transactions or
proposals from other parties relating to any competing or alternative
transactions) and the Company shall furnish promptly to Parent and Parent's
Representatives such information concerning its business, personnel, assets,
liabilities and properties as Parent may reasonably request. Parent and
Parent's Representatives (i) shall conduct any such activities in such a
manner as not to interfere unreasonably with the business or operations of the
Company and (ii) shall not be permitted to conduct any Phase II or other
intrusive sampling, testing or investigation (including of soil, water, air or
surfaces) at, on or under any real property of the Company or its
Subsidiaries. The Company shall not be obligated to provide such access or
information if the Company determines, in its reasonable judgment, that doing
so could violate applicable Law or a Contract or obligation of confidentiality
owing to a third party, waive the protection of an attorney-client privilege,
work product doctrine or other legal privilege or expose the Company to risk
of liability for disclosure of sensitive or personal information; _provided_ ,
that information shall be disclosed subject to execution of a joint defense
agreement in customary form to external counsel of Parent to the extent
reasonably required for the purpose of complying with applicable Antitrust
Laws. Without limiting the foregoing, in the event that the Company does not
provide access or information in reliance on the immediately preceding
sentence, it shall provide notice to Parent that it is withholding such access
or information and shall use its reasonable efforts to communicate, to the
extent feasible, the applicable information in a way that would not violate
the applicable Law, Contract or obligation or risk waiver of such privilege.
All requests for information made pursuant to this Section 5.05 shall be
directed to the General Counsel of the Company or other person designated by
the Company. For the avoidance of doubt, until the Effective Time, all
information provided by or on behalf of the Company or its Subsidiaries
pursuant to this Section 5.05 or pursuant to Section 5.02 will be subject to

  


 

  


 

  

 

53  

  


 

  


 

  

the terms of the Confidentiality Agreement, which shall remain in full force
and effect in accordance with its terms.

  


 

  

SECTION 5.06. _Indemnification and Insurance._

  


 

  

(a) From and after the Effective Time until the sixth anniversary of the date
on which the Effective Time occurs, each of Parent and the Surviving
Corporation shall, and Parent shall cause the Surviving Corporation to, (i)
indemnify and hold harmless each individual who at the Effective Time is, or
at any time prior to the Effective Time was, a director or officer of the
Company or of a Subsidiary of the Company (each, an " _Indemnitee_ ") with
respect to all claims, liabilities, losses, damages, judgments, fines,
penalties, costs (including amounts paid in settlement or compromise) and
expenses (including fees and expenses of legal counsel) in connection with any
Action (whether civil, criminal, administrative or investigative), whenever
asserted, based on or arising out of, in whole or in part, (A) the fact that
an Indemnitee was a director or officer of the Company or such Subsidiary or
(B) acts or omissions by an Indemnitee in the Indemnitee's capacity as a
director or officer of the Company or such Subsidiary or taken at the request
of the Company or such Subsidiary (including in connection with serving at the
request of the Company or such Subsidiary as a director, officer, employee,
agent, trustee or fiduciary of another person (including any employee benefit
plan)), in each case under clauses (A) or (B), at, or at any time prior to,
the Effective Time (including any Action relating in whole or in part to the
Transactions or relating to the enforcement of this provision or any other
indemnification or advancement right of any Indemnitee), to the fullest extent
the Company would have been permitted to do so under applicable Law, and (ii)
assume all obligations of the Company and its Subsidiaries to the Indemnitees
in respect of indemnification and exculpation from liabilities for acts or
omissions occurring at or prior to the Effective Time as provided in the
Company Certificate and the Company Bylaws and the organizational documents of
such Subsidiaries as in effect on the date hereof or in any agreement in
existence as of the date hereof providing for indemnification between the
Company and any Indemnitee. Without limiting the foregoing, Parent, from and
after the Effective Time, shall cause, unless otherwise required by Law, the
certificate of incorporation and the by-laws of the Surviving Corporation to
contain provisions no less favorable to the Indemnitees with respect to
limitation of liabilities of directors and officers and indemnification than
are set forth as of the date hereof in the Company Certificate and the Company
Bylaws, which provisions shall not be amended, repealed or otherwise modified
in a manner that would adversely affect the rights thereunder of the
Indemnitees. In addition, from and after the Effective Time, Parent shall, and
shall cause the Surviving Corporation to, advance any expenses (including fees
and expenses of legal counsel) of any Indemnitee under this Section 5.06
(including in connection with enforcing the indemnity and other obligations
referred to in this Section 5.06) as incurred to the fullest extent the
Company would have been permitted to do so under applicable Law; _provided_
that the individual to whom expenses are advanced provides an undertaking to
repay such advances if it shall be determined that such person is not entitled
to be indemnified pursuant to this Section 5.06(a).

  


 

  


 

  

 

54  

  


 

  


 

  

(b) None of Parent or the Surviving Corporation shall settle, compromise or
consent to the entry of any judgment in any threatened or actual Action
relating to any acts or omissions covered under this Section 5.06 for which
indemnification has been sought by an Indemnitee hereunder, unless such
settlement, compromise or consent includes an unconditional release of such
Indemnitee from all liability arising out of such Action or such Indemnitee
otherwise consents in writing to such settlement, compromise or consent. Each
of Parent, the Surviving Corporation and the Indemnitees shall cooperate in
the defense of any Action and shall provide access to properties and
individuals as reasonably requested and furnish or cause to be furnished
records, information and testimony, and attend such conferences, discovery
proceedings, hearings, trials or appeals, as may be reasonably requested in
connection therewith.

  


 

  

(c) For a period of six years from the Effective Time, Parent shall cause the
Surviving Corporation to maintain in effect the current policies of directors'
and officers' liability insurance and fiduciary liability insurance maintained
by the Company and its Subsidiaries covering acts or omissions occurring at or
prior to the Effective Time with respect to those current or former directors
or officers who are currently (and any additional directors or officers who
prior to the Effective Time become) covered by the Company's directors' and
officers' liability insurance policies; _provided_ that (i) if any Action
(whether arising before, at or after the Effective Time) is brought against an
Indemnitee on or prior to the sixth anniversary of the Effective Time, the
provisions of this Section 5.06 shall continue in effect until the full and
final resolution of such Action and (ii) if the aggregate annual premium for
such insurance exceeds 300% of the current annual premium for such insurance,
then Parent shall provide or cause to be provided a policy for the applicable
individuals with the greatest coverage as is then available at a cost up to
but not exceeding 300% of such current aggregate annual premium. At the
Company's option, the Company may (or if requested by Parent, the Company
shall) purchase, prior to the Effective Time, a six-year prepaid "tail" policy
on terms and conditions providing at least substantially equivalent benefits
as the current policies of directors' and officers' liability insurance and
fiduciary liability insurance maintained by the Company and its Subsidiaries
with respect to matters arising on or prior to the Effective Time, covering
without limitation the Merger and the other Transactions; _provided_ that in
no event shall the aggregate annual premium for such insurance exceed 300% of
the current annual premium for such insurance. If such prepaid "tail" policy
has been obtained by the Company prior to the Effective Time, Parent shall
cause such policy to be maintained in full force and effect, for its full
term, and cause all obligations thereunder to be honored by the Surviving
Corporation, and no other party shall have any further obligation to purchase
or pay for insurance pursuant to this Section 5.06(c).

  


 

  

(d) The provisions of this Section 5.06 are (i) intended to be for the benefit
of, and shall be enforceable by, each Indemnitee, his or her heirs and his or
her representatives and (ii) in addition to, and not in substitution for, any
other rights to indemnification or contribution that any such individual may
have under the Company Certificate or the Company Bylaws, by Contract or
otherwise. The obligations of Parent and the Surviving Corporation under this
Section 5.06 shall not be terminated or modified in such a manner as to
adversely affect the rights of any Indemnitee to whom this

  


 

  


 

  

 

55  

  


 

  


 

  

Section 5.06 applies unless (x) such termination or modification is required
by applicable Law or (y) the affected Indemnitee has consented in writing to
such termination or modification (it being expressly agreed that the
Indemnitees to whom this Section 5.06 applies shall be third-party
beneficiaries of this Section 5.06).

  


 

  

(e) In the event that Parent, the Surviving Corporation or any of their
respective successors or assigns (i) consolidates with or merges into any
other person and is not the continuing or surviving corporation or entity of
such consolidation or merger or (ii) transfers or conveys all or substantially
all of its properties and assets to any person, then, and in each such case,
proper provision shall be made so that the successors and assigns of parent or
the Surviving Corporation shall assume all of the obligations thereof set
forth in this Section 5.06.

  


 

  

(f) Nothing in this Agreement is intended to, shall be construed to or shall,
release, waive or impair any rights to directors' and officers' insurance
claims under any policy that is or has been in existence with respect to the
Company or any of its Subsidiaries for any of their respective directors,
officers or other employees, it being understood and agreed that the
indemnification provided for in this Section 5.06 is not prior to or in
substitution for any such claims under such policies.

  


 

  

SECTION 5.07. _Rule 16b-3._ Prior to the Effective Time, the Company shall be
permitted to take such steps as are necessary to cause dispositions of Company
equity securities (including derivative securities) pursuant to the
Transactions by each individual who is subject to Section 16 of the Exchange
Act to be exempt under Rule 16b-3 promulgated under the Exchange Act.

  


 

  

SECTION 5.08. _Employee Matters._

  


 

  

(a) During the period commencing at the Effective Time and ending on the first
anniversary of the Effective Time, Parent shall provide, or shall cause the
Surviving Corporation (or in the case of a transfer of all or substantially
all the assets and business of the Surviving Corporation, its successors and
assigns) to provide, each individual who is employed by the Company or any of
its Subsidiaries immediately prior to the Effective Time (each, a " _Company
Employee_ ") with (i) a base salary or wages (as applicable) that are no less
favorable than those in effect immediately prior to the Effective Time, (ii)
severance benefits that are no less favorable than those that would have been
provided to such Company Employee under the applicable severance benefit
plans, programs, policies, agreements and arrangements set forth in Section
5.08(a) of the Company Disclosure Letter and (iii) employee benefit plans and
arrangements (other than annual cash bonus and long-term incentive
opportunities and those referred to in clauses (i) and (ii) above) that are no
less favorable in the aggregate than those provided to the Company Employees
immediately prior to the Effective Time. In addition, (x) during the period
commencing at the Effective Time and ending on December 31, 2017, Parent shall
provide, or shall cause the Surviving Corporation (or in the case of a
transfer of all or substantially all the assets and business of the Surviving
Corporation, its successors and assigns) to provide each Company Employee with
target and maximum annual cash bonus opportunities that are no less favorable,
in each case, than those in effect

  


 

  


 

  

 

56  

  


 

  


 

  

immediately prior to the Effective Time and (y) during the period beginning on
January 1, 2018 and ending on December 31, 2018, Parent shall provide, or
shall cause the Surviving Corporation (or in the case of a transfer of all or
substantially all the assets and business of the Surviving Corporation, its
successors and assigns) to provide each Company Employee with a target annual
cash bonus opportunity that is no less favorable than that in effect
immediately prior to the Effective Time and on other terms and conditions no
less favorable than provided to similarly situated employees of Parent.

  


 

  

(b) Without limiting the generality of Section 5.08(a), Parent shall, or shall
cause the Surviving Corporation to, honor in accordance with their terms all
the Company Plans, as in effect at the Effective Time.

  


 

  

(c) With respect to all employee benefit plans of the Surviving Corporation
and its Subsidiaries, including any "employee benefit plan" (as defined in
Section 3(3) of ERISA) (including any vacation, paid time-off and severance
plans), for all purposes, including determining eligibility to participate,
level of benefits and vesting, each Company Employee's service with the
Company or any of its Subsidiaries (as well as service with any predecessor
employer of the Company or any such Subsidiary, to the extent service with the
predecessor employer was recognized by the Company or such Subsidiary) shall
be treated as service with the Surviving Corporation or any of its
Subsidiaries (or in the case of a transfer of all or substantially all the
assets and business of the Surviving Corporation, its successors and assigns);
_provided_ , _however_ , that such service need not be recognized (i) for the
purposes of benefit accruals under any defined benefit pension plan or other
plan, (ii) for purposes of early retirement subsidies, (iii) to the extent
that such recognition would result in any duplication of benefits for the same
period of service and (iv) to the extent that such service was not recognized
under any similar Company Plan.

  


 

  

(d) Without limiting the generality of Section 5.08(a), Parent shall, or shall
cause the Surviving Corporation to, use commercially reasonable efforts to
waive, or cause to be waived, any pre-existing condition limitations,
exclusions, activelyatwork requirements and waiting periods under any
welfare benefit plan maintained by the Surviving Corporation or any of its
Subsidiaries in which Company Employees (and their eligible dependents) will
be eligible to participate from and after the Effective Time, except to the
extent that such pre-existing condition limitations, exclusions, actively-at-
work requirements and waiting periods would not have been satisfied or waived
under the comparable Company Plan immediately prior to the Effective Time.
Parent shall, or shall cause the Surviving Corporation to, use commercially
reasonable efforts to recognize the dollar amount of all co-payments,
deductibles and similar expenses incurred by each Company Employee (and his or
her eligible dependents) during the calendar year in which the Effective Time
occurs for purposes of satisfying such year's deductible and co-payment
limitations under the relevant welfare benefit plans in which they will be
eligible to participate from and after the Effective Time.

  


 

  

(e) Immediately prior to the Closing Date, the Company shall pay, to each
Company Employee who is a participant in an annual incentive plan or
arrangement

  


 

  


 

  

 

57  

  


 

  


 

  

maintained by the Company and its Subsidiaries (each such plan or arrangement
as set forth on Section 5.08(e) of the Company Disclosure Letter, a " _Company
Bonus Plan_ "), a lump-sum cash payment in respect of the annual bonus payable
with respect to the Company's 2017 fiscal year (the " _Closing Fiscal Year_ ")
under the applicable Company Bonus Plan equal to the product of (i) the
applicable Company Employee's annual bonus amount (as described in the next
sentence) under the applicable Company Bonus Plan and (ii) a fraction, the
numerator of which is the number of days in the Closing Fiscal Year that
elapse prior to the Closing Date, and the denominator of which is 365. Upon
notice to and in consultation with Parent, the Company may determine in good
faith the annual bonus amount with respect to each Company Employee by basing
such annual bonus amount upon the applicable Company Employee's target bonus
for the Closing Fiscal Year under the applicable Company Bonus Plan and the
extent to which the Company determines that applicable performance goals would
have been achieved for the Closing Fiscal Year, by extrapolating the level of
actual performance during the portion of the Closing Fiscal Year that occurs
prior to the Closing Date through the end of the Closing Fiscal Year.

  


 

  

(f) With respect to any Company Employees based outside of the United States,
including those Company Employees based in Puerto Rico, Parent's obligations
under this Section 5.08 shall be modified to the extent necessary to comply
with applicable Laws of the foreign countries and political subdivisions
thereof in which such Company Employees are based.

  


 

  

(g) Parent hereby acknowledges that the consummation of the Transactions
constitutes a "change in control" or "change of control" (or a term of similar
import) for purposes of any Company Plan that contains a definition of "change
in control" or "change of control" (or a term of similar import), as
applicable.

  


 

  

(h) Prior to the Effective Time, if requested by Parent in writing, to the
extent permitted by applicable Law and the terms of the applicable plan or
arrangement, the Company, the Board of Directors of the Company or the
Compensation Committee, as applicable, shall adopt any resolutions necessary
to cause the Spectranetics Salary Savings Plan (the " _Company 401(k) Plan_ ")
to be terminated effective immediately prior to the Effective Time, subject to
the occurrence of Closing (and with all participant and employer contributions
attributable to payroll periods prior to the termination made as of such
time), and the Company shall provide Parent a reasonable opportunity to review
and comment on a copy of such resolution not later than three days preceding
the Effective Time. Without limiting the generality of Section 5.08(a) or the
scope of Parent's obligations thereunder, effective as of the Closing Date,
Parent shall, and shall cause its Affiliates to, have in effect a defined
contribution plan that includes a qualified cash or deferred arrangement
within the meaning of Section 401(k) of the Code (" _Parent 's 401(k) Plan_")
and Parent and the Company shall use commercially reasonable efforts to
cooperate in good faith for the purpose of providing benefits under Parent's
401(k) Plan as soon as administratively practicable following the Closing Date
to the Company Employees participating in the Company 401(k) Plan as of the
Closing Date. If the Parent requests that the Company 401(k) Plan be
terminated pursuant to this Section 5.08(i), then Parent shall permit each
Company Employee participating in the Company

  


 

  


 

  

 

58  

  


 

  


 

  

401(k) Plan to effect, and Parent agrees to cause Parent's 401(k) Plan to
accept, in accordance with applicable Law, a "direct rollover" (within the
meaning of Section 401(a)(31) of the Code) of his or her account balances
(including earnings thereon through the date of transfer and promissory notes
evidencing all outstanding loans) under the Company 401(k) Plan if such
rollover to Parent's 401(k) Plan is elected in accordance with applicable Law
by such Company Employee, subject to (i) the Company's reasonable satisfaction
that the Parent's 401(k) Plan, as applicable, is in compliance with all
applicable Laws and that such plan continues to satisfy the requirements for a
qualified plan under Section 401(a) of the Code and that the trust that forms
a part of such plan is exempt from tax under Section 501(a) of the Code and
(ii) Parent's reasonable satisfaction that the Company 401(k) Plan, as
applicable, is in compliance with all applicable Laws and that such plan
continues to satisfy the requirements for a qualified plan under Section
401(a) of the Code and that the trust that forms a part of such plan is exempt
from tax under Section 501(a) of the Code.

  


 

  

(i) As soon as reasonably practicable after the date of this Agreement (but in
no event later than twenty one days following the date of this Agreement), the
Company shall provide to Parent (i) a revised version of Section 3.10(a) of
the Company Disclosure Letter that contains an accurate and complete list of
each material Foreign Company Plan, (ii) a copy of each material Foreign
Company Plan and all amendments thereto, (iii) as applicable for each such
Foreign Company Plan, documents that are substantially comparable (taking into
account differences in applicable Law and practices) to the documents required
to be provided in clauses (i) through (vi) of Section 3.10(a) and (iv) the
most recent annual and periodic accounting of claims for each Company Plan
that is a self-insured plan governed by ERISA.

  


 

  

(j) Notwithstanding any provision of this Agreement to the contrary, the
provisions of this Section 5.08 are solely for the benefit of the parties to
this Agreement, and no provision of this Section 5.08 is intended to, or
shall, (i) constitute the establishment or adoption of or an amendment to any
employee benefit plan for purposes of ERISA or otherwise, (ii) prevent the
Company, Parent and the Surviving Corporation from amending or terminating any
of its benefit plans (including any Company Plan in accordance with its
terms), (iii) prevent Parent, after the Effective Time, from terminating the
employment of any employees of the Company or its Subsidiaries who continue to
be actively employed by the Surviving Corporation or (iv) create any third-
party beneficiary rights in no current or former employee, any other
individual associated therewith or any collective bargaining representative
thereof.

  


 

  

SECTION 5.09. _Notification of Certain Matters; Stockholder Litigation._

  


 

  

(a) Prior to the Effective Time, the Company shall give prompt notice to
Parent (and will subsequently keep Parent informed on a current basis of any
developments related to such notice) of (i) any notice or other communication
received by the Company from any Governmental Authority in connection with
this Agreement or the Transactions or from any person alleging that the
consent of such person is or may be required in connection with the
Transactions, if the subject matter of such communication

  


 

  


 

  

 

59  

  


 

  


 

  

or the failure of such party to obtain such consent could be material to the
Company, the Surviving Corporation or Parent, (ii) any Actions commenced or,
to the Knowledge of the Company, threatened against the Company which relates
to this Agreement or the Transactions and (iii) the occurrence or existence of
any fact, event or circumstance that (A) has had or would reasonably be
expected to have a Material Adverse Effect or (B) is reasonably likely to
result in any of the conditions set forth in Article VI or Annex I not being
able to be satisfied prior to the End Date; _provided_ that the failure of the
Company to provide any notice required under this Section 5.09(a), in and of
itself, shall not be deemed to be a failure of a condition to the Offer or the
Closing so long as the effect, change, event, occurrence, circumstance or
development underlying such notice is known to Parent prior to the Offer
Acceptance Time.

  


 

  

(b) Prior to the Effective Time, Parent shall give prompt notice to the
Company (and will subsequently keep the Company informed on a current basis of
any developments related to such notice) of the occurrence or existence of any
fact, event or circumstance that (i) has had or would reasonably be expected
have a Parent Material Adverse Effect or (ii) is reasonably likely to result
in any of the conditions set forth in Article VI or Annex I not being able to
be satisfied prior to the End Date; _provided_ that the failure of Parent to
provide any notice required under this Section 5.09(b), in and of itself,
shall not be deemed to be a failure of a condition to the Offer or the Closing
so long as the effect, change, event, occurrence, circumstance or development
underlying such notice is known to the Company prior to the Offer Acceptance
Time.

  


 

  

(c) The Company shall give Parent the opportunity to participate in the
defense and settlement of any stockholder litigation against the Company or
its directors relating to this Agreement or the Transactions. The Company
shall give Parent the right to review and comment in advance on all material
filings or responses to be made by the Company in connection with any such
litigation, and the right to consult on the settlement with respect to such
litigation, and the Company will in good faith take such comments into
account, and no settlement of such litigation shall be agreed to without
Parent's prior written consent (such consent not to be unreasonably withheld,
delayed or conditioned).

  


 

  

SECTION 5.10. _Parent Vote._ Immediately following the execution of this
Agreement, Parent shall execute and deliver, in accordance with Section 228 of
the DGCL and in its capacity as the sole stockholder of Merger Sub, a written
consent adopting this Agreement.

  


 

  

SECTION 5.11. _Tax Matters._

  


 

  

(a) Prior to the Closing Date, the Company shall deliver to Parent a
certificate described in U.S. Treasury Regulation Sections 1.1445-2(c)(3) and
1.897-2(h), certifying that the Company Common Stock does not constitute "U.S.
real property interests" within the meaning of Section 897(c) of the Code and
the U.S. Treasury Regulations promulgated thereunder together with evidence
that the Company has provided notice to the IRS in accordance with the
provisions of Treasury Regulation

  


 

  


 

  

 

60  

  


 

  


 

  

1.897-2(h)(2); _provided_ that failure to deliver such certificate or
evidence shall not be deemed a failure of a condition to the Offer or the
Closing.

  


 

  

(b) Within 21 calendar days of the date of this Agreement, the Company shall
make available to Parent copies of all income Tax Returns filed with any
non-U.S. Taxing Authority by the Company or any of its Subsidiaries for the
2014 and 2015 taxable years.

  


 

  

(c) The Company shall make available to Parent copies of all U.S. federal and
state income Tax Returns of the Company or any of its Subsidiaries for the
2016 taxable year promptly after the filing of such Tax Returns.

  


 

  

(d) Within 21 calendar days of the date of this Agreement, the Company shall
make available to Parent accurate and complete copies of any private letter
ruling requests, closing agreements or gain recognition agreements with
respect to Taxes of the Company or any of its Subsidiaries requested or
executed in the last six years.

  


 

  

SECTION 5.12. _Rule 14d-10 Matters._ Prior to the Offer Acceptance Time, the
Compensation Committee will cause each employment compensation, severance or
other employee benefit arrangement pursuant to which consideration is payable
to any officer, director or employee who is a holder of any security of the
Company to be approved by the Compensation Committee (comprised solely of
"independent directors") in accordance with the requirements of Rule
14d-10(d)(2) under the Exchange Act and the instructions thereto as an
"employment compensation, severance or other employee benefit arrangement"
within the meaning of Rule 14d-10(d)(2) under the Exchange Act and satisfy the
requirements of the non-exclusive safe harbor set forth in Rule 14d-10(d) of
the Exchange Act.

  


 

  

SECTION 5.13. _Key Product Matters_. During such times as Parent is in
compliance with the last sentence of this Section 5.13, the Company shall (a)
with respect to any correspondence, communication (oral or written) or notice
received after the date hereof from any Company Regulatory Agency with respect
to the Key Product that does not require a response from the Company to such
Company Regulatory Agency, to the extent practicable, promptly provide an
update to a member of the Communication Team of the material elements of such
correspondence, communication (oral or written) or notice, (b) with respect to
any correspondence, communication (oral or written) or notice received after
the date hereof from any Company Regulatory Agency with respect to the Key
Product that does not require a response from the Company to such Company
Regulatory Agency in twelve hours or less, (1) to the extent practicable,
promptly provide an update to a member of the Communication Team of the
material elements of such correspondence, communication (oral or written) or
notice and (2) to the extent practicable, provide the Communication Team an
opportunity to review, as reasonably in advance as practicable, and consider
in good faith any views expressed by the Communication Team concerning the
Company's applicable response to such Company Regulatory Agency and (c) with
respect to any correspondence, communication (oral or written) or notice
received after the date hereof from any Company Regulatory Agency

  


 

  


 

  

 

61  

  


 

  


 

  

with respect to the Key Product that requires a response from the Company to
such Company Regulatory Agency in twelve hours or less, provide to a member of
the Communication Team a copy of the Company's applicable response to such
Company Regulatory Agency promptly after such response is transmitted. Parent
shall cause a member of the Communication Team to remain on "telephone
standby" during the Company's business hours on each Business Day.

  


 

  

SECTION 5.14. _Stock Exchange Delisting._ Prior to the Closing Date, the
Company shall cooperate with Parent and use reasonable best efforts to cause
the delisting by the Surviving Corporation of all shares of Company Common
Stock from NASDAQ and the deregistration of all shares of Company Common Stock
under the Exchange Act as soon as reasonably practicable after the Effective
Time.

  


 

  

SECTION 5.15. _Convertible Notes._ To the extent required pursuant to the
Indenture, the Company, the Surviving Corporation and Parent shall take all
necessary action to execute and deliver a supplemental indenture to the
Trustee (as defined in the Indenture) to the Indenture, effective upon the
Effective Time, to provide, among other things, that on and after the
Effective Time, each holder of Convertible Notes shall have the right to
convert such Convertible Notes into the conversion consideration determined by
reference to the consideration receivable upon consummation of the Merger in
respect of each share of Company Common Stock in accordance with, and subject
to, the provisions of the Supplemental Indenture governing the conversions of
the Convertible Notes issued thereunder (including any applicable increase in
the "Conversion Rate"), in each case in accordance with, and subject to, the
Indenture (including the time periods specified therein). In addition, the
Company and the Surviving Corporation shall take commercially reasonable
efforts to take all such actions as may be required in accordance with, and
subject to, the terms of the Indenture (including the time periods specified
therein), including the giving of any notices that may be required in
connection with any repurchases or conversions of the Convertible Notes
occurring as a result of the Transactions constituting a "Fundamental Change"
and/or "Make-Whole Fundamental Change" as such terms are defined in the
Supplemental Indenture, and delivery of any supplemental indentures, legal
opinions, officers' certificates or other documents or instruments required in
connection with the consummation of the Merger. The Company shall not make any
settlement election under the Supplemental Indenture relating to the
Convertible Notes without the prior written consent of Parent, which consent
shall not be unreasonably withheld or delayed. The Company shall provide
Parent and its counsel reasonable opportunity to review and comment on any
written notice or communication to or with holders of Convertible Notes or
with the Trustee under the Indenture prior to the dispatch or making thereof,
and the Company shall give reasonable and good faith consideration to any
comment made by Parent or its counsel.

  


 

  


 

  

 

62  

  


 

  

  

ARTICLE VI

  


 

  

 _Conditions Precedent_

  


 

  

SECTION 6.01. _Conditions to Each Party 's Obligation to Effect the Merger._
The respective obligation of each party to effect the Merger is subject to the
satisfaction or (to the extent permitted by applicable Law) waiver on or prior
to the Closing Date of the following conditions:

  


 

  

(a) _No Injunctions or Restraints._ No Governmental Authority of competent
authority shall have issued an Order or enacted a Law (collectively, "
_Restraints_ ") that is in effect and prohibits, restrains or makes illegal
the consummation of the Merger.

  


 

  

(b) _Consummation of Offer._ Merger Sub shall have irrevocably acccepted for
payment all shares of Company Common Stock validly tendered and not properly
withdrawn pursuant to the Offer.

  


 

  

ARTICLE VII

  


 

  

 _Termination_

  


 

  

SECTION 7.01. _Termination._ This Agreement may be terminated and the
Transactions abandoned at any time prior to the Offer Acceptance Time (except
as otherwise expressly noted):

  


 

  

(a) by the mutual written consent of the Company and Parent duly authorized by
each of their respective Boards of Directors; or

  


 

  

(b) by either the Company or Parent:

  


 

  

(i) if the Offer Acceptance Time shall not have occurred on or prior to the
180th day following the date of this Agreement (the " _End Date_ ");
_provided_ , that if within 15 Business Days prior to the 180th day following
the date of this Agreement, any party hereto brings any Action, in accordance
with Section 8.07, to enforce specifically the performance of the terms and
provisions of this Agreement by any other party, the End Date shall
automatically be extended to the date that is 15 Business Days after the
commencement of such Action; _provided_ , _however_ , that the right to
terminate this Agreement under this Section 7.01(b)(i) shall not be available
to any party whose failure to fulfill any obligation under this Agreement
principally was the cause of or resulted in the failure of the Merger to be
consummated on or before such date (it being understood that Parent and Merger
Sub shall be deemed a single party for purposes of the foregoing proviso);

  


 

  

(ii) at any time prior to the Effective Time, if any Restraint having the
effect set forth in paragraph (b) of Annex I shall be in effect and shall have
become final and nonappealable; _provided_ , _however_ , that the right to
terminate

  


 

  


 

  

 

63  

  


 

  


 

  

this Agreement pursuant to this Section 7.01(b)(ii) shall not be available to
any party whose failure to fulfill any obligation under this Agreement
principally was the cause of or resulted in the failure to prevent the entry
of or to remove such Restraint; or

  


 

  

(c) by Parent:

  


 

  

(i) if the Company shall have breached any of its representations or
warranties or fails to perform any of its covenants or agreements set forth in
this Agreement, which breach or failure to perform (A) would give rise to the
failure of a condition set forth in paragraph (e) or (f) of Annex I and (B) is
incapable of being cured prior to the End Date or, if by its nature such
breach or failure is capable of being cured by the End Date, the Company does
not diligently attempt or ceases to diligently attempt to cure such breach or
failure after receiving notice from Parent describing such breach or failure
in reasonable detail; _provided_ , _however_ , that Parent shall not have the
right to terminate this Agreement pursuant to this Section 7.01(c)(i) if
Parent or Merger Sub is then in material breach of any of its representations,
warranties, covenants or agreements hereunder;

  


 

  

(ii) if the Board of Directors of the Company shall have made an Adverse
Recommendation Change;

  


 

  

(iii) if the Board of Directors of the Company shall have adopted, approved,
recommended, submitted to stockholders, declared advisable, executed or
entered into (or resolved, determined or proposed to adopt, approve,
recommend, submit to stockholders, declare advisable, execute or enter into)
any Company Acquisition Agreement (other than an Acceptable Confidentiality
Agreement entered into pursuant to Section 5.02(b));

  


 

  

(iv) if, in the event that a tender offer or exchange offer (other than the
Offer) has commenced for any of the Company's equity securities, and the Board
of Directors of the Company has failed to recommend, in a Tender Offer
Solicitation/Recommendation Statement on Schedule 14D-9, rejection of such
tender offer or exchange offer prior to the tenth Business Day following the
commencement of such tender offer or exchange offer (the " _Rejection Date_
"), it being understood and agreed that if the Company shall have furnished
the notice contemplated by clause (A) of the fifth sentence of Section 5.02(d)
with respect to such tender offer or exchange offer on or prior to such tenth
Business Day, then the Rejection Date shall be the first Business Day
following the lapse of the later of (A) the notice period contemplated by such
sentence and (B) such later notice period, if any, mandated by the sixth
sentence of such Section 5.02(d);

  


 

  

(v) if, in the event that a Takeover Proposal (other than any tender offer or
exchange offer) has been publicly disclosed, and the Board of Directors of the
Company has failed to publicly reaffirm the Company Board Recommendation prior
to the tenth Business Day following the Company's receipt of a written request
by Parent to provide such reaffirmation (the

  


 

  


 

  

 

64  

  


 

  


 

  

" _Reaffirmation Date_ "), it being understood and agreed that if the Company
shall have furnished the notice contemplated by clause (A) of the fifth
sentence of Section 5.02(d) with respect to such Takeover Proposal on or prior
to such tenth Business Day, then the Reaffirmation Date shall be the first
Business Day following the lapse of the later of (A) the notice period
contemplated by such sentence and (B) such later notice period, if any,
mandated by the sixth sentence of such Section 5.02(d); or

  


 

  

(d) by the Company:

  


 

  

(i) if (A) Merger Sub shall have failed to commence the Offer in accordance
with Section 1.01(a) or (B) Parent or Merger Sub shall have breached any of
its representations or warranties or failed to perform any of its covenants or
agreements set forth in this Agreement, which breach or failure to perform (x)
would give rise to a Parent Material Adverse Effect and (y) is incapable of
being cured prior to the End Date or, if by its nature such breach or failure
is capable of being cured by the End Date, Parent does not diligently attempt
or ceases to diligently attempt to cure such breach or failure after receiving
notice from the Company describing such breach or failure in reasonable
detail; _provided_ , _however_ , that the Company shall not have the right to
terminate this Agreement pursuant to this Section 7.01(d)(i) if the Company is
then in material breach of any of its representations, warranties, covenants
or agreements hereunder; or

  


 

  

(ii) concurrently with entering into a binding written definitive Company
Acquisition Agreement providing for consummation of a Superior Proposal in
accordance with Section 5.02(d), if and only if (A) the Company has complied
in all material respects with the requirements of Section 5.02, (B) the Board
of Directors of the Company, after complying in all material respects with the
requirements set forth in Section 5.02(c) through (h), shall have authorized
the Company to enter into such Company Acquisition Agreement and (C)
concurrently with such termination, the Company pays the Company Termination
Fee due to Parent under Section 7.03(a).

  


 

  

SECTION 7.02. _Effect of Termination._ In the event of the termination of this
Agreement as provided in Section 7.01, written notice thereof shall be given
to the other party or parties hereto, specifying the provision hereof pursuant
to which such termination is made, and this Agreement shall forthwith become
null and void (other than this Section 7.02, Section 1.01(g), Section 7.03,
Article VIII, the Confidentiality Agreement and the Guarantee, all of which
shall survive termination of this Agreement), and there shall be no liability
on the part of Parent, Merger Sub or the Company or their respective
directors, officers and Affiliates, except (a) as liability may exist pursuant
to the Sections specified in the immediately preceding parenthetical that
survive such termination and (b) that no such termination shall relieve any
party from liability for fraud or for any willful material breach of the
provisions of this Agreement prior to the date of termination. For purposes of
this Agreement, " _willful material breach_ " shall mean a material breach of
any representation, warranty or covenant or other

  


 

  


 

  

 

65  

  


 

  


 

  

agreement set forth in this Agreement that is a consequence of an act or
failure to act by the other party with the actual knowledge that the taking of
such act or failure to take such act would cause a breach of any such
representation, warranty, covenant or agreement.

  


 

  

SECTION 7.03. _Termination Fees._

  


 

  

(a) In the event that:

  


 

  

(i) (A) a bona fide Takeover Proposal has been publicly made, proposed or
communicated (and not withdrawn) after the date hereof and prior to the
termination of this Agreement, (B) following the occurrence of an event
described in the preceding clause (A), this Agreement is terminated by the
Company or Parent pursuant to Section 7.01(b)(i) or by Parent pursuant to
Section 7.01(c)(i) and (C) within 12 months of the date this Agreement is
terminated, the Company shall have entered into a definitive agreement
providing for the consummation of a Takeover Proposal or consummates a
Takeover Proposal (whether or not such Takeover Proposal was the same Takeover
Proposal referred to in clause (A)); _provided_ , that for purposes of clause
(C) of this Section 7.03(a)(i), the references to "20%" in the definition of
Takeover Proposal shall be deemed to be references to "50%";

  


 

  

(ii) this Agreement is terminated by the Company pursuant to Section
7.01(d)(ii); or

  


 

  

(iii) this Agreement is terminated by Parent pursuant to Section 7.01(c)(ii),
Section 7.01(c)(iii), Section 7.01(c)(iv) or Section 7.01(c)(v);

  


 

  

then, in each case, the Company shall pay to Parent a termination fee of
$61,000,000 in cash (the " _Company Termination Fee_ "), (x) in the case of
Section 7.03(a)(i), within four Business Days after the consummation of the
Takeover Proposal referred to in clause (i)(C) above, (y) in the case of
Section 7.03(a)(ii), simultaneously with such termination and (z) in the case
of Section 7.03(a)(iii), within four Business Days after such termination (it
being understood that in no event shall the Company be required to pay the
Company Termination Fee on more than one occasion).

  


 

  

(b) In the event that Parent receives full payment of the Company Termination
Fee pursuant to Section 7.03(a) under circumstances where a Company
Termination Fee was payable, the receipt of the Company Termination Fee shall
be the sole and exclusive monetary remedy for any and all losses or damages
suffered or incurred by Parent, Merger Sub, any of their respective Affiliates
or any other person in connection with this Agreement (and the actual or
purported termination hereof), the Merger and the Transactions (and the
abandonment thereof) or any matter forming the basis for such termination;
_provided_ , _however_ , that nothing in this Section 7.03(b) shall relieve
the Company of any liability for fraud or for any willful and material breach
of this Agreement.

  


 

  


 

  


 

  

 

66  

  

  

  

(c) The parties hereto acknowledge that the agreements contained in this
Section 7.03 are an integral part of the Transactions and that, without these
agreements, the parties hereto would not enter into this Agreement;
accordingly, if the Company fails to timely pay any amount due pursuant to
this Section 7.03, and, in order to obtain the payment, Parent commences an
Action which results in a judgment against the Company, the Company shall pay
Parent its reasonable and documented costs and expenses (including reasonable
and documented attorneys' fees) in connection with such suit, together with
interest on such amount at the prime rate as published in the Wall Street
Journal in effect on the date such payment was required to be made through the
date such payment was actually received.

  


 

  

ARTICLE VIII

  


 

  

 _Miscellaneous_

  


 

  

SECTION 8.01. _No Survival of Representations and Warranties._ None of the
representations and warranties in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Effective Time. This
Section 8.01 shall not limit any covenant or agreement of the parties which by
its terms contemplates performance after the Effective Time.

  


 

  

SECTION 8.02. _Amendment or Supplement._ At any time prior to the Offer
Acceptance Time, this Agreement may be amended or supplemented in any and all
respects. Any amendment or supplement to this Agreement shall be valid only if
set forth in an instrument in writing signed on behalf of each of the parties
hereto. This Agreement may not be amended or supplemented after the Offer
Acceptance Time.

  


 

  

SECTION 8.03. _Extension of Time, Waiver, Etc._ At any time prior to the Offer
Acceptance Time, Parent and the Company may, subject to applicable Law, (a)
waive any inaccuracies in the representations and warranties of the other
party, (b) extend the time for the performance of any of the obligations or
acts of the other party or (c) subject to the requirements of applicable Law,
waive compliance by the other party with any of the agreements contained
herein or, except as otherwise provided herein, waive any of such party's
conditions (it being understood that Parent and Merger Sub shall be deemed a
single party for purposes of the foregoing). Notwithstanding the foregoing, no
failure or delay by the Company, Parent or Merger Sub in exercising any right
hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise thereof or the
exercise of any other right hereunder. Any agreement on the part of a party
hereto to any such extension or waiver shall be valid only if set forth in an
instrument in writing signed on behalf of such party.

  


 

  

SECTION 8.04. _Assignment._ Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned, in whole or in part, by
operation of Law or otherwise, by any of the parties hereto without the prior
written consent of the other parties hereto, except that Merger Sub may assign
any and all of its rights under this Agreement, by written notice to the
Company, to another wholly owned direct or indirect Subsidiary of Parent in
lieu of Merger Sub, in which event all references

  


 

  


 

  

 

67  

  


 

  


 

  

to Merger Sub in this Agreement shall be deemed references to such other
Subsidiary, except that all representations and warranties made in this
Agreement with respect to Merger Sub as of the date of this Agreement shall be
deemed representations and warranties made with respect to such other
Subsidiary as of the date of such designation. No assignment by any party
shall relieve such party of any of its obligations hereunder. Subject to the
immediately preceding two sentences, this Agreement shall be binding upon,
inure to the benefit of, and be enforceable by, the parties hereto and their
respective successors and permitted assigns. Any purported assignment not
permitted under this Section 8.04 shall be null and void.

  


 

  

SECTION 8.05. _Counterparts._ This Agreement may be executed in one or more
counterparts (including by facsimile or email), each of which shall be deemed
to be an original but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts have
been signed by each of the parties hereto and delivered to the other parties
hereto.

  


 

  

SECTION 8.06. _Entire Agreement; Third-Party Beneficiaries; No Other
Representations or Warranties._

  


 

  

(a) This Agreement and any exhibits, annexes or schedules hereto, including
the Company Disclosure Letter, together with the Confidentiality Agreement and
the Guarantee, constitute the entire agreement, and supersede all other prior
agreements and understandings, both written and oral, among the parties and
their Affiliates, or any of them, with respect to the subject matter hereof
and thereof, and except for (i) if the Effective Time occurs, the right of the
holders of Company Equity Awards to receive the Equity Award Consideration,
(ii) if the Effective Time occurs, the right of the holders of Company Common
Stock to receive the Merger Consideration and (iii) the provisions set forth
in Section 5.06 of this Agreement.

  


 

  

(b) Each of Parent and Merger Sub acknowledges and agrees that (i) except for
the representations and warranties expressly contained in Article III, neither
the Company nor any other person makes any other express or implied
representation or warranty with respect to the Transactions, this Agreement,
the Company or any of its Subsidiaries or their respective businesses,
operations, assets, liabilities, condition (financial or otherwise) or
prospects or with respect to any information furnished, disclosed or made
available to Parent, Merger Sub or any of their respective Representatives in
the course of their due diligence investigation of the Company and its
Subsidiaries and the negotiation of this Agreement or otherwise in connection
with the Transactions and (ii) except for the representations and warranties
expressly contained in Article III, none of Parent, Merger Sub or their
respective Affiliates, stockholders, controlling persons and Representatives
has relied on any information furnished, disclosed or made available to any of
them by the Company or any of its Subsidiaries, or any of their respective
Representatives, in the course of Parent's, Merger Sub's or any of their
respective Representatives' due diligence investigation of the Company and its
Subsidiaries and the negotiation of this Agreement or otherwise in connection
with the Transactions. The term "information" as used in this Section 8.06
includes any information, documents or material furnished, disclosed or
otherwise made available in

  


 

  


 

  

 

68  

  


 

  


 

  

any form to Parent, Merger Sub or their respective Affiliates, stockholders,
controlling persons and Representatives, including in any data room or
management presentations (formal or informal) and including any financial
statements and any projections, forecasts, budgets, estimates or other
forward-looking information (including in any information or descriptive
memorandum, supplemental information or other materials or information with
respect to any of the foregoing).

  


 

  

(c) The Company acknowledges and agrees that (i) except for the
representations and warranties expressly contained in Article IV and the
Guarantee, neither Parent, Merger Sub nor any other person makes any other
express or implied representation or warranty with respect to the
Transactions, this Agreement, Parent, Merger Sub, or any of Parent's
Subsidiaries or their respective businesses, operations, assets, liabilities,
condition (financial or otherwise) or prospects or with respect to any
information furnished, disclosed or made available to the Company or any of
its respective Representatives in the course of the negotiation of this
Agreement or otherwise in connection with the Transactions and (ii) except for
the representations and warranties expressly contained in Article IV and the
Guarantee, neither the Company nor its respective Affiliates, stockholders,
controlling persons and Representatives has relied on any information
furnished, disclosed or made available to any of them by Parent, Merger Sub or
any of their respective Representatives, in the course of the Company's or any
of its respective Representatives' negotiation of this Agreement or otherwise
in connection with the Transactions.

  


 

  

SECTION 8.07. _Governing Law; Jurisdiction._

  


 

  

(a) This Agreement, and any cause of action between any of the parties
relating to or arising out of this Agreement or the Transactions, shall be
governed by, and construed in accordance with, the Laws of the State of
Delaware, regardless of the Laws that might otherwise govern under any
applicable conflict of laws principles.

  


 

  

(b) All actions and proceedings arising out of or relating to this Agreement
shall be heard and determined in the Court of Chancery of the State of
Delaware (and any state appellate court therefrom within the State of
Delaware) or if (and only if) the Court of Chancery of the State of Delaware
declines to accept jurisdiction over a particular matter, the Superior Court
of the State of Delaware (Complex Commercial Division), of if subject matter
jurisdiction over the matter which is the subject of the action or proceeding
is by Law vested exclusively in the courts of the United States of America,
the United States District Court for the District of Delaware (the " _Selected
Courts_ "). In addition, each of the parties hereto (i) consents to submit
itself, and hereby submits itself, to the exclusive jurisdiction and venue of
such courts in the event any dispute arises out of this Agreement or
Transactions, (ii) agrees that it will not attempt to deny or defeat such
personal jurisdiction by motion or other request for leave from any such
court, and agrees not to plead or claim any objection to the laying of venue
in any such court or that any judicial proceeding in any such court has been
brought in an inconvenient forum, (iii) agrees that it will not bring any
action relating to this Agreement or the Transactions in any court other than
the Selected Courts and

  


 

  


 

  

 

69  

  


 

  


 

  

(iv) consents to service of process being made through the notice procedures
set forth in Section 8.10.

  


 

  

SECTION 8.08. _Specific Enforcement._ The parties agree that irreparable
damage for which monetary relief, even if available, would not be an adequate
remedy, would occur in the event that any provision of this Agreement is not
performed in accordance with its specific terms or is otherwise breached,
including if the parties hereto fail to take any action required of them
hereunder to consummate this Agreement. Subject to the following sentence, the
parties acknowledge and agree that (a) the parties shall be entitled to an
injunction or injunctions, specific performance or other equitable relief to
prevent breaches of this Agreement and to enforce specifically the terms and
provisions hereof in the courts described in Section 8.07(b) without proof of
damages or otherwise, this being in addition to any other remedy to which they
are entitled under this Agreement and (b) the right of specific enforcement is
an integral part of the Transactions and without that right, neither the
Company nor Parent would have entered into this Agreement. The parties agree
not to assert that a remedy of specific enforcement is unenforceable, invalid,
contrary to Law or inequitable for any reason, and not to assert that a remedy
of monetary damages would provide an adequate remedy or that the parties
otherwise have an adequate remedy at law. The parties acknowledge and agree
that any party seeking an injunction or injunctions to prevent breaches of
this Agreement and to enforce specifically the terms and provisions of this
Agreement in accordance with this Section 8.08 shall not be required to
provide any bond or other security in connection with any such order or
injunction.

  


 

  

SECTION 8.09. _WAIVER OF JURY TRIAL._ EACH PARTY HERETO ACKNOWLEDGES AND
AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY
AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY
OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE
AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS
CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER
VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 8.09.

  


 

  

SECTION 8.10. _Notices._ All notices, requests, claims, demands and other
communications to any party hereunder shall be in writing and shall be deemed
given if delivered personally, by email (which is confirmed by the recipient
thereof) or if

  


 

  


 

  

 

70  

  


 

  


 

  

sent by overnight courier (providing proof of delivery) to the parties at the
following addresses:

  


 

  

(a) If to Parent or Merger Sub, to:

  


 

  

Philips Holding USA Inc.

  

3000 Minuteman Road

  

Andover, MA 01810

  

Attention: Senior Director, Legal Department

  

Email: joseph.innamorati@philips.com

  


 

  

(b) with a copy (which shall not constitute notice) to:

  


 

  

Sullivan and Cromwell LLP

  

125 Broad Street

  

New York, New York 10004

  

Attention: Matthew G. Hurd; Rita-Anne O'Neill

  

Email: hurdm@sullcrom.com; oneillr@sullcrom.com

  


 

  

(c) If to the Company, to:

  


 

  

The Spectranetics Corporation

  

9965 Federal Drive

  

Colorado Springs, Colorado 80921

  

Attention: Paul Gardon

  

Email: Paul.Gardon@spnc.com

  


 

  

(d) with a copy (which shall not constitute notice) to:

  


 

  

Cravath, Swaine and Moore LLP

  

Worldwide Plaza

  

825 Eighth Avenue

  

New York, New York 10019

  

Attention: Minh Van Ngo

  

Email: mngo@cravath.com

  


 

  

or such other address or email address as such party may hereafter specify by
like notice to the other parties hereto. All such notices, requests and other
communications shall be deemed received on the date of actual receipt by the
recipient thereof if received prior to 5:00 p.m. local time in the place of
receipt and such day is a Business Day in the place of receipt. Otherwise, any
such notice, request or communication shall be deemed not to have been
received until the next succeeding Business Day in the place of receipt.

  


 

  

SECTION 8.11. _Severability._ If any term, condition or other provision of
this Agreement is determined by a court of competent jurisdiction to be
invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all other terms, provisions and conditions of this Agreement shall
nevertheless remain in full

  


 

  


 

  

 

71  

  


 

  


 

  

force and effect. Upon such determination that any term, condition or other
provision is invalid, illegal or incapable of being enforced, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect
the original intent of the parties as closely as possible to the fullest
extent permitted by applicable Law in an acceptable manner to the end that the
Transactions are fulfilled to the extent possible.

  


 

  

SECTION 8.12. _Fees and Expenses._ Whether or not the Transactions are
consummated, all fees and expenses incurred in connection with the
Transactions and this Agreement shall be paid by the party incurring or
required to incur such fees or expenses, except as otherwise set forth in this
Agreement.

  


 

  

SECTION 8.13. _Definitions._ For purposes of this Agreement:

  


 

  

" _Affiliate_ " means, with respect to any person, another person that
directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such first person. For the
purposes of this definition, " _control_ " means, with respect to any person,
the power to direct or cause the direction of the management and policies of
such person, whether through the ownership of voting securities, by contract
or otherwise. The term "controlled" shall have a correlative meaning.

  


 

  

" _Antitrust Laws_ " means the Sherman Act, as amended, the Clayton Act, as
amended, the HSR Act, the Federal Trade Commission Act, as amended, all
applicable foreign antitrust Laws and all other applicable Laws issued by a
Governmental Authority that are designed or intended to prohibit, restrict or
regulate actions having the purpose or effect of monopolization or restraint
of trade or lessening of competition through merger or acquisition.

  


 

  

" _Business Day_ " means any day that is not a Saturday, Sunday or other day
on which banking institutions are required or authorized by law to be closed
in New York, New York.

  


 

  

" _Commonly Controlled Entity_ " means any person or entity that, together
with the Company or any of its Subsidiaries, is treated as a single employer
under Section 414(b), (c), (m) or (o) of the Code.

  


 

  

" _Communication Team_ " means the three individuals listed in Section 8.13 of
the Company Disclosure Letter.

  


 

  

" _Company Plan_ " means each plan, program, policy, agreement or other
arrangement, whether written or oral, covering current or former directors,
employees or consultants, that is (i) an employee welfare plan within the
meaning of Section 3(1) of ERISA (whether or not subject to ERISA), (ii) an
employee pension benefit plan within the meaning of Section 3(2) of ERISA
(whether or not subject to ERISA), (iii) a stock option, stock purchase, or
other equity or equity-based agreement, program or plan, (iv) an individual
employment, consulting, change-in-control, severance, retention or other
similar agreement or (v) a compensation, commission, bonus, incentive,
deferred compensation, profit-sharing, retirement, post-retirement, vacation
or other time-off

  


 

  


 

  

 

72  

  


 

  


 

  

benefits, health or medical benefit, employee assistance, disability or sick
leave benefits, workers' compensation, supplemental unemployment benefits,
severance or termination pay, benefit or fringe-benefit plan, program, policy,
agreement or other arrangement, in each case, that is sponsored, maintained or
contributed to by the Company or any of its Subsidiaries or to which the
Company or any of its Subsidiaries contributes or is obligated to contribute
to or with respect to which the Company or any of its Subsidiaries has or may
have any liability, other than (A) any agreement, program or plan mandated by
applicable Law, each as may be amended from time to time or (B) a
"multiemployer plan" within the meaning of Section 3(37) of ERISA.

  


 

  

" _Company Regulatory Agency_ " means any Governmental Authority that
regulates the quality, identity, strength, purity, safety, pricing,
reimbursement, efficacy, manufacturing, commercialization, marketing or
distribution of the Company's products, including, without limitation, the
FDA, CMS, and the equivalent foreign Governmental Authorities, which shall
include Notified Bodies.

  


 

  

" _Confidentiality Agreement_ " means the letter agreement, dated as of March
22, 2017, between the Company and Philips North America LLC, as may be amended
from time to time.

  


 

  

" _Contract_ " means any loan or credit agreement, bond, debenture, note,
mortgage, indenture, lease, license, contract or agreement, in each case
including all amendments thereto.

  


 

  

" _Convertible Notes_ " means the 2.625% Convertible Senior Notes due 2034
issued pursuant to the Indenture.

  


 

  

" _Credit Agreements_ " means (i) the Amended and Restated Term Credit and
Security Agreement, dated as of June 9, 2017, by and among the Company and
AngioScore Inc., as borrowers, MidCap Financial Trust, as administrative agent
and a lender, and the other lenders party thereto and (ii) the Amended and
Restated Revolving Credit and Security Agreement, dated as of June 9, 2017, by
and among the Company and AngioScore Inc., as borrowers, MidCap Funding IV
Trust, as administrative agent, and the lenders party thereto.

  


 

  

" _ERISA_ " means the Employee Retirement Income Security Act of 1974, as
amended.

  


 

  

" _Exchange Act_ " means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

  


 

  

" _executive officer_ " means each individual who is considered an officer of
the Company within the meaning of Section 16 of the Exchange Act.

  


 

  

" _Foreign Company Plan_ " means a Company Plan that is maintained for the
benefit of any employee or service provider (or former employee or service
provider) who performs services for the Company outside the United States.

  


 

  


 

  

 

73  

  


 

  


 

  

" _GAAP_ " means generally accepted accounting principles in the United
States.

  


 

  

" _Government Contract_ " means any Contract to which the Company or any of
its Subsidiaries is a party that involves the supply of goods or services
directly to a Governmental Authority, including a subcontract of any tier or
level below a prime contract, but excluding Contracts entered into in the
ordinary course of business with public universities, hospitals, clinics and
government agencies.

  


 

  

" _Government Official_ " means any official, officer, employee or
representative of, or any person acting in an official capacity for or on
behalf of, any Governmental Authority, and includes any official or employee
of any entity directly or indirectly owned or controlled by any Governmental
Authority and any officer or employee of a public international organization,
as well as any person acting in an official capacity for or on behalf of any
such Governmental Authority, or for or on behalf of any such public
international organization, and any familial relative of any such person.

  


 

  

" _Governmental Authority_ " means any government, court, tribunal; any
regulatory or administrative agency, commission, department, branch, bureau,
division, office, service, board, or authority; or other legislative,
executive or judicial governmental authority, whether federal, state or local,
domestic, foreign or multinational. This term shall also include any non-
governmental body that has been authorized by Law to act for a governmental
body.

  


 

  

" _HSR Act_ " means the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, and the rules and regulations promulgated thereunder.

  


 

  

" _Indebtedness_ " means, with respect to any person, (i) any indebtedness for
borrowed money (including the issuance of any debt security) to any person,
other than the Company or any of its Subsidiaries, and any capital leases
required to be capitalized in accordance with GAAP, (ii) any obligations
evidenced by notes, bonds, debentures or similar Contracts to any person other
than the Company or any of its Subsidiaries, (iii) any obligations in respect
of letters of credit and bankers' acceptances (other than letters of credit
used as security for leases), (iv) any obligation for the deferred purchase
price of property or services (other than obligations for raw materials,
inventory, services and supplies incurred in the ordinary course of business),
including "earn-outs," indemnities, post-closing price adjustments, and
"seller notes" payable with respect to the acquisition of any business, assets
or securities, (v) any obligation under interest rate, currency or commodity
derivatives or hedging transactions or (vi) any guaranty of any such
obligations described in clauses (i) through (v) of any person other than the
Company or any of its Subsidiaries (other than, in each case, accounts payable
to trade creditors and accrued expenses, in each case arising in the ordinary
course of business), in each case of clauses (i) through (vi) including
interest, premium, fees, expenses, penalties (including prepayment and early
termination penalties) related thereto.

  


 

  


 

  

 

74  

  


 

  


 

  

" _Indenture_ " means the Indenture, dated as of June 3, 2014, between the
Company and Wells Fargo Bank, National Association (the " _Trustee_ "), as
supplemented by the First Supplemental Indenture, dated June 3, 2014 (the "
_Supplemental Indenture_ "), by and between the Company and Wells Fargo Bank,
National Association, as trustee with respect to the Convertible Notes.

  


 

  

" _Intellectual Property_ " means all intellectual property, all rights
associated therewith and other similar rights in any jurisdiction, whether
registered or unregistered, including such rights in and to any: (i) patents
(including all applications, reissues, divisions, continuations,
continuations-in-part, re-examinations, substitutions and extensions thereof)
and inventions (collectively, " _Patents_ "); (ii) trademarks, service marks,
trade names, business names, brand names, domain names, social media
identifiers, logos, slogans, trade dress, design rights, Internet domain
names, uniform resource locators and other similar designations of source or
origin, including any common law rights thereto and all goodwill associated
therewith (collectively, " _Trademarks_ "); (iii) copyrights and copyrightable
subject matter and database rights together with all common law rights and
moral rights therein, and any applications and registrations therefor
(collectively, " _Copyrights_ "); and (iv) trade secrets, know-how and other
information of a confidential nature (collectively " _Trade Secrets_ ").

  


 

  

" _IRS_ " means the U.S. Internal Revenue Service.

  


 

  

" _IT Assets_ " means computers, software, middleware, servers, workstations,
routers, hubs, switches, data communications lines, all other information
technology equipment, and all associated documentation, in each case, used by
the Company or any of its Subsidiaries.

  


 

  

" _Key Product_ " means the Stellarex drug-coated balloon platform.

  


 

  

" _Knowledge_ " means, (i) with respect to the Company, the actual knowledge
of those individuals listed in Section 8.13 of the Company Disclosure Letter,
and (ii) with respect to Parent or Merger Sub, the actual knowledge of any of
the executive officers of Parent or Merger Sub.

  


 

  

" _Liens_ " means any pledge, lien, charge, encumbrance, security interest,
hypothecation or mortgage.

  


 

  

" _Material Adverse Effect_ " means any effect, change, event, occurrence,
circumstance or development that, individually or in the aggregate with other
effects, changes, events, occurrences, circumstances or developments (i) would
prevent or materially delay, interfere with, impair or hinder the consummation
by the Company of the Transactions on a timely basis or (ii) has a material
adverse effect on the business, results of operations, assets or financial
condition of the Company and its Subsidiaries, taken as a whole; _provided_ ,
_however_ , that none of the following, and no effect, change, event,
occurrence, circumstance or development arising out of, or resulting from, the
following, shall constitute or be taken into account, individually or in the
aggregate, in determining whether a Material Adverse Effect has occurred or
may occur: (A) changes

  


 

  


 

  

 

75  

  


 

  


 

  

generally affecting the economy, credit or financial or capital markets, in
the United States or elsewhere in the world, including changes in interest or
exchange rates; (B) changes generally affecting the medical device industry;
(C) changes in Law or GAAP or in accounting standards; (D) the negotiation,
execution, announcement, pendency or performance of this Agreement or the
consummation or pendency of the Transactions (other than for purposes of any
representation or warranty contained in Sections 3.03(c) and 3.03(d)),
including the impact thereof on relationships, contractual or otherwise, with
customers, suppliers, distributors, partners, employees or Governmental
Authorities, or any litigation arising from allegations of breach of fiduciary
duty or violation of Law relating to this Agreement or the Transactions; (E)
acts of war (whether or not declared), sabotage or terrorism, or any
escalation or worsening of any such acts of war (whether or not declared),
sabotage or terrorism; (F) volcanoes, tsunamis, pandemics, earthquakes,
floods, storms, hurricanes, tornados or other natural disasters; (G) any
action taken by the Company or its Subsidiaries that is required by this
Agreement or with Parent's written consent or at Parent's written request, or
the failure to take any action by the Company or its Subsidiaries if that
action is prohibited by this Agreement to the extent Parent fails to give its
consent thereto after a written request therefor pursuant to Section 5.01; (H)
changes resulting or arising from the identity of, or any facts or
circumstances relating to, Parent, Merger Sub or any of their respective
Affiliates; (I) changes or prospective changes in the Company's credit
ratings; (J) changes in the price or trading volume of the Company Common
Stock; or (K) any failure to meet any internal or public projections,
forecasts, guidance, estimates, milestones, budgets or internal or published
financial or operating predictions of revenue, earnings, cash flow or cash
position (it being understood that the exceptions in clauses (I), (J) and (K)
shall not prevent or otherwise affect a determination that the underlying
cause of any such change or failure referred to therein (if not otherwise
falling within any of the exceptions provided by clauses (A) through (K)
hereof) is a Material Adverse Effect); _provided_ _further_ , _however_ , that
any effect, change, event, occurrence, circumstance or development referred to
in clauses (A), (B), (E) or (F) may be taken into account in determining
whether or not there has been a Material Adverse Effect to the extent such
effect, change, event, occurrence, circumstance or development has a
materially disproportionate adverse affect on the Company and its
Subsidiaries, taken as a whole, as compared to other participants in the
medical device industry (in which case only the incremental materially
disproportionate impact or impacts may be taken into account in determining
whether or not there has been or may be a Material Adverse Effect).

  


 

  

" _Parent Material Adverse Effect_ " means any effect, change, event,
circumstance or occurrence that would prevent or materially delay, interfere
with, impair or hinder (i) the consummation by Parent or Merger Sub of any of
the Transactions on a timely basis or (ii) the compliance by Parent or Merger
Sub with their obligations under this Agreement.

  


 

  

" _Permitted Liens_ " means (i) statutory Liens for Taxes, assessments or
other charges by Taxing Authorities not yet due and payable without penalty or
interest, (ii) mechanics', materialmen's, carriers', workmen's,
warehouseman's, repairmen's, landlords' and similar Liens granted or which
arise in the ordinary course of business,

  


 

  


 

  

 

76  

  


 

  


 

  

(iii) Liens securing payment, or any obligation, of the Company or its
Subsidiaries with respect to outstanding Indebtedness so long as there is no
default under such Indebtedness, (iv) pledges or deposits under workmen's
compensation Laws, unemployment insurance Laws or similar legislation, or good
faith deposits in connection with bids, tenders, Contracts (other than for the
payment of Indebtedness) or leases to which such entity is a party, or
deposits to secure public or statutory obligations of such entity or to secure
surety or appeal bonds to which such entity is a party, or deposits as
security for contested Taxes, in each case incurred or made in the ordinary
course of business, (v) easements, covenants, rights of way and other similar
restrictions that do not adversely affect the current use of the applicable
property, (vi) zoning and building Laws and codes and other similar land use
Laws that do not adversely affect the current use of the applicable real
property, (vii) Liens that have been placed by any developer, landlord or
other third party on any leased real property and subordination or similar
agreements relating thereto, (viii) non-exclusive licenses (without any rights
to sublicense) of Intellectual Property granted to third parties in the
ordinary course of business by the Company or its Subsidiaries, (ix) Liens
discharged at or prior to the Effective Time, (x) such other Liens or
imperfections of title that are not material in amount or do not materially
detract from the value of or materially impair the existing use of the
property affected by such Lien or imperfection of title and (xi) Liens that
are disclosed on the most recent consolidated balance sheet of the Company or
the notes thereto.

  


 

  

" _person_ " means an individual, firm, corporation, partnership, limited
liability company, joint venture, association, trust, unincorporated
organization or any other entity, including any Governmental Authority.

  


 

  

" _Personally Identifiable Information_ " means any information that alone or
in combination with other information held by the Company or its Subsidiaries
can be used to specifically identify an individual person, including any
protected health information subject to HIPAA protections.

  


 

  

" _Registered Intellectual Property_ " means all Patents (including patent
applications), registered Trademarks (including Internet domain names),
applications to register Trademarks, Copyright registrations and applications
and registered designs, design applications and any other Intellectual
Property that is the subject of an application, certificate, filing,
registration or other document issued by, filed with, or recorded by any
Governmental Authority.

  


 

  

" _Regulation S-K_ " means Regulation S-K promulgated by the SEC under the
Securities Act and the Exchange Act.

  


 

  

" _Regulation S-X_ " means Regulation S-X promulgated by the SEC under the
Securities Act and the Exchange Act.

  


 

  

" _Representatives_ " means, with respect to any person, such person's
officers, directors, employees, consultants, agents, financial advisors,
investment bankers, attorneys, accountants, other advisors, Affiliates and
other representatives.

  


 

  

 

77  

  


 

  


 

  

" _Sarbanes-Oxley Act_ " means the Sarbanes-Oxley Act of 2002, as amended and
any rules and regulations promulgated thereunder.

  


 

  

" _SEC_ " means the U.S. Securities and Exchange Commission.

  


 

  

" _Securities Act_ " means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.

  


 

  

" _Subsidiary_ " means, with respect to any person, another person, an amount
of the voting securities, other voting rights or voting partnership interests
of which is sufficient to elect at least a majority of its board of directors
or other governing body (or, if there are no such voting interests, 50% or
more of the equity interests of which) is owned directly or indirectly by such
first person.

  


 

  

" _Tax Return_ " means any return, filing, report, questionnaire, information
statement, claim for refund, declaration of estimated Taxes, including any
schedule or attachment thereto or any amendment thereof, with respect to Taxes
filed or required to be filed with any Taxing Authority, including
consolidated, combined and unitary tax returns.

  


 

  

" _Taxes_ " means any and all federal, state, local or non-U.S. taxes, fees,
levies, duties tariffs, imposts, and other similar charges in the nature of a
tax (together with any and all interest, penalties and additions to tax)
imposed by any Taxing Authority, including taxes or other charges on or with
respect to income, franchises, windfall or other profits, gross receipts,
property, sales, use, capital stock, payroll, employment, social security,
workers' compensation, unemployment compensation, or net worth; taxes or other
charges in the nature of excise (including medical device excise taxes),
withholding, ad valorem, stamp, transfer, value added, or gains taxes;
license, registration, recording and documentation fees; and customs duties,
tariffs, and similar charges (together with any and all interest, penalties
and additions to tax) imposed by any Taxing Authority.

  


 

  

" _Taxing Authority_ " means any Governmental Authority excercising regulatory
authority in respect of Taxes or responsible for the imposition of any Tax.

  


 

  

" _Transactions_ " means, collectively, the transactions contemplated by this
Agreement, including the Offer and the Merger.

  


 

  

" _U.S. Company Plan_ " means any Company Plan that is not a Foreign Company
Plan (which shall include any Company Plan maintained for employees or service
providers who perform services for the Company in Puerto Rico).

  


 

  

SECTION 8.14. _Interpretation._

  


 

  

(a) For purposes of this Agreement, whenever the context requires: the
singular number shall include the plural, and vice versa; the masculine gender
shall include the feminine and neuter genders; the feminine gender shall
include the masculine and neuter genders; and the neuter gender shall include
masculine and feminine genders.

  


 

  


 

  

 

78  

  


 

  


 

  

(b) The parties hereto agree that any rule of construction to the effect that
ambiguities are to be resolved against the drafting party shall not be applied
in the construction or interpretation of this Agreement.

  


 

  

(c) As used in this Agreement, the words "include" and "including", and
variations thereof, shall not be deemed to be terms of limitation, but rather
shall be deemed to be followed by the words "without limitation". The phrase
"ordinary course of business" shall mean "ordinary course of business
consistent with past practice".

  


 

  

(d) The words "hereof", "herein" and "hereunder" and words of similar import
when used in this Agreement shall refer to this Agreement as a whole and not
to any particular provision of this Agreement. The words "date hereof" when
used in this Agreement shall refer to the date of this Agreement.

  


 

  

(e) Except as otherwise indicated, all references in this Agreement to
"Sections", "Exhibits", "Annexes" and "Schedules" are intended to refer to
Sections of this Agreement and Exhibits, Annexes or Schedules to this
Agreement.

  


 

  

(f) The terms "or", "any" and "either" are not exclusive.

  


 

  

(g) Unless otherwise specifically indicated, all references to "dollars" or
"$" shall refer to the lawful money of the United States.

  


 

  

(h) The table of contents and headings contained in this Agreement are for
convenience of reference only, shall not be deemed to be a part of this
Agreement and shall not be referred to in connection with the construction or
interpretation of this Agreement.

  


 

  

(i) Whenever the words "made available to Parent" are used in this Agreement
with respect to any documents or other information, such words shall mean that
such documents or information were available to Parent prior to the date of
this Agreement and through the date of this Agreement in the electronic data
room maintained on behalf of the Company by Intralinks.

  


 

  

[Signature Page Follows]

  


 

  


 

  

 

79  

  


 

  

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed and delivered as of the date first above written.

 

  

  

     |  

 **THE SPECTRANETICS CORPORATION**

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Scott Drake |   
     |  | Name: Scott Drake |   
     |  | Title: President, Chief Executive Officer |   
     |  |  |   
  

  


 


     |  

 **PHILIPS HOLDING USA INC.**

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Jacob Giannotti |   
     |  | Name: Jacob Giannotti |   
     |  | Title: Authorized Signatory |   
  

  

 


    

  |  

By:

  | /s/ Joseph E. Innamorati |   
---|---|---|--- 
     |  | Name: Joseph E. Innamorati |   
     |  | Title: Authorized Signatory |   
     |  |  |   
  

  


 


     |  

 **HEALTHTECH MERGER SUB, INC.**

  |   
---|---|--- 
     |  |  |   
    

  |  

By:

  | /s/ Jacob Giannotti |   
     |  | Name: Jacob Giannotti |   
     |  | Title: Authorized Signatory |   
  

  

 


    

  |  

By:

  | /s/ Joseph E. Innamorati |   
---|---|---|--- 
     |  | Name: Joseph E. Innamorati |   
     |  | Title: Authorized Signatory |   
     |  |  |   
  

  

 

 

 

 

 

  

  

[Signature Page to Merger Agreement]

  

 


 

  


 

    

 

  

  

 _Index of Defined Terms_

  

 


 

  


 

      |  

 _Section_

   
---|--- 
     |   
    

Acceptable Confidentiality Agreement

  |  

5.02(b)

   
    

Actions

  |  

3.06

   
    

Adverse Recommendation Change

  |  

5.02(d)

   
    

Affiliate

  |  

8.13

   
    

Agreement

  |  

Preamble

   
    

Antitrust Law

  |  

8.13

   
    

Appraisal Shares

  |  

2.01(d)

   
    

Bankruptcy and Equity Exception

  |  

3.03(a)

   
    

Book Entry Shares

  |  

2.01(c)

   
    

Business Day

  |  

8.13

   
    

Capital Expense Budget

  |  

5.01(a)(vii)

   
    

Capitalization Date

  |  

3.02(a)

   
    

Certificate

  |  

2.01(c)

   
    

Certificate of Merger

  |  

1.05

   
    

Change in Circumstance

  |  

5.02(h)

   
    

Closing

  |  

1.04

   
    

Closing Date

  |  

1.04

   
    

Closing Fiscal Year

  |  

5.08(e)

   
    

Code

  |  

1.01(i)

   
    

Commonly Controlled Entity

  |  

8.13

   
    

Communication Team

  |  

8.13

   
    

Company

  |  

Preamble

   
    

Company 401(k) Plan

  |  

5.08(h)

   
    

Company Acquisition Agreement

  |  

5.02(d)

   
    

Company Board Recommendation

  |  

3.03(b)

   
    

Company Bonus Plan

  |  

5.08(e)

   
    

Company Bylaws

  |  

3.01(a)

   
    

Company Certificate

  |  

3.01(a)

   
    

Company Common Stock

  |  

Recitals

   
    

Company Disclosure Letter

  |  

Article III

   
    

Company Employee

  |  

5.08(a)

   
    

Company Equity Award

  |  

2.03(e)(i)

   
    

Company ESPP

  |  

2.03(e)(ii)

   
    

Company Plan

  |  

8.13

   
    

Company Preferred Stock

  |  

3.02(a)

   
    

Company Products

  |  

3.08(a)

   
    

Company PSU

  |  

2.03(e)(iii)

   
    

Company Regulatory Agency

  |  

8.13

   
    

Company Restricted Share

  |  

2.03(e)(iv)

   
    

Company RSU

  |  

2.03(e)(v)

   
    

Company SEC Documents

  |  

3.04(a)

   
    

Company Securities

  |  

3.02(b)

   
    

Company Stock Option

  |  

2.03(e)(vi)

   
   


 

  


 

    

 

  

  

    

Company Stock Plans

  |  

2.03(e)(vii)

   
---|--- 
    

Company Termination Fee

  |  

7.03(a)

   
    

Compensation Committee

  |  

2.03(d)

   
    

Confidentiality Agreement

  |  

8.13

   
    

Contract

  |  

8.13

   
    

Convertible Notes

  |  

8.13

   
    

Copyrights

  |  

8.13

   
    

Credit Agreements

  |  

8.13

   
    

Data Protection Requirements

  |  

3.08(g)

   
    

DGCL

  |  

Recitals

   
    

DOJ

  |  

5.03(d)

   
    

Effective Time

  |  

1.05

   
    

End Date

  |  

7.01(b)(i)

   
    

Environmental Laws

  |  

3.12(a)

   
    

Equity Award Consideration

  |  

2.03(b)

   
    

ERISA

  |  

8.13

   
    

ESPP Purchase Right

  |  

2.03(e)(viii)

   
    

Exchange Act

  |  

8.13

   
    

Exchange Fund

  |  

2.02(a)

   
    

executive officer

  |  

8.13

   
    

Expiration Time

  |  

1.01(d)

   
    

FCPA

  |  

3.07(c)

   
    

FDA

  |  

3.08(a)

   
    

Final Investment Date

  |  

2.03(c)

   
    

Foreign Company Plan

  |  

8.13

   
    

FTC

  |  

5.03(d)

   
    

GAAP

  |  

8.13

   
    

Government Contract

  |  

8.13

   
    

Government Official

  |  

8.13

   
    

Governmental Authority

  |  

8.13

   
    

Guarantee

  |  

Recitals

   
    

Guarantor

  |  

Recitals

   
    

Hazardous Substance

  |  

3.12(a)

   
    

HIPAA

  |  

3.08(g)

   
    

HSR Act

  |  

8.13

   
    

Indebtedness

  |  

8.13

   
    

Indemnitee

  |  

5.06(a)

   
    

Indenture

  |  

8.13

   
    

Initial Expiration Time

  |  

1.01(d)

   
    

Intellectual Property

  |  

8.13

   
    

IP License Agreements

  |  

3.13(b)(xiv)

   
    

IRB approval

  |  

3.08(a)

   
    

IRS

  |  

8.13

   
    

IT Assets

  |  

8.13

   
    

Key Product

  |  

8.13

   
    

Knowledge

  |  

8.13

   
  

  

  

    

  

  

 


 

     

Law

  |  

3.03(c)

   
---|--- 
    

Leased Real Property

  |  

3.16(b)

   
    

Leases

  |  

3.16(b)

   
    

Liens

  |  

8.13

   
    

Material Adverse Effect

  |  

8.13

   
    

Material Contract

  |  

3.17(a)

   
    

Merger

  |  

Recitals

   
    

Merger Consideration

  |  

2.01(c)

   
    

Merger Sub

  |  

Preamble

   
    

Minimum Condition

  |  

Annex I

   
    

NASDAQ

  |  

1.01(e)(ii)

   
    

Offer

  |  

Recitals

   
    

Offer Acceptance Time

  |  

1.01(b)

   
    

Offer Conditions

  |  

1.01(b)

   
    

Offer Documents

  |  

1.01(h)

   
    

Offer Price

  |  

Recitals

   
    

Offer to Purchase

  |  

1.01(c)

   
    

Option Consideration

  |  

2.03(b)

   
    

Order

  |  

3.03(c)

   
    

Owned Real Property

  |  

3.16(a)

   
    

Parent

  |  

Preamble

   
    

Parent Material Adverse Effect

  |  

8.13

   
    

Parent's 401(k) Plan

  |  

5.08(h)

   
    

Patents

  |  

8.13

   
    

Paying Agent

  |  

2.02(a)

   
    

Permits

  |  

3.07(b)

   
    

Permitted Liens

  |  

8.13

   
    

person

  |  

8.13

   
    

Personally Identifiable Information

  |  

8.13

   
    

PSU Consideration

  |  

2.03(b)

   
    

Reaffirmation Date

  |  

7.01(c)(v)

   
    

Recall

  |  

3.08(d)

   
    

Registered Intellectual Property

  |  

8.13

   
    

Registered IP

  |  

3.13(a)

   
    

Regulation S-K

  |  

8.13

   
    

Regulation S-X

  |  

8.13

   
    

Rejection Date

  |  

7.01(c)(iv)

   
    

Representatives

  |  

8.13

   
    

Restraints

  |  

6.01(a)

   
    

Restricted Share Consideration

  |  

2.03(b)

   
    

RSU Consideration

  |  

2.03(b)

   
    

Sarbanes-Oxley Act

  |  

8.13

   
    

Schedule 14D-9

  |  

1.02(a)

   
    

Schedule TO

  |  

1.01(h)

   
    

SEC

  |  

8.13

   
    

Secretary of State

  |  

1.05

   
   


 

  


 

  


 

    

  

  


 

     

Securities Act

  |  

8.13

   
---|--- 
    

Selected Courts

  |  

8.07(b)

   
    

Significant Subsidiary

  |  

3.01(b)

   
    

Subsidiary

  |  

8.13

   
    

Superior Proposal

  |  

5.02(g)

   
    

Supplemental Indenture

  |  

8.13

   
    

Surviving Corporation

  |  

1.03

   
    

Takeover Law

  |  

3.14(b)

   
    

Takeover Proposal

  |  

5.02(f)

   
    

Tax Return

  |  

8.13

   
    

Taxes

  |  

8.13

   
    

Taxing Authority

  |  

8.13

   
    

Trademarks

  |  

8.13

   
    

Trade Secrets

  |  

8.13

   
    

Transactions

  |  

8.13

   
    

Trustee

  |  

8.13

   
    

U.S. Company Plan

  |  

8.13

   
    

willful material breach

  |  

7.02

   
   


 

  


 

    

 

 

  

  

 

Annex I

  


 

  

Conditions to the Offer

  


 

  

Notwithstanding any other provision of the Agreement or the Offer and in
addition to (and not in limitation of) Merger Sub's right to extend and amend
the Offer pursuant to the provisions of the Agreement, Merger Sub shall not be
required to (and Parent shall not be required to cause Merger Sub to) accept
for payment or, subject to any applicable rules and regulations of the SEC,
including Rule 14e-1(c) under the Exchange Act, pay for any shares of Company
Common Stock validly tendered and not properly withdrawn pursuant to the Offer
if any of the following conditions exist, or have occurred and are continuing,
at the scheduled Expiration Time of the Offer:

  


 

  

(a) _Minimum Condition._ The number of shares of Company Common Stock validly
tendered (and not properly withdrawn) prior to the expiration of the Offer
(but excluding shares tendered pursuant to guaranteed delivery procedures that
have not yet been received), together with the shares of Company Common Stock
then owned by Merger Sub, does not represent at least one share more than 50%
of the then outstanding shares of Company Common Stock (the " _Minimum
Condition_ ").

  


 

  

(b) _Restraints._ Any Restraint shall be in effect enjoining or otherwise
prohibiting consummation of the Offer or the Merger.

  


 

  

(c) _Governmental Consents._ The waiting period (and any extension thereof)
applicable to the consummation of the Offer and the Merger under Antitrust
Laws shall not have expired and early termination thereof shall not have been
granted and the approvals under the Antitrust Laws shall not have been
received.

  


 

  

(d) _Representations and Warranties._ The representations and warranties of
the Company (i) set forth in Section 3.02(a) shall not be true and correct in
all respects as of the Expiration Time with the same effect as though made as
of the Expiration Time (except to the extent expressly made as of an earlier
date, in which case as of such earlier date), except where the failure to be
true and correct in all respects would not reasonably be expected to result in
additional liability to the Company, Parent or their respective Affiliates in
excess of $10,000,000 in the aggregate, (ii) set forth in Section 3.02(b),
Section 3.14 and Section 3.22 shall not be true and correct (disregarding all
qualifications or limitations as to "Knowledge of the Company," "materiality",
"Material Adverse Effect" and words of similar import set forth therein) in
all material respects as of the Expiration Time with the same effect as though
made as of the Expiration Time (except to the extent expressly made as of an
earlier date, in which case as of such earlier date), and (iii) set forth in
the Agreement, other than those Sections specifically identified in clause (i)
or (ii) of this paragraph (d), shall not be true and correct (disregarding all
qualifications or limitations as to "Knowledge of the Company," "materiality",
"Material Adverse Effect" and words of similar import set forth therein) as of
the Expiration Time with the same effect as though made as of the Expiration
Time (except to the extent expressly made as of an earlier date, in which case
as of such earlier date), except, in the case of this clause (iii), where the
failure to be true and correct would

  


 

  


 

    

  


 

  


 

  

not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect. Parent shall not have received a certificate signed
on behalf of the Company by an executive officer of the Company to such
effect.

  


 

  

(e) _Compliance with Covenants._ The Company shall not have complied with or
performed in all material respects its obligations required to be complied
with or performed by it prior to the Expiration Time under the Agreement and
such failure to comply or perform shall not have been cured by the Expiration
Time. Parent shall not have received a certificate signed on behalf of the
Company by an executive officer of the Company to such effect.

  


 

  

(f) _Company Material Adverse Effect Condition._ Since the date of the
Agreement there shall have been any effect, change, event or occurrence that,
individually or in the aggregate, has had or would reasonably be expected to
have a Material Adverse Effect.

  


 

  

(g) _No Termination of Agreement._ This Agreement shall have been terminated
in accordance with its terms.

  


 

  

The foregoing conditions are for the sole benefit of Parent and Merger Sub
and, other than the Minimum Condition, may be waived by Parent and Merger Sub
in whole or in part at any time and from time to time in their sole
discretion, in each case subject to the terms and conditions of this Agreement
and to the extent such waiver is permitted by applicable Law. The failure by
Parent, Merger Sub or any other Affiliate of Parent at any time to exercise
any of the foregoing rights shall not be deemed a waiver of any such right,
the waiver of any such right with respect to particular facts and
circumstances shall not be deemed a waiver with respect to any other facts and
circumstances and each such right shall be deemed an ongoing right that may be
asserted at any time and from time to time.

  


 

  

The capitalized terms used in this Annex I shall have the meanings set forth
in this Agreement to which it is annexed.

  


 

  


 

    

  


 

  


 

  

Exhibit A

  


 

  

Form of Guarantee

  

  

    

  


 

  

GUARANTEE AGREEMENT

  


 

  

THIS GUARANTEE AGREEMENT (this " _Guarantee_ "), dated as of June 27, 2017, is
made by KONINKLIJKE PHILIPS N.V., a corporation organized and existing under
the laws of the Netherlands (the " _Guarantor_ "), in favor of THE
SPECTRANETICS CORPORATION, a corporation organized under the laws of the State
of Delaware (the " _Company_ ").

  


 

  

PRELIMINARY STATEMENTS:

  


 

  

WHEREAS, pursuant to the Agreement and Plan of Merger dated as of June 27,
2017, (the " _Merger Agreement_ "), among the Company, PHILIPS HOLDING USA
INC., a Delaware corporation (" _Parent_ "), and HEALTHTECH MERGER SUB, INC.,
a Delaware corporation and a wholly owned subsidiary of Parent (" _Merger Sub_
", and together with Parent, the " _Acquiring Companies_ "), Merger Sub has
agreed to commence a cash tender offer to acquire any and all of the
outstanding shares of the common stock, par value $0.001 per share, of the
Company for $38.50 per share, net to the seller in cash, without interest;

  


 

  

WHEREAS, following the consummation of the Offer (such term and each other
capitalized term used but not defined herein shall have the meaning assigned
thereto in the Merger Agreement), upon the terms and subject to the conditions
set forth in the Merger Agreement and in accordance with Section 251(h) of the
General Corporation Law of the State of Delaware, Merger Sub will be merged
with and into the Company, with the Company surviving the Merger;

  


 

  

WHEREAS, the Guarantor desires to make this Guarantee simultaneously with the
execution and delivery of the Merger Agreement to which the Guarantor will
guarantee the obligations of the Acquiring Companies under the Merger
Agreement;

  


 

  

NOW, THEREFORE, in consideration of the premises and in order to induce
Company to enter into the Merger Agreement, the Guarantor hereby agrees as
follows:

  


 

  

Section 1. _Guarantee._ The Guarantor hereby irrevocably and unconditionally
guarantees to the Company the full and timely performance by the Acquiring
Companies of their respective obligations under the Merger Agreement,
including payment obligations and performance of all covenants, agreements,
duties and obligations which apply to the Acquiring Companies under the Merger
Agreement (all such payment and performance obligations being the "
_Obligations_ ") and agrees to take all actions which apply to affiliates of
the Acquiring Companies under the Merger Agreement.

  


 

  

Section 2. _Guarantee Absolute._ The Guarantor hereby irrevocably and
unconditionally guarantees that the Obligations will be duly and punctually
paid or fully and completely performed in accordance with the terms of the
Merger Agreement. The obligations of the Guarantor under this Guarantee are
independent of the Obligations, and a separate action or actions may be
brought by Company and prosecuted against the

  


 

  


 

    

  


 

  


 

  

Guarantor to enforce this Guarantee, irrespective of whether any action is
brought against either of the Acquiring Companies or whether either of the
Acquiring Companies or any of their affiliates is joined in any such action or
actions. If for any reason the Acquiring Companies or their affiliates shall
fail or be unable to duly and punctually pay or to fully and completely
perform, or cause to be duly and punctually paid or fully and completely
performed, any Obligation as and when the same shall become due and payable or
otherwise required to be performed by such party, the Guarantor shall
forthwith duly and punctually pay or fully and completely perform, or cause to
be duly and punctually paid or fully and completely performed, such
Obligation. The Guarantor agrees that this Guarantee, to the extent it
requires the payment of money, constitutes a guarantee of payment when due and
not of collection and is in no way conditioned or contingent upon any attempt
to collect from the Acquiring Companies.

  


 

  

This Guarantee shall continue to be effective or be reinstated, as the case
may be, if at any time any payment of any of the Obligations is rescinded or
must otherwise be returned by Company upon the insolvency, bankruptcy or
reorganization of either of the Acquiring Companies or otherwise, all as
though such payment had not been made.

  


 

  

Section 3. _Waiver._ (a) The Guarantor hereby agrees that it shall not be
released from any of its obligations under this Guarantee by any act, thing or
circumstance whatsoever which might, but for this provision, be deemed a legal
or equitable discharge, release or defense of a guarantor or surety (other
than the full payment and performance of the Obligations).

  


 

  

(b) Without limiting the generality of paragraph (a) above, the Guarantor
hereby unconditionally waives any and all notices that may be required by any
applicable foreign or domestic statute, law (including common law), ordinance,
code, standard, requirement, policy, determination, procedure, Order
(including executive order), rule or regulation enacted, adopted or
promulgated by any applicable Governmental Authority, to the extent legally
binding and finally determined, now or hereafter in effect, including
promptness, diligence, notice of acceptance and any other notice with respect
to any of the Obligations and this Guarantee and any requirement that the
Company first present to, proceed against or make a demand against the
Acquiring Companies or otherwise exhaust any right, power or remedy under the
Merger Agreement, before requesting payment or performance by the Guarantor
hereunder or that the Company protects, secures, perfects or insures any
security interest or lien or any property subject thereto or exhaust any other
right to take any action against the Acquiring Parties or any collateral.

  


 

  

(c) The Guarantor acknowledges that it will receive substantial direct and
indirect benefits from the Transactions and that the waivers set forth in this
Guarantee are knowingly made in contemplation of such benefits.

  


 

  

Section 4. _Subrogation._ The Guarantor will not exercise any rights which it
may acquire by way of subrogation under this Guarantee, by any payment made

  


 

  


 

    

  


 

  


 

  

hereunder or otherwise, until all the Obligations and all other amounts
payable under this Guarantee shall have been paid and performed in full. If
any amount shall be paid to the Guarantor on account of such subrogation
rights at any time prior to the payment or performance in full of the
Obligations and all other amounts payable to Company under this Guarantee,
such amount shall be held in trust for the benefit of Company and shall
forthwith be paid to the Company to be credited and applied upon the
Obligations, whether matured or unmatured, in accordance with the terms of the
Merger Agreement or be held by the Company as collateral security for any
Obligations thereafter existing.

  


 

  

Section 5. _Representations and Warranties._ The Guarantor hereby represents
and warrants as follows:

  


 

  

(a) The Guarantor is a corporation duly organized and validly existing under
the laws of the Netherlands.

  


 

  

(b) The Guarantor has full power and authority to execute and deliver this
Guarantee and to perform its obligations under this Guarantee. The execution
and delivery of this Guarantee by the Guarantor and the performance by the
Guarantor of its obligations hereunder have been duly and validly authorized
by all necessary corporate action on the part of the Guarantor. This Guarantee
has been duly executed and delivered by the Guarantor and constitutes the
legal, valid and binding agreement of the Guarantor, enforceable against the
Guarantor in accordance with its terms, subject to the Bankruptcy and Equity
Exception.

  


 

  

(c) The execution, delivery and performance of this Guarantee and the
fulfillment of and compliance with the terms and conditions hereof do not
violate or conflict with (i) any term or provision of the charter documents of
the Guarantor, (ii) any judgment, decree or order of any Governmental
Authority to which the Guarantor is a party or by which the Guarantor is bound
or (iii) any applicable Law applicable to the Guarantor, except, in the case
of clauses (ii) and (iii), as would not be reasonably expected to have a
material adverse effect. No consent, approval, order or authorization of, or
registration, declaration or filing with, any Governmental Authority is
required with respect to the Guarantor in connection with the execution,
delivery or performance of this Guarantee.

  


 

  

(d) There are no conditions precedent to the effectiveness of this Guarantee.

  


 

  

Section 6. _Amendments, Etc._ No amendment or waiver of any provision of this
Guarantee, and no consent to any departure by the Guarantor herefrom, shall in
any event be effective unless the same shall be in writing and signed by the
Company, and then such waiver or consent shall be effective only in the
specific instance and for the specific purpose for which given.

  


 

  

Section 7. _Notices._ All notices, requests, claims, demands and other
communications to any party hereunder shall be in writing and shall be deemed
given if

  


 

  


 

    

  


 

  


 

  

delivered personally, by email (which is confirmed by the recipient thereof)
or if sent by overnight courier (providing proof of delivery) to the parties
at the following addresses:

  


 

     

To the Acquiring Companies or Guarantor:

  |  

Philips Holding USA Inc.

  

3000 Minuteman Road

  

Andover, MA 01810

  

Attention: Senior Director, Legal Department

  

Email: joseph.innamorati@philips.com

   
---|--- 
     |   
    

with a copy to:

  |  

Sullivan and Cromwell LLP

  

125 Broad Street

  

New York, New York 10004

  

Attention: Matthew G. Hurd; Rita-Anne O'Neill

  

Email: hurdm@sullcrom.com; oneillr@sullcrom.com

   
     |   
    

To the Company:

  |  

The Spectranetics Corporation

  

9965 Federal Drive

  

Colorado Springs, Colorado 80921

  

Attention: Paul Gardon

  

Email: Paul.Gardon@spnc.com

   
     |   
    

with a copy to:

  |  

Cravath, Swaine and Moore LLP

  

Worldwide Plaza

  

825 Eighth Avenue

  

New York, New York 10019

  

Attn: Minh Van Ngo

  

Email: mngo@cravath.com

   
   


 

  

Section 8. _No Waiver; Remedies._ No failure on the part of the Company to
exercise, and no delay in exercising, any right hereunder shall operate as a
waiver thereof; nor shall any single or partial exercise of any right
hereunder preclude any other or further exercise thereof or the exercise of
any other right. The remedies herein provided are cumulative and not exclusive
of any remedies provided by law.

  


 

  

Section 9. _C_ _ontinuing Guarantee; Assignment._ This Guarantee is a
continuing guarantee and shall (a) remain in full force and effect until the
payment and performance in full of the Obligations and the payment of all
other amounts payable under this Guarantee, (b) be binding upon the Guarantor,
its successors and permitted assigns, and (c) inure to the benefit of, and be
enforceable by, the Company and its successors and permitted assigns. No
assignment or transfer by either the Guarantor of its obligations or the
Company of its rights hereunder shall be made except with the prior written
consent of the other and any attempted assignment or transfer in violation of
this Section 9 shall be void.

  


 

  

Section 10. _Consent to Jurisdiction; Waiver of Immunities._ (a) All actions
and proceedings arising out of or relating to this Guarantee shall be heard
and determined in the Court of Chancery of the State of Delaware (and any
state appellate

  


 

  


 

    

  


 

  


 

  

court therefrom within the State of Delaware) or if (and only if) the Court of
Chancery of the State of Delaware declines to accept jurisdiction over a
particular matter, the Superior Court of the State of Delaware (Complex
Commercial Division), or if subject matter jurisdiction over the matter which
is the subject of the action or proceeding is by Law vested exclusively in the
courts of the United States of America, the United States District Court for
the District of Delaware (the " _Selected Courts_ "). In addition, the
Guarantor (i) consents to submit itself, and hereby submits itself, to the
exclusive jurisdiction and venue of such courts in the event any dispute
arises out of this Guarantee, (ii) agrees that it will not attempt to deny or
defeat such personal jurisdiction by motion or other request for leave from
any such court, and agrees not to plead or claim any objection to the laying
of venue in any such court or that any judicial proceeding in any such court
has been brought in an inconvenient forum, (iii) agrees that it will not bring
any action relating to this Guarantee in any court other than the Selected
Courts and (iv) consents to service of process being made through the notice
procedures set forth in Section 7. The Guarantor agrees that a final judgment
in any such action or proceeding shall be conclusive and may be enforced in
other jurisdictions by suit on the judgment or in any other manner provided by
law.

  


 

  

(b) To the extent that the Guarantor has or hereafter may acquire any immunity
from jurisdiction of any court or from any legal process (whether through
service or notice, attachment prior to judgment, attachment in aid of
execution, execution or otherwise) with respect to itself or its property, the
Guarantor hereby irrevocably waives such immunity in respect of its
obligations under this Guaranty and, without limiting the generality of the
foregoing, agrees that the waivers set forth in this subsection (b) shall have
the fullest scope permitted under the Foreign Sovereign Immunities Act of 1976
of the United States and are intended to be irrevocable for purposes of such
Act.

  


 

  

Section 11. _Governing Law._ This Guarantee, and any cause of action between
any of the parties relating to or arising out of this Guarantee, shall be
governed by, and construed in accordance with, the Laws of the State of
Delaware, regardless of the Laws that might otherwise govern under any
applicable conflict of laws principles.

  


 

  

Section 12. _Severability._ Whenever possible each provision of this Guarantee
shall be interpreted in such manner as to be effective and valid under
applicable Law, but if any provision of this Guarantee shall be held invalid,
illegal or unenforceable, such invalidity, illegality or unenforceability
shall not affect any other provisions of this Guarantee, and this Guarantee
shall be construed as if any such provision had never been contained herein.

  


 

  

Section 13. _Counterparts._ This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, and it shall not be
necessary in making proof of this Agreement or the terms hereof to produce or
account for more than one of such counterparts.

  


 

  

[Remainder of the page intentionally left blank]

  


 

  


 

    

 

  

  

IN WITNESS WHEREOF, the Guarantor has caused this Guarantee to be duly
executed and delivered by its officer thereunto duly authorized as of the date
first above written.

  

  


     |  

GUARANTOR:

  

  |   
---|---|--- 
     |  

 

 **KONINKLIJKE PHILIPS N.V.**

  

  

 

  |   
     |  |  |   
    

  |  

By:

  | /s/  |   
     |  | Name:  |   
     |  | Title:  |   
   

 


    

  |  

By:

  | /s/  |   
---|---|---|--- 
     |  | Name:  |   
     |  | Title:  |   
     |  |  |   
  

  

  


 

    

 

 

  

  

 

Exhibit B

  


 

  

Certificate of Incorporation of Surviving Corporation

  

  

    

  


 

  

SECOND AMENDED AND RESTATED

  


 

  

CERTIFICATE OF INCORPORATION

  


 

  

OF

  


 

  

THE SPECTRANETICS CORPORATION

  


 

  

FIRST. The name of the corporation is The Spectranetics Corporation (the "
_Company_ ").

  


 

  

SECOND. The address of the Company's registered office in the State of
Delaware is 251 Little Falls Drive, in the City of Wilmington, County of New
Castle, Delaware 19808. The name of its registered agent at such address is
Corporation Service Company.

  


 

  

THIRD. The purpose of the Company is to engage in any lawful act or activity
for which corporations may be organized under the General Corporation Law of
Delaware (the " _DGCL_ ").

  


 

  

FOURTH. The total number of shares that the Company shall have authority to
issue is 1,000 shares of common stock, and the par value of each of such
shares is $0.001.

  


 

  

FIFTH. The board of directors of the Company (the " _Board_ ") is expressly
authorized to adopt, amend or repeal bylaws of the Company (the " _Bylaws_ ").

  


 

  

SIXTH. Elections of directors need not be by written ballot except and to the
extent provided in the Bylaws.

  


 

  

SEVENTH. The number of directors of the Company shall be fixed from time to
time pursuant to the Bylaws.

  


 

  

EIGHTH. The Company shall indemnify and hold harmless, and advance expenses
to, to the fullest extent permitted by applicable law as it presently exists
or may hereafter be amended, any person who was or is made or is threatened to
be made a party or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (a " _Proceeding_ ")
by reason of the fact that he, or a person for whom he is the legal
representative, is or was a director or officer of the Company or of a
subsidiary of the Company, against all liability and loss suffered and
expenses reasonably incurred by such person. The Company shall be required to
indemnify a person in connection with a Proceeding initiated by such person
only if the Proceeding was authorized by the Board.

  


 

  

NINTH. A director of the Company shall not be personally liable to the Company
or its stockholders for monetary damages for breach of fiduciary duty as
director, except to the extent such exemption from liability or limitation
thereof is not permitted under the DGCL as the same exists or may hereafter be
amended.

  


 

  

TENTH. Until the date that is six years following the adoption of this
certificate of incorporation, no repeal or modification of any provision of
Article Eighth or

  


 

  


 

    

  


 

  


 

  

Article Ninth shall adversely affect any right or protection of a director of
the Company existing hereunder with respect to any act or omission occurring
prior to the time of such repeal or modification.

  


 

  


 

    

  


 

  

Exhibit C

  


 

  

By-laws of Surviving Corporation

  


 

  


 

    

  

  


 

  

SECOND AMENDED AND RESTATED BYLAWS

  


 

  

OF

  


 

  

THE SPECTRANETICS CORPORATION (the " _Corporation_ ")

  


 

  

ARTICLE I

  

  

 _Stockholders_

  

  

Section 1.1. _Annual Meetings_. An annual meeting of stockholders shall be
held for the election of directors at such date, time and place either within
or without the State of Delaware as may be designated by the Board of
Directors from time to time. Any other proper business may be transacted at
the annual meeting.

  


 

  

Section 1.2. _Special Meetings_. Special meetings of stockholders may be
called at any time by the Chairman of the Board, if any, the Vice Chairman of
the Board, if any, the President or the Board of Directors, to be held at such
date, time and place either within or without the State of Delaware as may be
stated in the notice of the meeting. A special meeting of stockholders shall
be called by the Secretary upon the written request, stating the purpose of
the meeting, of stockholders who together own of record a majority of the
outstanding shares of each class of stock entitled to vote at such meeting.

  


 

  

Section 1.3. _Notice of Meetings_. Whenever stockholders are required or
permitted to take any action at a meeting, a written notice of the meeting
shall be given stating the place, date and hour of the meeting and, in the
case of a special meeting, the purpose or purposes for which the meeting is
called. Unless otherwise provided by law, the written notice of any meeting
shall be given neither less than ten nor more than sixty days before the date
of the meeting to each stockholder entitled to vote at such meeting. If
mailed, such notice shall be deemed to be given when deposited in the United
States mail, postage prepaid, directed to the stockholder at such
stockholder's address as it appears on the records of the Corporation.

  


 

  

Section 1.4. _A_ _djournments_. Any meeting of stockholders, annual or
special, may be adjourned from time to time, to reconvene at the same or some
other place, and notice need not be given of any such adjourned meeting if the
time and place thereof are announced at the meeting at which the adjournment
is taken. At the adjourned meeting, the Corporation may transact any business
which might have been transacted at the original meeting. If the adjournment
is for more than thirty days, or if after the adjournment a new record date is
fixed for the adjourned meeting, a notice of the adjourned meeting shall be
given to each stockholder of record entitled to vote at such meeting.

  


 

  

Section 1.5. _Quorum_. At each meeting of stockholders, except where otherwise
provided by law or the certificate of incorporation or these Bylaws, the
holders of a majority of the outstanding shares of stock entitled to vote on a
matter at the meeting, present in person or represented by proxy, shall
constitute a quorum. In the absence of a quorum of the holders of any class of
stock entitled to vote on a matter, the holders of such class so present or
represented

  


 

  


 

    

  


 

  


 

  

may, by majority vote, adjourn the meeting of such class from time to time in
the manner provided by Section 1.4 of these Bylaws until a quorum of such
class is so present or represented. Shares of its own capital stock belonging
on the record date for the meeting to the Corporation or to another
corporation, if a majority of the shares entitled to vote in the election of
directors of such other corporation is held, directly or indirectly, by the
Corporation, shall neither be entitled to vote nor be counted for quorum
purposes; provided, however, that the foregoing shall not limit the right of
the Corporation to vote stock, including but not limited to its own stock,
held by it in a fiduciary capacity.

  


 

  

Section 1.6. _Organization_. Meetings of stockholders shall be presided over
by the Chairman of the Board, if any, or, in the absence of the Chairman of
the Board, by the Vice Chairman of the Board, if any, or, in the absence of
the Vice Chairman of the Board, by the President, or, in the absence of the
President, by a Vice President, or, in the absence of the foregoing persons,
by a chairman designated by the Board of Directors, or, in the absence of such
designation, by a chairman chosen at the meeting. The Secretary, or in the
absence of the Secretary, an Assistant Secretary, shall act as secretary of
the meeting, but in the absence of the Secretary and any Assistant Secretary,
the chairman of the meeting may appoint any person to act as secretary of the
meeting. The order of business at each such meeting shall be as determined by
the chairman of the meeting. The chairman of the meeting shall have the right
and authority to prescribe such rules, regulations and procedures and to do
all such acts and things as are necessary or desirable for the proper conduct
of the meeting, including, without limitation, the establishment of procedures
for the maintenance of order and safety, limitations on the time allotted to
questions or comments on the affairs of the Corporation, restrictions on entry
to such meeting after the time prescribed for the commencement thereof and the
opening and closing of the voting polls.

  


 

  

Section 1.7. _Voting; Proxies_. Unless otherwise provided in the certificate
of incorporation, each stockholder entitled to vote at any meeting of
stockholders shall be entitled to one vote for each share of stock held by
such stockholder who has voting power upon the matter in question. Each
stockholder entitled to vote at a meeting of stockholders or to express
consent or dissent to corporate action in writing without a meeting may
authorize another person or persons to act for such stockholder by proxy, but
no such proxy shall be voted or acted upon after three years from its date,
unless the proxy provides for a longer period. A duly executed proxy shall be
irrevocable if it states that it is irrevocable and if, and only as long as,
it is coupled with an interest sufficient in law to support an irrevocable
power, regardless of whether the interest with which it is coupled is an
interest in the stock itself or an interest in the Corporation generally. A
stockholder may revoke any proxy that is not irrevocable by attending the
meeting and voting in person or by filing an instrument in writing revoking
the proxy or another duly executed proxy bearing a later date with the
Secretary of the Corporation. Voting at meetings of stockholders need not be
by written ballot unless the holders of a majority of the outstanding shares
of all classes of stock entitled to vote thereon present in person or
represented by proxy at such meeting shall so determine. Directors shall be
elected by a plurality of the votes of the shares present in person or
represented by proxy at the meeting and entitled to vote on the election of
directors. In all other matters, unless otherwise provided by law or by the
certificate of incorporation or these Bylaws, the affirmative vote of the
holders of a majority of the shares present in person or represented by proxy
at the meeting and entitled to vote on the subject matter shall be the act of
the stockholders. Where a separate vote by class or classes is required,

  


 

  


 

  

 

-2-  

  


 

  


 

  

the affirmative vote of the holders of a majority of the shares of such class
or classes present in person or represented by proxy at the meeting shall be
the act of such class or classes, except as otherwise provided by law or by
the certificate of incorporation or these Bylaws.

  


 

  

Section 1.8. _Fixing Date for Determination of Stockholders of Record_. In
order that the Corporation may determine the stockholders entitled to notice
of or to vote at any meeting of stockholders or any adjournment thereof, the
Board of Directors may fix a record date, which record date shall not precede
the date upon which the resolution fixing the record date is adopted by the
Board of Directors, and which record date shall be neither more than sixty nor
less than ten days before the date of such meeting. If no record date is fixed
by the Board of Directors, the record date for determining stockholders
entitled to notice of or to vote at a meeting of stockholders shall be at the
close of business on the day next preceding the day on which notice is given,
or, if notice is waived, at the close of business on the day next preceding
the day on which the meeting is held. A determination of stockholders of
record entitled to notice of or to vote at a meeting of stockholders shall
apply to any adjournment of the meeting; provided, however, that the Board of
Directors may fix a new record date for the adjourned meeting.

  


 

  

In order that the Corporation may determine the stockholders entitled to
consent to corporate action in writing without a meeting, the Board of
Directors may fix a record date, which record date shall not precede the date
upon which the resolution fixing the record date is adopted by the Board of
Directors, and which date shall not be more than ten days after the date upon
which the resolution fixing the record date is adopted by the Board of
Directors. If no record date has been fixed by the Board of Directors, the
record date for determining stockholders entitled to consent to corporate
action in writing without a meeting, when no prior action by the Board of
Directors is required by law, shall be the first date on which a signed
written consent setting forth the action taken or proposed to be taken is
delivered to the Corporation by delivery to its registered office in the State
of Delaware, its principal place of business, or an officer or agent of the
Corporation having custody of the book in which proceedings of meetings of
stockholders are recorded. Delivery made to the Corporation's registered
office shall be by hand or by certified or registered mail, return receipt
requested. If no record date has been fixed by the Board of Directors and
prior action by the Board of Directors is required by law, the record date for
determining stockholders entitled to consent to corporate action in writing
without a meeting shall be at the close of business on the day on which the
Board of Directors adopts the resolution taking such prior action.

  


 

  

In order that the Corporation may determine the stockholders entitled to
receive payment of any dividend or other distribution or allotment of any
rights or the stockholders entitled to exercise any rights in respect of any
change, conversion or exchange of stock, or for the purpose of any other
lawful action, the Board of Directors may fix a record date, which record date
shall not precede the date upon which the resolution fixing the record date is
adopted, and which record date shall be not more than sixty days prior to such
action. If no record date is fixed, the record date for determining
stockholders for any such purpose shall be at the close of business on the day
on which the Board of Directors adopts the resolution relating thereto.

  


 

  

Section 1.9. _List of Stockholders Entitled to Vote_. The Secretary shall
prepare and make, at least ten days before every meeting of stockholders, a
complete list of the

  


 

  


 

  

 

-3-  

  


 

  


 

  

stockholders entitled to vote at the meeting, arranged in alphabetical order,
and showing the address of each stockholder and the number of shares
registered in the name of each stockholder. Such list shall be open to the
examination of any stockholder, for any purpose germane to the meeting, during
ordinary business hours, for a period of at least ten days prior to the
meeting, either at a place within the city where the meeting is to be held,
which place shall be specified in the notice of the meeting, or, if not so
specified, at the place where the meeting is to be held. The list shall also
be produced and kept at the time and place of the meeting during the whole
time thereof and may be inspected by any stockholder who is present.

  


 

  

Section 1.10. _Consent of Stockholders in Lieu of Meeting_. Unless otherwise
provided in the certificate of incorporation or by law, any action required by
law to be taken at any annual or special meeting of stockholders of the
Corporation, or any action which may be taken at any annual or special meeting
of such stockholders, may be taken without a meeting, without prior notice and
without a vote, if a consent or consents in writing, setting forth the action
so taken, is signed by the holders of outstanding stock having not less than
the minimum number of votes that would be necessary to authorize or take such
action at a meeting at which all shares entitled to vote thereon were present
and voted and shall be delivered to the Corporation by delivery to (a) its
registered office in the State of Delaware by hand or by certified mail or
registered mail, return receipt requested, (b) its principal place of business
or (c) an officer or agent of the Corporation having custody of the book in
which proceedings of meetings of stockholders are recorded. Every written
consent shall bear the date of signature of each stockholder who signs the
consent and no written consent shall be effective to take the corporate action
referred to therein unless, within sixty days of the earliest dated consent
delivered in the manner required by this bylaw to the Corporation, written
consents signed by a sufficient number of holders to take action are delivered
to the Corporation by delivery to (i) its registered office in the State of
Delaware by hand or by certified or registered mail, return receipt requested,
(ii) its principal place of business or (iii) an officer or agent of the
Corporation having custody of the book in which proceedings of meetings of
stockholders are recorded. Prompt notice of the taking of the corporate action
without a meeting by less than unanimous written consent shall be given to
those stockholders who have not consented in writing and who, if the action
had been taken at a meeting, would have been entitled to notice of the meeting
if the record date for such meeting had been the date that written consents
signed by a sufficient number of stockholders to take the action were
delivered to the Corporation as provided in this Section 1.10.

  


 

  

ARTICLE II

  


 

  

 _Board of Directors_

  


 

  

Section 2.1. _Powers; Number; Qualifications_. The business and affairs of the
Corporation shall be managed by or under the direction of the Board of
Directors, except as may be otherwise provided by law or in the certificate of
incorporation. The Board of Directors shall consist of one or more members,
the number thereof to be determined from time to time by the Board of
Directors. Directors need not be stockholders.

  


 

  


 

  

 

-4-  

  


 

  


 

  

Section 2.2. _Election; Term of Office; Resignation; Removal; Vacancies_. Each
director shall hold office until his or her successor is elected and qualified
or until his or her earlier resignation or removal. Any director may resign at
any time upon written notice to the Board of Directors or to the President or
the Secretary of the Corporation. Such resignation shall take effect at the
time specified therein, and unless otherwise specified therein no acceptance
of such resignation shall be necessary to make it effective. Any director or
the entire Board of Directors may be removed, with or without cause, by the
holders of a majority of the shares then entitled to vote at an election of
directors. Unless otherwise provided in the certificate of incorporation or
these Bylaws, vacancies and newly created directorships resulting from any
increase in the authorized number of directors elected by all of the
stockholders having the right to vote as a single class or from any other
cause may be filled by a majority of the directors then in office, although
less than a quorum, or by the sole remaining director. Any director elected or
appointed to fill a vacancy shall hold office until the next annual meeting of
the stockholders and his or her successor is elected and qualified or until
his or her earlier resignation or removal.

  


 

  

Section 2.3. _Regular Meetings_. Regular meetings of the Board of Directors
may be held at such places within or without the State of Delaware and at such
times as the Board of Directors may from time to time determine, and if so
determined notice thereof need not be given.

  


 

  

Section 2.4. _Special Meetings_. Special meetings of the Board of Directors
may be held at any time or place within or without the State of Delaware
whenever called by the Chairman of the Board, if any, by the Vice Chairman of
the Board, if any, by the President or by any two directors. Reasonable notice
thereof shall be given by the person or persons calling the meeting.

  


 

  

Section 2.5. _Participation in Meetings by Conference Telephone Permitted_.
Unless otherwise restricted by the certificate of incorporation or these
Bylaws, members of the Board of Directors, or any committee designated by the
Board of Directors, may participate in a meeting of the Board of Directors or
of such committee, as the case may be, by means of conference telephone or
similar communications equipment by means of which all persons participating
in the meeting can hear each other, and participation in a meeting pursuant to
this bylaw shall constitute presence in person at such meeting.

  


 

  

Section 2.6. _Quorum; Vote Required for Action_. At all meetings of the Board
of Directors, one-third of the entire Board of Directors shall constitute a
quorum for the transaction of business. The vote of a majority of the
directors present at a meeting at which a quorum is present shall be the act
of the Board of Directors unless the certificate of incorporation or these
Bylaws shall require a vote of a greater number. In case at any meeting of the
Board of Directors a quorum shall not be present, the members of the Board of
Directors present may adjourn the meeting from time to time until a quorum
shall be present.

  


 

  

Section 2.7. _Organization_. Meetings of the Board of Directors shall be
presided over by the Chairman of the Board, if any, or, in the absence of the
Chairman of the Board, by the Vice Chairman of the Board, if any, or, in the
absence of the Vice Chairman of the Board, by the President, or, in their
absence, by a chairman chosen at the meeting. The Secretary or, in the absence
of the Secretary, an Assistant Secretary, shall act as secretary of the
meeting, but in the

  


 

  


 

  

 

-5-  

  


 

  


 

  

absence of the Secretary and any Assistant Secretary, the chairman of the
meeting may appoint any person to act as secretary of the meeting.

  


 

  

Section 2.8. _Action by Directors Without a Meeting_. Unless otherwise
restricted by the certificate of incorporation or these Bylaws, any action
required or permitted to be taken at any meeting of the Board of Directors, or
of any committee thereof, may be taken without a meeting if the number of
directors that would be necessary to authorize or take such action at a
meeting of the Board of Directors or of such committee, as the case may be,
consent thereto in writing and the writing or writings are filed with the
minutes of proceedings of the Board of Directors or such committee, as
applicable.

  


 

  

Section 2.9. _Compensation of Directors_. Unless otherwise restricted by the
certificate of incorporation or these Bylaws, the Board of Directors shall
have the authority to fix the compensation of directors.

  


 

  

ARTICLE III

  

  

 _Committees_

  

  

Section 3.1. _Committees_. The Board of Directors may designate one or more
committees, each committee to consist of one or more of the directors of the
Corporation. The Board of Directors may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified
member at any meeting of the committee. In the absence or disqualification of
a member of a committee, the member or members thereof present at any meeting
and not disqualified from voting, whether or not such member or members
constitute a quorum, may unanimously appoint another member of the Board of
Directors to act at the meeting in the place of any such absent or
disqualified member. Any such committee, to the extent provided in the
resolution of the Board of Directors or in these Bylaws, shall have, and may
exercise, all the powers and authority of the Board of Directors in the
management of the business and affairs of the Corporation and may authorize
the seal of the Corporation to be affixed to all papers that may require it,
but no such committee shall have the power or authority in reference to the
following matters: (a) approving or adopting, or recommending to the
stockholders, any action or matter expressly required by law to be submitted
to stockholders for approval, (b) adopting, amending or repealing these Bylaws
or (c) removing or indemnifying directors.

  


 

  

Section 3.2. _Committee Rules_. Unless the Board of Directors otherwise
provides, each committee designated by the Board of Directors may adopt, amend
or repeal rules for the conduct of its business. In the absence of a provision
by the Board of Directors or a provision in the rules of such committee to the
contrary, a majority of the entire authorized number of members of such
committee shall constitute a quorum for the transaction of business, the vote
of a majority of the members present at a meeting at the time of such vote if
a quorum is then present shall be the act of such committee, and in other
respects each committee shall conduct its business in the same manner as the
Board of Directors conducts its business pursuant to Article II of these
Bylaws.

  


 

  


 

  

 

-6-  

  


 

  


 

  

ARTICLE IV

  


 

  

 _Officers_

  


 

  

Section 4.1. _Officers; Election_. From time to time, the Board of Directors
shall elect a President and a Secretary and it may, if it so determines, elect
from among its members a Chairman of the Board and a Vice Chairman of the
Board. The Board of Directors may also elect one or more Vice Presidents, one
or more Assistant Vice Presidents, one or more Assistant Secretaries, a
Treasurer or one or more Assistant Treasurers or such other officers as the
Board of Directors may deem desirable or appropriate and may give any of them
such further designations or alternate titles as it considers desirable. Any
number of offices may be held by the same person unless the certificate of
incorporation or these Bylaws otherwise provide.

  


 

  

Section 4.2. _T_ _erm of Office; Resignation; Removal; Vacancies_. Unless
otherwise provided in the resolution of the Board of Directors electing any
officer, each officer shall hold office until his or her successor is elected
and qualified or until his or her earlier resignation or removal. Any officer
may resign at any time upon written notice to the Board of Directors or to the
President or the Secretary of the Corporation. Such resignation shall take
effect at the time specified therein, and unless otherwise specified therein
no acceptance of such resignation shall be necessary to make it effective. The
Board of Directors may remove any officer with or without cause at any time.
Any such removal shall be without prejudice to the contractual rights of such
officer, if any, with the Corporation, but the election of an officer shall
not of itself create contractual rights. Any vacancy occurring in any office
of the Corporation by death, resignation, removal or otherwise may be filled
by the Board of Directors at any regular or special meeting.

  


 

  

Section 4.3. _Chairman of the Board_. The Chairman of the Board, if any, shall
preside at all meetings of the Board of Directors and of the stockholders at
which he or she is present and shall have, and may exercise, such powers as
may, from time to time, be assigned to him or her by the Board of Directors or
as may be provided by law.

  


 

  

Section 4.4. _Vice Chairman of the Board_. In the absence of the Chairman of
the Board, the Vice Chairman of the Board, if any, shall preside at all
meetings of the Board of Directors and of the stockholders at which he or she
is present and shall have, and may exercise, such powers as may, from time to
time, be assigned to him or her by the Board of Directors or as may be
provided by law.

  


 

  

Section 4.5. _President_. In the absence of the Chairman of the Board and Vice
Chairman of the Board, the President shall preside at all meetings of the
Board of Directors and of the stockholders at which he or she is present. The
President shall be the chief executive officer and shall have general charge
and supervision of the business of the Corporation and, in general, shall
perform all duties incident to the office of president of a corporation and
such other duties as may, from time to time, be assigned to him or her by the
Board of Directors or as may be provided by law.

  


 

  

Section 4.6. _Vice Presidents_. The Vice President or Vice Presidents, at the
request or in the absence of the President or during the President's inability
to act, shall perform the duties of the President, and when so acting shall
have the powers of the President. If there be

  


 

  


 

  

 

-7-  

  


 

  


 

  

more than one Vice President, the Board of Directors may determine which one
or more of the Vice Presidents shall perform any of such duties; or if such
determination is not made by the Board of Directors, the President may make
such determination; otherwise any of the Vice Presidents may perform any of
such duties. The Vice President or Vice Presidents shall have such other
powers and shall perform such other duties as may, from time to time, be
assigned to him or her or them by the Board of Directors or the President or
as may be provided by law.

  


 

  

Section 4.7. _Secretary_. The Secretary shall have the duty to record the
proceedings of the meetings of the stockholders, the Board of Directors and
any committees in a book to be kept for that purpose, shall see that all
notices are duly given in accordance with the provisions of these Bylaws or as
required by law, shall be custodian of the records of the Corporation, may
affix the corporate seal to any document the execution of which, on behalf of
the Corporation, is duly authorized, and when so affixed may attest the same,
and, in general, shall perform all duties incident to the office of secretary
of a corporation and such other duties as may, from time to time, be assigned
to him or her by the Board of Directors or the President or as may be provided
by law.

  


 

  

Section 4.8. _Treasurer_. The Treasurer shall have charge of and be
responsible for all funds, securities, receipts and disbursements of the
Corporation and shall deposit or cause to be deposited, in the name of the
Corporation, all moneys or other valuable effects in such banks, trust
companies or other depositories as shall, from time to time, be selected by or
under authority of the Board of Directors. If required by the Board of
Directors, the Treasurer shall give a bond for the faithful discharge of his
or her duties, with such surety or sureties as the Board of Directors may
determine. The Treasurer shall keep or cause to be kept full and accurate
records of all receipts and disbursements in books of the Corporation, shall
render to the President and to the Board of Directors, whenever requested, an
account of the financial condition of the Corporation, and, in general, shall
perform all the duties incident to the office of treasurer of a corporation
and such other duties as may, from time to time, be assigned to him or her by
the Board of Directors or the President or as may be provided by law.

  


 

  

Section 4.9. _Other Officers_. The other officers, if any, of the Corporation
shall have such powers and duties in the management of the Corporation as
shall be stated in a resolution of the Board of Directors which is not
inconsistent with these Bylaws and, to the extent not so stated, as generally
pertain to their respective offices, subject to the control of the Board of
Directors. The Board of Directors may require any officer, agent or employee
to give security for the faithful performance of his or her duties.

  


 

  

ARTICLE V

  


 

  

 _Stock_

  


 

  

Section 5.1. _Stock Certificates and Uncertificated Shares_. The shares of
stock in the Corporation shall be represented by certificates, provided that
the Board of Directors may provide by resolution or resolutions that some or
all of any or all classes or series of the Corporation's stock shall be
uncertificated shares. Any such resolution shall not apply to shares
represented by a certificate theretofore issued until such certificate is
surrendered to the

  


 

  


 

  

 

-8-  

  


 

  


 

  

Corporation. Notwithstanding the adoption of such a resolution by the Board of
Directors, every holder of stock represented by certificates, and upon
request, every holder of uncertificated shares, shall be entitled to have a
certificate signed by or in the name of the Corporation by the Chairman or
Vice Chairman of the Board, if any, or the President or a Vice President, and
by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant
Secretary, of the Corporation, representing the number of shares of stock
registered in certificate form owned by such holder. If such certificate is
manually signed by one officer or manually countersigned by a transfer agent
or by a registrar, any other signature on the certificate may be a facsimile.
In case any officer, transfer agent or registrar who has signed or whose
facsimile signature has been placed upon a certificate shall have ceased to be
such officer, transfer agent or registrar before such certificate is issued,
it may be issued by the Corporation with the same effect as if such person
were such officer, transfer agent or registrar at the date of issue.

  


 

  

Except as otherwise expressly provided by law, the rights and obligations of
the holders of uncertificated shares and the rights and obligations of the
holders of certificates representing stock of the same class and series shall
be identical.

  


 

  

Section 5.2. _Lost, Stolen or Destroyed Stock Certificates; Issuance of New
Certificates_. The Corporation may issue a new certificate of stock or
uncertificated shares in the place of any certificate theretofore issued by
it, alleged to have been lost, stolen or destroyed, and the Corporation may
require the owner of the lost, stolen or destroyed certificate, or such
owner's legal representative, to give the Corporation a bond sufficient to
indemnify it against any claim that may be made against it on account of the
alleged loss, theft or destruction of any such certificate or the issuance of
such new certificate or uncertificated shares.

  


 

  

ARTICLE VI

  


 

  

 _Indemnification_

  


 

  

Section 6.1. _Indemnification of Directors and Officers_. The Corporation
shall indemnify and hold harmless, to the fullest extent permitted by the
General Corporation Law of the State of Delaware (the " _DGCL_ ") as it
presently exists or may hereafter be amended, any director or officer of the
Corporation who was or is made or is threatened to be made a party or is
otherwise involved in any action, suit or proceeding, whether civil, criminal,
administrative or investigative (a " _Proceeding_ ") by reason of the fact
that he or she, or a person for whom he or she is the legal representative, is
or was a director or officer of the Corporation or one of its subsidiaries
against all liability and loss suffered and expenses (including attorneys'
fees) reasonably incurred by such person in connection with any such
Proceeding. Notwithstanding the preceding sentence, except as otherwise
provided in Section 6.4, the Corporation shall be required to indemnify a
person in connection with a Proceeding initiated by such person only if the
Proceeding was authorized in the specific case by the Board.

  


 

  

Section 6.2. _Indemnification of Others_. The Corporation shall have the power
to indemnify and hold harmless, to the extent permitted by applicable law as
it presently exists or may hereafter be amended, any employee or agent of the
Corporation who was or is made or is threatened to be made a party or is
otherwise involved in any Proceeding by reason of the fact

  


 

  


 

  

 

-9-  

  


 

  


 

  

that he or she, or a person for whom he or she is the legal representative, is
or was an employee or agent of the Corporation or is or was serving at the
request of the Corporation as a director, officer, employee or agent of
another corporation or of a partnership, joint venture, trust, enterprise or
non-profit entity, including service with respect to employee benefit plans,
against all liability and loss suffered and expenses reasonably incurred by
such person in connection with any such Proceeding.

  


 

  

Section 6.3. _Prepayment of Expenses_. The Corporation shall to the fullest
extent not prohibited by applicable law pay the expenses (including attorneys'
fees) incurred by any officer or director of the Corporation, and may pay the
expenses incurred by any employee or agent of the Corporation, in defending
any Proceeding in advance of its final disposition; _provided_ , _however_ ,
that, to the extent required by law, such payment of expenses in advance of
the final disposition of the Proceeding shall be made only upon receipt of an
undertaking by the person to repay all amounts advanced if it should be
ultimately determined that the person is not entitled to be indemnified under
this Article IX or otherwise.

  


 

  

Section 6.4. _Determination; Claim_. If a claim for indemnification (following
the final disposition of such Proceeding) or advancement of expenses under
this Article VI is not paid in full within 60 days after a written claim
therefor has been received by the Corporation, the claimant may file suit to
recover the unpaid amount of such claim and, if successful in whole or in
part, shall be entitled to be paid the expense of prosecuting such claim to
the fullest extent permitted by law. In any such action the Corporation shall
have the burden of proving that the claimant was not entitled to the requested
indemnification or payment of expenses under applicable law.

  


 

  

Section 6.5. _Non-Exclusivity of Rights_. The rights conferred on any person
by this Article VI shall not be exclusive of any other rights which such
person may have or hereafter acquire under any statute, provision of the
certificate of incorporation or of these Bylaws, agreement, vote of
stockholders or disinterested directors or otherwise.

  


 

  

Section 6.6. _Insurance_. The Corporation may purchase and maintain insurance
on behalf of any person who is or was a director, officer, employee or agent
of the Corporation, or is or was serving at the request of the Corporation as
a director, officer, employee or agent of another corporation, partnership,
joint venture, trust enterprise or non-profit entity against any liability
asserted against him or her and incurred by him or her in any such capacity,
or arising out of his or her status as such, whether or not the Corporation
would have the power to indemnify him or her against such liability under the
provisions of the DGCL.

  


 

  

Section 6.7. _Other Indemnification_. The Corporation's obligation, if any, to
indemnify or advance expenses to any person who was or is serving at its
request as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust, enterprise or non-profit entity shall be
reduced by any amount such person may collect as indemnification or
advancement of expenses from such other corporation, partnership, joint
venture, trust, enterprise or non-profit enterprise.

  


 

  

Section 6.8. _Continuation of Indemnification_. The rights to indemnification
and to prepayment of expenses provided by, or granted pursuant to, this
Article VI shall continue

  


 

  


 

  

 

-10-  

  


 

  


 

  

notwithstanding that the person has ceased to be a director or officer of the
Corporation and shall inure to the benefit of the estate, heirs, executors,
administrators, legatees and distributees of such person.

  


 

  

Section 6.9. _Amendment or Repeal_. Until the date that is six years following
the adoption of these Bylaws, the provisions of this Article VI shall
constitute a contract between the Corporation, on the one hand, and, on the
other hand, each individual who served as a director or officer of the
Corporation before the adoption of these Bylaws, in consideration of such
person's performance of such services, and pursuant to this Article VI the
Corporation intends to be legally bound to each such former director or
officer of the Corporation. With respect to former directors and officers of
the Corporation, the rights conferred under this Article VI are present
contractual rights and such rights are fully vested, and shall be deemed to
have vested fully, immediately upon adoption of these Bylaws. No repeal or
modification of the foregoing provisions of this Article VI shall, until the
date that is six years following the adoption of these Bylaws, adversely
affect any right or protection (a) hereunder of any person in respect of any
act or omission occurring prior to the time of such repeal or modification or
(b) under any agreement providing for indemnification or advancement of
expenses to an officer or director of the Corporation in effect prior to the
time of such repeal or modification.

  


 

  

ARTICLE VII

  


 

  

 _Miscellaneous_

  


 

  

Section 7.1. _Fiscal Year_. The fiscal year of the Corporation shall be
determined by the Board of Directors.

  


 

  

Section 7.2. _S_ _eal_. The Corporation may have a corporate seal which shall
have the name of the Corporation inscribed thereon and shall be in such form
as may be approved from time to time by the Board of Directors. The corporate
seal may be used by causing it or a facsimile thereof to be impressed or
affixed or in any other manner reproduced.

  


 

  

Section 7.3. _Waiver of Notice of Meetings of Stockholders, Directors and
Committees_. Whenever notice is required to be given by law or under any
provision of the certificate of incorporation or these Bylaws, a written
waiver thereof, signed by the person entitled to notice, whether before or
after the time stated therein, shall be deemed equivalent to notice.
Attendance of a person at a meeting shall constitute a waiver of notice of
such meeting, except when the person attends a meeting for the express purpose
of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened. Neither the
business to be transacted at, nor the purpose of, any regular or special
meeting of the stockholders, directors or members of a committee of directors
need be specified in any written waiver of notice unless so required by the
certificate of incorporation or these Bylaws.

  


 

  


 

  

Section 7.4. _Interested Directors; Quorum_. No contract or transaction
between the Corporation and one or more of its directors or officers, or
between the Corporation and any other corporation, partnership, association or
other organization in which one or more of its

  


 

  


 

  

 

-11-  

  


 

  


 

  

directors or officers are directors or officers, or have a financial interest,
shall be void or voidable solely for this reason, or solely because the
director or officer is present at or participates in the meeting of the Board
of Directors or committee thereof which authorizes the contract or
transaction, or solely because his or her or their votes are counted for such
purpose, if: (a) the material facts as to his or her relationship or interest
and as to the contract or transaction are disclosed or are known to the Board
of Directors or the committee, and the Board of Directors or committee in good
faith authorizes the contract or transaction by the affirmative votes of a
majority of the disinterested directors, even though the disinterested
directors be less than a quorum; (b) the material facts as to his or her
relationship or interest and as to the contract or transaction are disclosed
or are known to the stockholders entitled to vote thereon, and the contract or
transaction is specifically approved in good faith by vote of the
stockholders; or (c) the contract or transaction is fair as to the Corporation
as of the time it is authorized, approved or ratified, by the Board of
Directors, a committee thereof or the stockholders. Common or interested
directors may be counted in determining the presence of a quorum at a meeting
of the Board of Directors or of a committee which authorizes the contract or
transaction.

  


 

  

Section 7.5. _Form of Records_. Any records maintained by the Corporation in
the regular course of its business, including its stock ledger, books of
account and minute books, may be kept on, or be in the form of, punch cards,
magnetic tape, photographs, microphotographs or any other information storage
device, provided that the records so kept can be converted into clearly
legible form within a reasonable time. The Corporation shall so convert any
records so kept upon the request of any person entitled to inspect the same.

  


 

  

Section 7.6. _Amendment of Bylaws_. These Bylaws may be amended or repealed,
and new Bylaws adopted, by the Board of Directors, but the stockholders
entitled to vote may adopt additional Bylaws and may amend or repeal any bylaw
whether or not adopted by them.

  


 

    

  

  

  

-12-

      '

